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ABSTRACT 
GENERATION OF DIVERSE MOLECULAR COMPLEXITY  
FROM SIMPLE HYDROCARBONS 
 
 
Anobick Sar, PhD 
 
Marquette University, 2011 
 
 
In an effort to make diverse molecular complexity from simple hydrocarbons, 
tricarbonyl(cyclohexadienyl)iron(+1) cation was prepared in two steps from 1, 3-
cycloxehadiene. Reactivity of the symmetric iron cation with heteroatom nucleophiles 
and stabilized carbon nucleophiles was studied. Nucleophilic attack of potassium 
phthalimide at the dienyl terminus of the cation followed by oxidative decomplexation 
with Ce4+ provided the ligand N-(2,4-cyclohexadiene-1-yl)phthalimide. A series of 
stereochemically diverse polyhydroxyl aminocyclohexane “aminocyclitols” derivatives 
and a number of racemic and optically active hydroxy-and polyhydroxy 1,3-
diaminocyclohexane derivatives have been synthesized from N-(2,4-cyclohexadiene-1-
yl)phthalimide. The relative stereochemistries of the compounds ware assigned on the 
basis of the 1H NMR data as well as X-ray single crystal diffraction analysis. 
In a similar attempt tricabonyl(η5-6-styrylcyclohepta-2,4-diene-1-yl)iron(+1) 
cation was synthesized in three steps from 1, 3, 5, 7-cyclooctatetraene. Reactivity with 
various nucleophiles was studied. Nucleophilic attack of lithium dimethylallyl malonate 
at the less hindered pentadienyl terminus of the cation, decomplexation by Ce4+ followed 
by rearranged ring closing metathesis using 1st generation Grubbs catalyst gave skeletally 
unusual (5E, 7Z, 9Z)-dimethylbicyclo[4.4.1]undeca-5,7,9-triene-2,2-dicarboxylate. 
Reaction of potassium phthalimide with tricabonyl(η5-6-styrylcyclohepta-2,4-
diene-1-yl)iron(+1) cation in a similar fashion, followed by decomplexation with Ce4+ 
gave racemic 2-(1S, 6R)-6-((E)-styryl)cyclohepta-2, 4-diene-1-yl)isoindoline-1, 3-dione. 
Asymmetric dihydroxylation of the iron free ligand with ADmix-β followed by 
cycloaddition with singlet oxygen generated two optically active separable 
diastereomeric endoperoxides, which led to the synthesis of a number of racemic and 
optically active functionalized endoperoxides.  
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Chapter I 
 
 
IA. General Introduction 
Building complex molecularity starting from simple molecules is a continuing 
challenging task in organic synthesis. Many researchers have already made complex 
molecules starting from simple hydrocarbons like benzene (Scheme 2),1-8 
cyclopentadiene, (Scheme 3)9 and cycloheptatriene (Scheme 4).10  These synthetic 
successes have very much relied on the efficient oxidation and/or functionalization of the 
hydrocarbons. The detailed in vivo and in vitro study of oxidation of benzene and 
substituted benzene derivatives by the microorganism Pseudomonas putida unfolded a 
key syn dihydroxylation method (Scheme 1). Over a period of time, many researchers 
have used this syn dihydroxylation method successfully and made diverse complex 
molecules (Scheme 2), such as conduritols, conduramines, sugars, azasugars, 
Amaryllidaceae alkaloids and sesquiterpenes. 
  
 
 
 
Scheme 1. syn Dihydroxylation of benzene derivatives by P. putida. 
2    
Elegant and efficient synthetic strategies helped to make a wide variety of drug 
candidates and natural products from simple chemical building blocks, such as 
cyclopentadiene (Scheme 3) and cycloheptatriene (Scheme 4).  
 
Scheme 2. Partial list of targets prepared by P. putida dihydroxylation of benzene and 
substituted benzene. 
 
 
 
 
3    
 
Scheme 3. Partial list of targets prepared from cyclopentadiene. 
 
 
 
 
 
 
Scheme 4. Partial list of targets prepared from cycloheptatriene. 
The use of 1,3-cyclohexadiene (1) as a diene in [4 + 2] cycloaddition reactions, as 
well as a substrate in 1,4-additions, selective dihydroxylations, or selective epoxidations 
is well known in organic synthesis. Many researchers have used the above protocols to 
prepare diverse molecular complexity (Scheme 5) from 1,3-cyclohexadiene.11 
4    
 
 
 
 
 
 
 
Scheme 5. Partial list of targets prepared from 1,3-cyclohexadiene 1. 
Pioneering work by Birch12 and Pearson13 have demonstrated the utility of the 
[(η5-cyclohexadienyl)Fe(CO)3]+ cation 3 and its ring substituted derivatives in 
stoichiometric organic synthesis. The cation 3 can easily be synthesized from 1,3-
cyclohexadiene (Scheme 6).14  
 
    
   
 
Scheme 6. Synthesis of [(η5-cyclohexadienyl)Fe(CO)3]+ cation 3.  
5    
Very recently the synthesis of antiostatins, carbazoles known for their pharmacological 
potential, was reported by Knolker’s group15 based on the reaction of the cation 3 with 
arylamines 4 (Scheme 7).  
 
Scheme 7. Synthesis of antiosotatins from cation 3.   
Electrophilic substitution of the arylamines 4 by reaction with cation 3 followed 
by series of reactions gave the carbazole 5. Reaction of common precursor 5 in a 
divergent way leads to the synthesis of all antiosotatins.  
 
6    
Recently researchers have used cyclooctatetraene (6), a simple hydrocarbon 
which can be made by the Ni-catalyzed cyclotetramerization of acetylene,16 to make 
complex molecules. Compounds such as aminocyclitols,17a bis-homoconduritols,17b bis-
homoinositol,17c pentacycloanammoxic acid methyl ester,17d the polyene segment of 
roxaticin,17e and cyclooctitols17f (Scheme 8) are made very recently from 
cyclooctatetraene 6. 
 
Scheme 8. Synthesis of cyclooctatetraene and target recently prepared from this 
hydrocarbon.  
Complexation of cyclooctatetraene 6 gives tricarbonyl(cyclooctatetraene)iron 7 
[(COT)Fe(CO)3] (Scheme 9).18 Synthetic applications of 7 by other research groups are 
limited. A σ-alkyl-π-allyl complex 819 forms through rearrangement of 7 on treatment 
with a Lewis acid. Barbaralone 9 can be made on decomplexation of 8 under high 
pressure of CO.  The synthesis of triquinacene-2-carboxylic acid 12, 20 was reported by 
Paquette’s group based on the reaction of 7 with tetracyanoethylene to give bicyclic σ-
7    
alkyl-π-allyl complex 10. Oxidative decomplexation followed by C-C bond formation led 
to tricyclo[5.2.1.04,10]deca-2,5-diene 11. Further manipulation of 11 gave the final 
product 12. 
 
 
 
      
Scheme 9. Preparation of (COT)Fe(CO)3 and previous synthetic applications. 
 
Reported attacks on 7 by a variety of electrophiles are shown in Schemes 10 and 
11.  The neutral compounds, complexed aldehyde 13 or styrylcycloheptatriene complex 
14   were prepared by the Vilsmeyer-Hack formylation of 7 or upon electrophilic attack 
of tropylium cation in presence of pyridine on 7 (Scheme 10). 21a 
 
 
 
8      
 
 
Scheme 10. Reaction of (COT)Fe(CO)3 with electrophiles. 
 
Scheme 11. Reactions of (COT)Fe(CO)3 with electrophiles, generation of cationic 
compounds.  
In contrast, a wide variety of skeletally rearranged cationic complexes (15, 16, 17, 
and 18)21b-f were formed by the attack of other electrophiles on 7 (Scheme 11). 
A mechanistic rationale for the formation of these rearranged structures is given 
in Schemes 12 and 13. The generic addition of an electrophile to a non-coordinated olefin 
9    
of 7 generates a homobutyl cation 20 (Scheme 12). The homobutyl cation 20 rearranges 
into a cyclopropylcarbinyl cation of structure 21. The bicyclo[5.1.0]octadienyl cation 21 
was stable and isolable (i.e. products 15/16) when the electrophile was H+ or p-
nitrophenyl+.21b-d   
 
 
 
 
Scheme 12. generic attack of electrophile on (COT)Fe(CO)3. 
On the other hand, for El+ = acylium ion, the acyl group present at C7 of 21 
makes the adjacent cyclopropane bond weak and a subsequent [1,4]-shift relieves the 
strain to form the bicyclo[3.2.1]octadienyl cation 18 (Scheme 13).21e,f In the case of 
tropylium cation as an electrophile, 21 undergoes a [3,3] Cope rearrangement to 
generates the norcaradiene intermediate 22, which upon deprotonation gives the 
styrylcycloheptatriene complex 14.21a Finally, for cyclopropenyl cation as electrophile, 
20 rearranges to a bicyclo[6.3.0]nonatetraenyl cation 23. The cation 23 transforms into a 
tricyclic cation 17 through an intramolecular bond formation. 
 
 
10    
 
Scheme 13. Proposed mechanism for the generation of the skeletal rearranged products. 
The reactivity of the cationic compounds 15a/b/c & 18b with several nucleophiles 
has been studied by Donaldson et al. In case of 15a/b most of the times exo attack of 
nucleophiles on the terminal carbon was observed. The (±)-cis-2-(2’-
carboxycyclopropyl)glycine, believed to be a common feature for inhibitors of glutamate 
transport,  has been synthesized upon nucleophilic attack of potassium phthalimide on 
cation 15b followed by few more steps (Scheme 14).22 
 
 
11      
 
   
Scheme 14. Synthesis of (±)-cis-2-(2’-carboxycyclopropyl)glycine from 15b.  
The reactivity of 18b with various nucleophiles is given in Scheme 15. Attack of 
the nucleophiles at the η3–allyl fragment gave several diene complexes (Scheme 15). This 
relatively unpredicted reactivity was utilized to synthesize the protected amino acid 
analog 29.23 
 
 
 
 
 
 
 
 
Scheme 15. Reactivity of 18b with various nucleophiles, synthesis of protected amino 
acid analog 29. 
12    
IB. Aminocyclitols 
Polyhydroxylated cyclohexanes are popularly known as cyclitols, and a subclass 
cyclohexanepentols are trivially known as the quercitols (six member carbasugar). These 
classes of compounds are biologically relevant because of their sugar-mimetic structure. 
Aminocyclitols, another subclass of cyclitols, possess important biological activity like 
inhibitory activity against various glycosidases. Aminocyclitols are also present as non- 
sugar (aglycon) units of numerous aminoglycoside antibiotics, e.g., streptomycin and 
fortimycin,24 which possess inhibitory activity against various glycosidases as a single 
structural unit.   Examples of naturally occurring and synthetic aminocyclitols possessing 
various biological activities are given in Scheme 16. 
    
Scheme 16. Partial list of naturally occurring and synthetic aminocyclitols and 
derivatives. 
Naturally occurring polyhydroxyl aminocyclohexanes, such as validamine and 
valiolamine shows inhibitory activity against various glycosidases.25  Similarly, synthetic 
13    
analogues like 3026 and 3127 were found to be inhibitors of α-glucoside and α-
galactosides (IC50 = 12.5 and 20 µM, respectively). 2-Deoxy-scyllo-inosamine 32 is an 
intermediate in the biosynthesis of deoxystreptamine, an aglycon unit of the 
aminoglycosidase antibiotics.28 
IC. Mode of Action of Aminocyclitols as Glycosidase Inhibitors 
The glycosidic bond, shown in Scheme 17, is the mixed acetal linkage between 
two sugar residues. This bond is very stable towards hydrolysis; in particular, the linkage 
between two sugar residues is known to be the most stable within naturally occurring 
biopolymers. The half life for the hydrolysis of glycosidic bond between cellulose and 
starch (β-glucoside) is in the range of 5 million years. 
 
 
 
 
Scheme 17. Glycosidic bond between two sugar residues. 
Glycosidase enzymes catalyze the hydrolysis reaction accelerating the cleavage 
reaction with rate constant up to 1000 s-1 and have the reputation of being among the 
most efficient enzyme catalysts. Several mechanisms have been proposed for the 
hydrolysis of the glycosidic linkage.29 One such mechanism with retention of 
configuration at the anomeric carbon is shown in Scheme 18. 
14    
 
Scheme 18. Mechanism of the hydrolysis of glycosidic bond with retention of 
configuration at anomeric carbon. 
The mechanism for enzymatic glycolysis involves the presence of two carboxylic 
acid residues. In this particular case (retention at the anomeric carbon), the distance 
between the two acid residues is ~ 5.5 Å. In the first step, one of the acid groups 
functions as a general acid catalyst and protonates the glycosidic oxygen with subsequent 
bond cleavage forming the oxonium ion. The oxonium ion may be stabilized by the other 
acid residue by forming a covalent glycosyl–enzyme intermediate. In the final step, the 
water molecule is directed to attack the anomeric center by the carboxylate general base. 
The cleavage of the glycoside bonds is an important biological process. There are 
numerous natural and non-natural sugar mimics having a protonated nitrogen 
functionality under physiological pH which may form tight a ion pair within the active 
site of the acid residues of glycosidase enzymes and subsequently inhibiting the enzyme. 
These inhibitors may be of importance as potential antiviral, antitumor and antidiabetic 
agents. For example, inhibition of intestinal α-glycosidase lowers blood sugar levels and 
as such these inhibitors may be of use for the treatment of diabetes. Additionally, 
15    
inhibition of glycosidase can disrupt the synthesis of oligosaccharides which are involved 
in cell-cell or cell-virus recognition. 
ID. Recent Synthetic Studies of Aminocyclitols           
Several synthesis of aminocyclitols and derivatives have been reported starting 
from quercitols (deoxyinositols),26,27 from inositols via deoxygenation,30 from 
carbohydrates via Ferrier carbocyclic ring-closure,31,32 via 6-exo radical cyclization of 
carbohydrate derived from oximes,33 and from chiral 1,7-octadienes via ring closing 
metathesis.34 
 
 
 
 
 
 
 
 
 
16    
 
Scheme 19. Synthesis of aminocyclitols from (+)-proto-Quercitol. 
Synthesis of 5-amino-1,2,3,4-cyclohexanetetrols 40 and 30, found to be α-
glucosidase inhibitors, from naturally occurring (+)-proto-quercitol 35 was reported by 
Phuwapraisirisan, et al. (Scheme 19).26 The (+)-proto-quercitol 35, isolated from the 
stems of Arfeuillea arborescene was converted into bis-acetonide 36 (Scheme 19). A 
series of functional groups  transformations of common precursor 36 in a divergent way 
leads to the generation of two isomeric 5-amino-1,2,3,4-cyclohexanetetrols (40 and 30). 
17    
Spencer, et al., reported the synthesis of (±)-2-deoxy-scyllo-inosamine (±)-32 
from myo-inositol via deoxygenation (Scheme 20).30 Two of the cis-hydroxyls of myo-
inositol 45 were protected as the acetonide to give 46. Protection of the remaining 
hydroxyls followed by chemo-selective deprotection gave 48. Regioselective tosylation 
of the equatorial hydroxyl of 48 generated the monotosylate 49. The displacement of the 
tosyl group by lithium trimethylborohydride (LTBH) gave deoxygenated product 50. 
Three more standard functional group transformation leads to the generation of 2-deoxy-
scyllo-inosamine (±)-32. 
 
Scheme 20. Synthesis of (±)- 2-deoxy-scyllo-inosamine from myo-inositol. 
18    
Many researchers have also synthesized aminocyclitols using chiral pool 
strategies starting from optically active carbohydrates. The synthesis of orthogonally 
protected 2-deoxystreptamine (2-DOS) from methyl-α-D glucopyranoside was reported 
by Claude Bauder (Scheme 21).32  
 
 Scheme 21. Synthesis of aminocyclitol from methyl-α-D glucopyranoside. 
Methyl α-D glucopyranoside 53 was converted into 54 in four steps following 
literature procedure.32 Ferrier carbocyclic ring-closure31, 32 of 54 gave exclusively a single 
epimeric β-hydroxy-cyclohexanone 55. Treatment of 55 with O-benzylhydroxylamine 
hydrochloride in EtOH-pyr gave benzyloxime 56. Diastereoselective reduction of oxime 
functionality by tetramethylammonium triacetoxyborohydride/TFA gave a derivative of 
2-DOS 57. 
Vankar, et al., reported the synthesis of 5-amino-5-deoxy-D-vibo-quercitol 
starting from commercially available D-mannitol (Scheme 22).34a Reaction of D-mannitol 
derived  aldehyde 58 with allyl magnesium bromide in the presence of zinc gave a 
diastereomeric mixture (81:19 anti : syn) of homoallyl alcohols 59. Tosylation followed 
19    
by treatment with NaN3 gave the corresponding diastereomeric azides 61. 
Reduction/acetylation of the mixture gave a chromatographically separable mixture of 
two diastereomeric acetates 62 and 63. Acetonide deprotection followed by acetate 
formation of the major acetonide 63 gave the dienetriacetate 64 suitable for metathesis. 
Ring-closing metathesis of 64, syn-dihydroxylation and acetate formation gave a 
derivative of 5-amino-5-deoxy-D-vibo-quercitol 66. 
 
  Scheme 22. Synthesis of aminocyclitols from D-mannitol. 
Riera, et al., reported the synthesis of a series of aminocyclitols derivatives 
starting from readily available epoxy alcohol 67 via a ring closing metathesis protocol.34b 
Synthesis of two of the several isomers are shown in Scheme 23. Epoxy alcohol 67 was 
converted to amino alcohol 68 with anti configuration following literature procedure 
20    
(epoxide ring opening, azide reduction, protection).35 Protection followed  by 
chemoselective deprotection gave the alcohol 70. Oxidation of the alcohol 70 followed by 
addition of vinyl magnesium bromide and acetate formation gave a chromatographically 
separable mixture of cis-anti-71 and cis-syn-72. Ring closing metathesis of both 71 and 
72 using first generation Grubbs catalyst gave 73 and 74 respectively. Catalytic syn 
dihydroxylation of 73 or 74 followed by acetate formation gave two isomeric 
aminocyclitols derivatives 75 or 76 respectively. 
 
Scheme 23. Synthesis of aminocyclitols from epoxy alcohol. 
1E. 1,3-Diaminocyclohexanes 
Just like aminocyclohexanes, trihydroxy-1,3-diaminocyclohexanes and their 
derivatives are important biological entities. Examples of biologically relevant 1,3-
diaminocyclohexanes derivatives are given in Scheme 24. Compound 7736 is present as 
21    
an  important structural unit in kanamycin A 78 (an aminoglucoside antibiotic which 
binds to bacterial 16S ribosomal RNA). While the relative orientation of the two amino 
functionalities in the 1,3 positions in majority of the aminoglucoside antibiotics is cis, 
some synthetic analogue like 79, 8037 and 81 possess a trans-1,3-diaminocyclohexane 
subunit. Compound 7938 is a sugar mimic and 81 was utilized as an intermediate in the 
synthesis of CC chemokine receptor 2 antagonists.39 
 
Scheme 24. Partial list of biologically relevant 1,3-diaminocyclohexanes. 
1F. Recent Synthetic Studies of 1,3-diaminocyclohexanes 
Synthesis of  (±)-79 was reported by Landais, et al., from commercially available 
tropylium fluoroborate 82 (Scheme 25).38 Silylcycloheptatriene 83 was synthesized from 
tropylium fluoroborate using trimethylsilyl methyl-magnesium chloride as nucleophile. 
Cycloaddition of 83 with an acyl-nitroso reagent gave a separable mixture of 84 and 85. 
Catalytic dihydroxylation of 84 followed by N-O bond reduction of 86 by SmI2 gave (±)-
79.   
22    
 
Scheme 25. Synthesis of sugar mimic (±)-79 from tropylium fruoroborate. 
The synthesis of a derivative of 77 has been reported by Xin-Shan Ye, et al. 
(Scheme 26).37 The iodo precursor 87 was synthesized from methyl-α-D glucopyranoside 
53 following the literature procedure. Reaction of 87 with allylbromide and sodium 
hydride gave the allyl protected exo-alkene 88. Ferrier II rearrangement of 88 gave the 
hydroxyl ketone 89. Reduction of 89 by NaBH4 gave exclusively 90. Benzylation, 
deprotection of allyl ether and reprotection followed by nucleophilic displacement of the 
axial benzoates by azide anion gave the final compound 93. 
 
 
 
 
23    
 
Scheme 26. Synthesis if 1,3-diaminocyclohexane derivative from sugar. 
1G. Ring-expanded Homologs of Aminocyclitols   
 Nature has always favored five- and six-membered ring monosaccharides as 
essential structural motifs over the ring-expanded homologues. Similarly, synthetic 
chemists are also interested in making five- and six-membered carbasugars, because of 
their sugar-mimetic structure, leaving preparation of the higher carbocycles largely 
untouched. Very recently Casiraghi, et al., 40and Landais, et al.,41have reported the 
synthesis of 7-membered carbocycles, shown in Scheme 27.  
 
   
 
 
 
24      
  
 
 
 
Scheme 27. Partial list of recently synthesized seven-membered carbasugars. 
 
 
 
 
 
 
 
 
 
 
Scheme 28. Synthesis of 97 from commercially available tropylium fluoroborate. 
25    
Commercially available tropylium fluoroborate 82 was converted into 
silylcycloheptatriene 98 using a bis-silyl zinc reagent (Scheme 28). Sharpless 
dihydroxylation followed by acetylation gave 100. Cycloaddition of 100 with an acyl-
nitroso reagent generated three isomeric compounds 101, 102 and 103. The major acyl-
nitroso adduct 101 was transformed into the final product 97 following several standard 
functional groups manipulations. 
Lewis acid catalyzed intermolecular aldol condensation between aldehyde 109 
(readily available from (+)-tartrate) and pyrrole derivative 110 furnished the unsaturated 
lactam 111 as a single diastereomer (Scheme 29). Chemoselective reduction of the 
carbon-carbon double bond followed by protection of hydroxyl group gave 112. 
Exchange of the N-protecting group, selective deprotection and Swern oxidation gave the 
aldehyde 114. The silylative intramolecular aldol condensation of 114 gave compound 
115 as a single diastereoisomer. Again, exchange of N-protecting group followed by 
reductive cleavage of the amide bond and acid hydrolysis leads to the isolation of 94.  
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Scheme 29. Synthesis of 94 from (+)-tartrate.  
As part of our long term interest in the generation of molecular complexity from 
simple hydrocarbons, we have synthesized a series of racemic polyhydroxyl 
aminocyclohexane derivatives, a number of racemic and optically active trans-1,3-
diaminocyclohexane derivatives and some of their amine salts from commercially 
available  1,3 cyclohexadiene. In a similar attempt, a number of racemic and optically 
active functionalized endoperoxides were prepered from readily available 
cyclooctatetraene.    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Chapter II 
Polyhydroxyl Aminocyclohexanes 
 
 
II A. Synthesis of Aminocyclitols from Cyclohexadiene 
In an effort to synthesis stereochemically diverse 
polyhydroxylaminocyclohexanes like 30 or its isomeric derivatives, the iron cation 3 was 
prepared from 1,3-cyclohexadiene 1 following literature procedure (Scheme 6).14 
Nucleophilic attack of potassium phthalimide (KNPhth) at the dienyl terminus of the 
symmetric cation 3 gave (±)-117. Oxidative decomplexation of (±)-117 with 
CAN/MeOH gave the iron free ligand (±)-118 (Scheme 30). 
  
Scheme 30. Synthesis of iron free ligand (±)-118 from the cation 3. 
The structure of the η4-bonded iron complex (±)-117 was assigned based on its 1H 
and 13C NMR spectral data. Signals at δ 2.77, 3.13, 5.53, and 5.67 ppm in its 1H NMR 
spectrum and at δ 57.1, 58.2, 86.0, 86.7 in its 13C NMR spectrum are consistent with the 
η4-attachment of the iron with the diene portion of the ligand.42 Assignment of the 
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diastereotopic methylene protons 6-Hα (δ 2.00, br d, J = 15.1 Hz) and 6-Hβ (δ 2.31, ddd, J 
= 4.2, 11.4 and 15.1 Hz) was based on the magnitude of their geminal coupling and 
splitting pattern. 
The structure of (±)-118 was similarly assigned on the basis of its NMR spectral 
data. Signals at δ 2.38 ppm (ddd, J = 5.6, 10.0 and 17.2 Hz, 6-H), 2.78 ppm (tdd, J = 3.1, 
15.2, 17.6, 6-H’) and 5.20 (tdd, J = 2.9, 9.6, 15.2 1H) in the 1H NMR spectrum and at δ 
27.0 and 47.9 ppm in its 13C NMR spectrum corresponded to the two sp3 hybridized 
carbons and their attached hydrogens.  
Cycloaddition of (±)-118 with singlet oxygen gave a separable mixture of 
endoperoxides (±)-119 and (±)-120 (Scheme 31) (Fig. 1 and 2).  
 
 
 
      
 
Scheme 31.  Synthesis of isomeric endoperoxides (±)-119 and (±)-120. 
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The major product comes from approach of singlet oxygen on the face opposite to 
the phthalimide substituent. This facial selectivity was similar to that previously reported 
for cycloaddition of nitrosobenzene with 3-methyl-5-phenyl-1,3-cyclohexadiene.43 The 
structural assignments of the two endoperoxides were based on their 1H NMR spectral 
data. The assignment of the two diastereotopic methylene protons of (±)-119, H3’ (δ 2.42, 
ddd, J = 2.0, 4.4, 13.6 Hz) and H3 (δ 2.80, ddd, J = 4.0, 9.6, 13.6) were based on the 
magnitude of their coupling with H2. Two diastereotopic protons of (±)-120, H3’ (δ 3.64, 
td, J = 4.2, 13.8 Hz) and H3 (δ 1.88, ddd, J = 1.9, 11.8, 13.8 Hz) was assigned on the 
same basis. The upfield shift for H3’ for (±)-119 compared to H3’ for (±)-120 and H3 for 
(±)-120 compared to H3 of (±)-119 were due to the anisotropic effect of the olefin 
functionality. The structural assignments were finally confirmed from single crystal X-
ray  diffraction analysis (Fig. 1 and Fig. 2). 
 
 
 
 
 
 
Figure 1. X-ray crystal structure of (±)-119. 
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Figure 2. X-ray crystal structure of (±)-120.  
The major endoperoxide (±)-119 was reduced to diol (±)-121 using thiourea-
methanol. In a similar fashion (±)-120 was reduced to (±)-122 (Scheme 32).  
 
 
 
 
 
 
 
Scheme 32. Thiourea/methanol reduction of (±)-119 and (±)-120. 
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The structural characterization of each was based on their 1H NMR spectral data. 
For (±)-121, the signal at δ 5.92 (m, 2H) indicates that the olefinic double bond was 
intact after the thiourea reduction. The relative trans-orientation of two substituents at C-
1/C-5 was assigned on the basis of the coupling patterns as well as the magnitude of the 
couplings of the two diastereotopic methylene protons H-6eq (δ 1.97 ppm,  br d, J = 14.0 
Hz) and  6-Hax (δ 2.82 ppm, dt, J = 4.8 and 13.6 Hz). Similarly, the trans-orientation of 
substituents at C-1/C-2 was confirmed from the magnitude of the coupling between 1-Hax 
(4.58, ddd, J = 3.2, 10.0 and 13.6 Hz) and 2-Hax (4.84, br d, J = 9.2 Hz). 
The structure of (±)-122 was assigned based on its 1H NMR spectral data. The 
splitting pattern and the magnitude of the coupling of the two-diastereotopic methylene 
protons 6-Hax (δ 2.85 ppm, ddd, J = 10.8, 12.8 and 14.4 Hz) and 6-Heq (δ 2.21 ppm, br d, 
J = 12.8 Hz) indicate that the substituents at C-1/C-5 are cis to each other. In particular, 
three large couplings for the 6-Hax were due to two diaxial vicinal coupling of 6-Hax with 
5-Hax and 1-Hax and a geminal coupling with 6-Heq. Signals around δ 5.96-5.97 (m, 2H) 
were assigned to the CH=CH functionality. 
Catalytic hydrogenation of enediols (±)-121 and (±)-122 gave the corresponding 
saturated N-(dihydroxycyclohexyl)phthalimides  (±)-123 and (±)-124 (Scheme 33). The 
structures were assigned based on the the structures of their precursors. Their 1H NMR 
spectral data were consistent with these assignments. The saturated diol (±)-123 was 
converted to its amine salt (±)-125.   
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Scheme 33. Catalytic hydrogenation of (±)-121 and (±)-122. 
A brief exposure (30 min) of (±)-118 to OsO4/NMO (Scheme 34) gave a diol (±)-
126. Acetylation of the diol (±)-126 using acetic anhydride/pyridine gave the 
corresponding diacetate (±)-127. The structure of the diacetate was assigned based on the 
single crystal X-ray diffraction analysis (Fig. 3), which consequently corroborated the 
structural assignment of (±)-126. Dihydroxylation of (±)-118 occurs more rapidly at the 
olefin remote to the electron withdrawing phthalimide substituent. 
    
 
 
 
 
 
 
 
Scheme 34. Dihydroxylation of (±)-118 and related reactions. 
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Catalytic hydrogenation of (±)-126 gave a saturated diol (±)-128, whose structure was 
assigned based on the structure of its precursor. The saturated diol (±)-128 was converted 
to its amine salt (±)-129.   
 
 
 
 
 
 
 
Figure 3. X-ray crystal structure of (±)-127. 
Catalytic dihydroxylation of enediols  (±)-121, (±)-122 and (±)-126  with OsO4/ 
NMO is shown in Scheme 35. 
 
 
 
 
 
 
 
 
Scheme 35. Dihydroxylation of  (±)-121, (±)-122 and (±)-126. 
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The structures of the tetraols  (±)-130 and (±)-131  were assigned based on their 
1H NMR spectral data. For (±)-130, the assignment of  the C-1 phthalimide and the C-5 
hydroxyl as trans  is based on the appearance of the H-6ax signal and magnitude of its 
coupling (dt, J = 2.8, 13.2 Hz). The one smaller coupling is due to an axial-equatorial 
disposition of H-6ax and H-5eq. The trans relationship between the hydroxyls at C-2 and 
C-3 was evidenced by the large coupling between the H-2ax and H-3ax protons (J = 9.6 
Hz). For (±)-131, the cis relationship of the C-1 phthalimide and C-5 hydroxyl was based 
on the appearance of the H-6ax signal and magnitude of its couplings (q, J = 12.4 Hz). 
These three large couplings are due to the axial-axial couplings to H-1 and H-5 and the 
geminal coupling to H-6eq. The trans-diequatorial relationship of the C-4 and C-5 
hydroxyls was evidenced by the axial-axial coupling between H-4ax and H-5ax (J = 9.8 
Hz). These structural assignments were consistent with the syn-dihydroxylation and the 
selectivity noted by Kishi, et al.,44 On the other hand, the structure of   (±)-132 was 
assigned based on the single crystal X-ray diffraction analysis (Fig. 4), which indicated 
that the C-1 phthalimide and the  C-2 and C-5 hydroxyl are equatorial and C-3 and C-5 
hydroxyls are axial. Tetraol  (±)-130 was shown to be diastereomeric with  (±)-132 by 
NMR spectroscopy. For diol (±)-126, dihydroxylation occurs on the face opposite to 
phthalimide substituent. It has been noticed that the directing influence of the phthalimide 
group towards hydroxylation   was greater than the C-4 hydroxyl group.  
Due to the low yield for dihydroxylation of (±)-126, the diacetate (±)-127 was 
converted into tetraacetate (±)-134 (Eq. 1).  Compound (±)-134 was shown to be the 
tetraacetate of (±)-132 by NMR spectroscopy. 
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Figure 4. X-ray crystal structure of (±)-132. 
 
Treatment of endiols (±)-121, (±)-122 and (±)-126 with mCPBA gave 
corresponding epoxides (±)-135, (±)-136 and (±)-137 (Scheme 36). 
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Scheme 36. Epoxidation of (±)-121, (±)-122 and (±)-126. 
The structure of epoxides (±)-135 and (±)-137 were assigned based on their single 
crystal X-ray diffraction analysis (Fig. 5 and Fig. 6). In both the crystsl structures, the 
cyclohexane ring is in the half chair form and the phthalimide group is pseudo 
equatorially oriented. Structure of (±)-136 was assigned based on the comparison of its 
1H NMR spectrum with that of isomeric (±)-135. In all of these cases, epoxidation occurs 
on the same face of the olefin as the adjacent hydroxyl groups. The facial selectivity of 
epoxidation could be explained on the basis of hydrogen bonded association between the 
hydroxyl group of the endiol and the carbonyl group of the m-chloroperbenzoic acid 
(Scheme 37).45 The relative low yield (15%) of (±)-136 could be potentially explained on 
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the basis of the steric hindrances due to the syn orientation of all the substituents, 
including the epoxide ring. 
 
 
 
 
 
 
 
 
Scheme 37. Rational for the facial selectivity of epoxidation. 
 
 
 
 
 
 
 
 
 
Figure 5. X-ray crystal structure of (±)-135. 
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Figure 6. X-ray crystal structure of (±)-137. 
 
Hydrolysis followed by acetylation of epoxides (±)-135 and (±)-137 required 
using different acid conditions for the hydrolysis steps as is shown in Scheme 38. 
Epoxide (±)-137 gave a single tetraacetate (±)-138. On the contrary, epoxide (±)-135 
gave a mixture of two tetraacetates (±)-139 and (±)-140 (ca. 2:1 ratio by 1H NMR 
integration). Slow recrystallization of the mixture (139 and 140) from ethyl acetate 
generated two distinct crystalline forms of the two tetraacetates, which allowed them to 
be separated by tweezers. 
 
Scheme 38. Hydrolysis of epoxide (±)-137 and (±)-135.  
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The structures of tetraacetates (±)-139 and (±)-140 were assigned based on their 
single crystal X-ray diffraction analysis (Fig. 7 and Fig. 8). The structure of (±)-138 was 
assigned based on its 1H NMR spectral data. For (±)-138, the trans relationship between 
the C-1 phthalimide and C-5 acetoxy group was assigned on the appearance and the 
coupling magnitude of H-6ax (br t, J = 11.0 Hz). The two large couplings are due to the 
vicinal coupling to H-1ax and geminal coupling to H-6eq. The absence of the third large 
coupling is consistent with H-5 being equatorial (i.e. a small ax-eq coupling). 
Furthermore the appearance of H-1 (ddd, J = 3.3, 4.5, 11.1 Hz) indicates that the C-2 
hydroxyl is axial/H-2 equatorial. The two smaller coupling are due to H-1ax/H-6eq and H-
1ax/H-2eq. As anticipated, products 138 arise by a diaxial ring opening of the epoxide 
ring. On the contrary, the ring opening of epoxide (±)-135 (Scheme 39), could be 
rationalized by considering two active conformers of (±)-135. Product (±)-139 (the major 
tetraacetate) could arise either by the diaxial ring opening (path b) of the epoxide from 
conformer (±)-135x, via a twist boat-like transition state (±)-135x’ or by diaxial ring 
opening of epoxide from conformer (±)-135y, via a chair-like transition state (±)-135y’ 
followed by a chair-chair inversion. The rational for the formation of the minor 
tetraacetate (±)-140 is also given in Scheme 39. 
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Scheme 39. Rational for epoxide hydrolysis. 
 
 
 
 
 
 
 
 
 
Figure 7.  X-ray crystal structure of (±)-140. 
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Figure 8. X-ray crystal structure of (±)-139. 
 
Reaction of the major endoperoxide (±)-119 with diazabicyclo[5.4.0]undecene 
(DBU) (Kornblum-DeLaMare rearrangement)46 (Eq. 2) gave a mixture of (±)-142, (±)-
143 and (±)-144.  Purification by column chromatography gave (±)-142 as a pure 
compound and (±)-143 and (±)-144 as an inseparable mixture. The major cyclohexenone 
(±)-142 arises due to the deprotonation of the sterically less hindered proton of (±)-119 
by DBU (pathway a). The structure of (±)-142 was assigned by the comparison of its 
NMR spectral data with that of 5-azido-4-(triisopropylsolyloxy)-2-cyclohexene-1-one 
(145).47 In particular, signals for (±)-142 at δ 6.11 (d) and 7.02 (dd) ppm in the 1H NMR 
spectrum and δ 129.6 and 152.3 ppm in the 13C NMR spectrum are a close match for the 
corresponding olefinic protons and carbons of 145 which appear at δ 6.01 (d), 6.84 (dd), 
129.1 and 150.5 ppm respectively.  The two diastereotopic methylene protons 6-Hα (δ 
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2.67 ppm, dd, J = 4.8 and 16.4 Hz) and 6-Hβ (δ 3.43 ppm, dd, J = 13.6 and 16.4 Hz) 
were assigned based on the magnitude of their geminal coupling. 
 
 
 
 
 
 
 
 
 
 
 
The structures of the other two cyclohexenones were also assigned based on their 
1H NMR spectral data. The magnitude of the coupling of  H-6β (δ 2.81, td, J = 11.4, 14.4 
Hz) in (±)-143 indicates that the substituents at C-1/C-5 are cis. On the other hand, the 
presence of only a single large coupling (J = 13.2 Hz) for H-6β (δ 2.26) in (±)-144 
indicates that the C-1/C-5 substituents   are trans. The stereoisomer (±)-143 presumably 
is the result of base catalyzed epimerization of the proton α to the carbonyl of (±)-144; 
the diequatorial stereoisomer (±)-143 being more stable than the axial-equatorial 
stereoisomer (±)-144. 
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Reduction of (±)-142 under Luche conditions (NaBH4/CeCl3) 48 gave a single diol 
(±)-146 (Eq. 3). The structure of the (±)-146 was assigned based on its 1H NMR spectral 
data. In particular, the signal for the 6-Hax (δ 2.46 ppm, ddd,  J =  10.0, 12.0, 13.2 Hz) 
was a doublet of doublet of doublets. These three large couplings are due to the diaxial 
relative orientations of 6-Hax with respect to 1-H and 5-H as well as the geminal coupling 
to 6-Heq. This also confirms that the substituents at C-1 and C-5 are cis to each other. 
 
 
 
 
 
 
The double bond of the diol (±)-146 was reduced catalytically using H2-Pd/C 
(Scheme 38) to afford (±)-147; the structure was assigned based on the structure of its 
precursor. The catalytic dihydroxylation of (±)-146 with OsO4 and NMO followed by 
acetylation with acetic anhydride/pyridine (Scheme 40) gave an equimolar mixture of 
two tetraacetates (±)-148 and (±)-149.44 The structures of these two tetraacetates were 
assigned based on the 1H NMR spectral data of the mixture. In particular, the 6-Hax 
signals of each evidences three large couplings. Fortuitously, the structural assignment of 
(±)-149 was confirmed from single crystal X-ray diffraction analysis of a crystal selected 
from a recrystallization of the mixture (Fig. 9).  
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Scheme 40. Catalytic hydrogenation/hydroxylation of (±)-146. 
 
 
 
 
 
 
 
 
Figure 9. X-ray crystal structure of (±)-149. 
Treatment of the major endoperoxide (±)-119 with Grubbs 2nd generation 
catalyst49 in absence of any external olefin led to the fragmentation of the endoperoxide 
into a mixture of 150, 151, (±)-152 and (±)-153 (Scheme 41). Chromatographic 
separation of the mixture gave 151, (±)-152 and (±)-153 as pure fractions.  The structure 
of 150 was assigned based on comparison of  the 1H NMR spectral data of the crude to 
the literature data.50 N-vinylphthalimide 151 was identified by comparison of its literature 
mp and 1H NMR spectral data with literature values.51 The structure of (±)-153 was 
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assigned based on its 1H NMR spectral data. In particular, the four relatively narrow one-
proton signals at δ 3.26, 3.30, 3.54-3.56 and 3.58-3.60 ppm corresponds to the four 
epoxide methine protons; these signals are similar to those of other cyclohexene 
diepoxides.52 The structural assignment of the oxetane (±)-152 was also based on its 1H 
NMR spectral data. In particular, signals at δ 10.15 (d, J  = 7.2 Hz), 6.88 (ddd, 0.8, 6.8, 
and 11.5) and 6.07 (dd, J = 7.2 and 11.6 Hz) were indicative of the presence of the 3-oxo-
1-Z-butenyl sidechain. The signals at 6.33 (q, J = 7.2 Hz) and 6.40 (ddd, J = 1.2, 5.0, and 
8.3 Hz) correspond to 3-H and 1-H, and are similar to those of a 2,4-trans substituted 
oxetone ring.53 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 41. Reaction of (±)-119 with Grubbs 2nd generation catalyst.  
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The hydrolysis of the bisepoxide (±)-153 in an unusual fashion on column   (SiO2-
H2O/EtOAc) gave the epoxydiol (±)-154. The structure was assigned based on its single 
crystal X-ray diffraction analysis (Fig. 10).  The 1H NMR spectral data of (±)-154 were 
consistent with the structure. Further hydrolysis of (±)-154 using H2O-H2SO4 gave a 
single tetraol (±)-131. The structure (±)-131 was identified by comparison of its spectral 
data with the sample prepared by dihydroxylation of (±)-122. 
  
 
 
 
 
Figure 10. X-ray crystal structure of (±)-154. 
The transition metal-mediated fragmentation of 1,4-epiperoxides (endoperoxides), 
including the use of Ru(II) reagents, has been reported.54 An inner-sphere radical 
mechanism can be proposed to explain the formation of the products. Coordination of 
coordinatively unsaturated Ru(II) with the sterically less hindered oxygen of the 
endoperoxide (±)-119 followed by a single electron exchange leads to the breaking of 
weak O-O bond and generating an oxyradical 156. Interaction of oxyradical with the 
internal double bond gave the bisepoxide (±)-153. Alternatively, the oxyradical 
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rearranges into a more stable nitrogen stabilized radical species 157 through a homolytic 
C-C bond breaking. Reaction of the carbon radical at oxygen gave the oxetane (±)-152 
and further homolytic C-C bond cleavage of 157 gave 150 and 151. A similar 
mechanistic explanation was reported for the formation of β-lactones from the keto 
endoperoxide of phenol.55 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 42. Proposed mechanistic explanation for the formation of four different 
products upon treatment of (±)-119 with Grubbs 2nd generation catalyst.  
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In conclusion, we were able to synthesize a number of stereochemically diverse 
polyhydroxyl aminocyclohexanes derivatives and some of their amine salts from a single 
precursor (±)-118. 
II B. Synthesis of trans-1,3-Diaminocyclohexanes from Cyclohexadiene 
In an attempt to synthesis structurally diverse 1,3-diaminocyclohexane, the 
cycloaddition  reaction of  (±)-118 with nitrosobenzene  was studied (Eq. 4).56    
 
 
 
 
 
The cycloaddition was regio as well as diastereoselective and gave a single isomer 
8-aza-7-oxabicyclo[2.2.2]oct-5-ene (±)-158. The structure of (±)-158 was assigned based 
on its 1H NMR spectral data. The assignment of the two diastereotopic methylene protons 
[H3 (δ 2.81) and H3’ (δ 2.59)] was done based on the magnitude of their vicinal coupling 
with H2, the syn-coupling 9.6 Hz (ca. 00 dihedral angle) is larger than the anti-coupling 
3.6 Hz (ca. 1200 dihedral angle). The upfield shift of H3’ (δ 2.59) compared to that of H3 
(δ 2.81) was due to the anisotopic effect of the olefin functionality on H3’. The 
assignment was confirmed from its single crystal X-ray diffraction analysis (Fig. 11). 
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Figure 11. X-ray crystal structure of (±)-158. 
To achieve the goal of synthesizing stereochemically diverse 1,3-
diaminocyclohexanes, several reactions were studied with the nitroso adduct (±)-158, the 
results are shown in Scheme 43.  
 
 
 
 
 
 
 
 
Scheme 43. Reactions of nitroso adduct (±)-158. 
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The N-O bond of (±)-158 was selectively reduced by heating at reflux with 
Mo(CO)6 in CH3CN for one hour (Scheme 43).57 The structure of (±)-159 was assigned 
based on its 1H NMR spectral data. In particular, signals at δ 4.39 and δ 4.84 (downfield 
compare to its precursor) are consistent with the N-O bond cleavage. This structural 
assignment was further confirmed by derivatization. Catalytic dihydroxylation of the 
olefin (±)-159 by OsO4/N-methylmorpholine N-oxide gave the triol (±)-160. 
Dihydroxylation occurred on the face of the olefin opposite to the C-2 hydroxyl. The 
anti- orientation of C-2 and C-3 hydroxyl groups was confirmed based on the magnitude 
of the coupling (J = 9.6 Hz) between 2-Hax and 3-Hax. 
The olefinic double bond and the N-O bond of (±)-158 were catalytically reduced 
in a single step by H2/Raney-Ni (Scheme 43). The structure of (±)-161 was assigned 
based on its 1H NMR spectral data and subsequently confirmed from its single crystal X-
ray diffraction analysis (Fig. 12). 
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Figure 12. X-ray crystal structure of (±)-161. 
Catalytic dihydroxylation of (±)-158 by OsO4 in presence of N-methylmorpholine 
N-oxide gave a single diol (±)-163 (Scheme 43). The dihydroxylation was anticipated to 
occur on the face of the olefin opposite to the sterically bulky phthalimide group. This 
relative stereochemistry was further confirmed by derivatization of (±)-163. The N-O 
bond of (±)-163 was successfully cleaved using H2 (40 psi)/Raney-Ni. The relative 
stereochemistry of (±)-164 was assigned based on its 1H NMR spectral data, which also 
confirmed the structural assignment of (±)-163. The different splitting pattern and the 
magnitude of coupling of the two diastereotopic methylene protons 6-Hax (dt, J = 3.2, 
13.2 Hz) and 6-Heq (td, J = 3.8, 13.2 Hz) indicates that the C-1 phthalimide and C-5 
phenylamino substituents are trans. The small coupling between 2-Hax (δ 4.34, dd, J = 
2.6, 10.8 Hz) and 3-Heq (δ 4.21, t, J = 2.6 Hz) is consistent with an axial-equatorial 
relationship between these two protons and thus indicates that the C-2 and C-3 hydroxyl 
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groups are cis to each other. Compounds (±)-161 and (±)-164 were converted to their 
respective amine salts (±)-162 and (±)-165 by treatment by 6N HCl. 
To explore the preparation of optically active 1,3-diaminocyclohexanes, the 
cycloaddition reaction of (±)-118 with chiral acylnitroso compounds were studied 
(Scheme 44).58 
 
 
 
 
 
 
 
 
Scheme 44. Cycloaddition of (±)-118 with acylnitroso compounds. 
Racemic and optically active mandelohydroxamic acid, (±)-166 and (-)-R-166 
was prepared from corresponding racemic and optically active methyl mandelate 
following literature procedure.58 In the case of racemic mandelohydroxamic acid (±)-166, 
cycloaddition of the in situ generated acylnitroso intermediate with (±)-118 gave a 
chromatographically inseparable mixture of diastereomers  (±)-167, (±)-168 and (±)-169 
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(ca. 5:3:2 from 1H NMR integration). Fractional crystallization from CH3CN gave (±)-
167 as a pure compound (25%, isolated yield). The structural assignment of (±)-167 was 
based on its 1H NMR spectral data and was confirmed by single crystal X-ray diffraction 
analysis (Fig. 13). Similarly, structural assignments for (±)-168 and (±)-169 were based 
on the 1H NMR spectral data of the mixture. The upfield chemical shift of H2 of (±)-168 
(δ 4.36 ppm), relative to that of H2 of (±)-167 or (±)-169 (δ 4.81 or 4.68 ppm 
respectively) was due to the anisotopic effect of the olefin functionality. 
  
 
 
 
 
Figure 13. X-ray crystal structure of (±)-168. 
In a similar fashion optically active mandelohydroxamic acid (-)-166 gave a 
chromatographically inseparable optically active mixture of diastereomeric (+)-167, 168 
and 169 (ca.5:3:2 from 1H NMR integration). Pure (+)-167 (11%, isolated yield) was 
isolated by fractional crystallization from CH3CN and as expected the 1H and 13C NMR 
spectral data of (+)-167 was identical with the racemic compound (±)-167.  
In an effort to purify more isomers, the mixture of racemic compounds (±)-167, 
(±)-168 and (±)-169 was acetylated using acetic anhydride and pyridine (Eq. 5). Pure (±)-
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168* (19%, isolated yield) was separated by preparative TLC from the mixture of (±)-
167*, (±)-168* and (±)-169*. The chemical shifts for the signals of the 8-aza-7-oxo-
bicyclo[2.2.2]octane core of acetates (±)-167* and (±)-169* were relatively similar to 
those for the alcohols (±)-167 and (±)-169. 
 
 
 
 
 
 
The diastereoselectivity for the cycloaddition (Scheme 44) could be rationalized 
on the basis of the energy of the transition states leading to the products. It has been 
proposed that the six-membered cyclic hydrogen bonded conformer of the nitrosoacyl 
dienophile derived from the mandelohydroxamic acid is the active form of the dienophile 
in the cycloaddition reaction with the diene.58a Keeping this proposal in consideration, 
different transition states can be drawn (Scheme 45). In TS 1, i.e. the approach of (R)-
nitroso dienophile on the exo-face of the (R)-118 does not have any major steric 
repulsion, leading to the major product 167. On the other hand, approach of (R)-nitroso 
dienophile on the endo-face of the (R)-118 (TS 2) has major steric repulsion between 4-H 
and the phenyl substituent and nitroso oxygen and the phthalimide substituent leading to 
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no cycloaddition. In comparison, approach of (R)-nitroso dienophile on the exo-face of 
the (S)-118 (TS 3) and endo-face of (S)-118 (TS 4) has minor steric repulsion or equally 
matched in energy leading to the products 168 and 169 respectively. 
 
 
 
 
 
 
Scheme 45.  Proposed transition state explanation for the selectivity of cycloaddition of 
acylnitroso reagents with (±)-118.  
The “N-O” bond of the racemic (±)-167 and optically active (+)-167 was reduced 
using titanocene (III) chloride (Scheme 46).59 The structures of the products (±)-170 and 
(-)-170 were assigned based on the comparison of their 1H NMR spectral data with that 
of previously prepared (±)-159. The “C=C” bonds of the (±)-170 and (-)-170 was 
catalytically reduced by H2-Pd/C. The structures of (±)-171 and (-)-171 were assigned 
based on the comparison of their 1H NMR spectral data with that of their precursors. 
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Scheme 46. Selective reduction of “N-O” bond of (±)-167 and (-)-167. 
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Chapter III 
 
III A. Synthesis of Tricarbonyl(η5-6-styrylcyclohepta-2,4-dien-1-yl)iron(+1) from 
Cyclooctatetraene and its Reactivity study 
The synthesis of tricarbonyl(η5-6-styrylcyclohepta-2,4-dien-1-yl)iron(+1) 
tetrafluoroborate (±)-172 from cyclooctatetraene (6) was first reported by Woodward, et 
al., in 1984.60 Despite the structural diversity represented by this transformation an 
examination of  the reactivity of (±)-14 and its application in organic synthesis is not 
known. To study the reactivity of tricarbonyl(η5-6-styrylcyclohepta-2,4-dien-1-
yl)iron(+1) cation, it was synthesized in three steps from cyclooctatetraene following the 
literature procedure. (Scheme 47).18,60 
 
Scheme 47. Synthesis of cation (±)-172 from cyclooctatetraene 6. 
58      The complexation of cyclooctatetraene with iron(pentacarbonyl) (Scheme 47) in 
the presence of trimethylamine N-oxide gave 7.  Compound 7 was characterized based on 
its 1H and 13C NMR spectral data. A single peak at 5.25 ppm in 1H NMR and two peaks 
at 212.5 and 100.1 ppm in 13C NMR indicated the fluxional nature of 7 on the  NMR time 
scale at ambient temperature and was consistent with the literature.61 
 Compound (±)-14 was prepared by the reaction of 
tricarbonyl(cyclooctatetraene)iron 7 with tropylium tetrafluoroborate in the presence of 
pyridine following literature procedure.60 A slight modification in the literature procedure 
using one equivalent of pyridine and repeated extraction of the reaction mixture resulted 
in an improvement from 41% to 75% yield. The structure was assigned based on 
comparison of its 1H and 13C NMR spectral data with the literature60 values. 
  Protonation of the 14 by fluoroboric acid followed by precipitation from co-
solvent ether gave the cation (±)-172. The cation was characterized by the comparison of 
its 1H and 13C spectral data with the literature values.60    
The reactivity of (±)-172 with various heteroatom and stabilized carbon based 
nucleophiles was studied and the results are   shown in the Scheme 48.  
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Scheme 48. Reactivity of cation (±)-172 with various nucleophiles. 
In all the above cases nucleophilic attack at the less hindered dienyl terminus (C-
1) of the cation was observed. Nucleophilic attack occurs exo to the tricarbonyliron 
moiety. Evidence in support of exo-attack (i.e. 5,7-cis-disubstituted cycloheptadiene) was 
present in the NMR spectra of (±)-173 (±)-176 and (±)-177. In particular, two signals at 
ca. δ 87-91 ppm in their 13C NMR spectra and multiplets integrating to two protons at ca. 
δ 4.9-5.6 ppm in their 1H NMR spectra are consistent with the two internal carbons (C-
2/C-3) and their attached protons. In addition, an apparent quartet at ca. 0.9-2.0 ppm (J = 
60    
ca. 12 Hz) in the 1H NMR spectra for (±)-173 (±)-174 (±)-176 and (±)-177 was assigned 
to H-6. The three large couplings are due to diaxial vicinal coupling of H-6 with H-5 and 
H-7 and a geminal coupling to H-6’ (Fig. 14).  
 
 
 
 
 
Figure 14. Generic structure of (±)-173, (±)-174, (±)-176 and (±)-177. 
 For the reaction of (±)-172 with the anion from dimethyl allylmalonate, the 
product was isolated as an inseparable mixture of (±)-178 and unreacted dimethyl 
allylmalonate. The stereochemistry of (±)-174, (±)-176, and (±)-178 are eventually 
corroborated by decomplexation.  
The reaction of cation (±)-172 with sodium cyanoborohydride gave an inseparable 
mixture of (±)-179 and (±)-180 in a nearly equimolar ratio (Eq. 6).  
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Diene complex (±)-179 was formed by hydride attack at the less sterically 
hindered dienyl terminus (C-1). The structure of diene complex (±)-179 was clearly 
identified as non-symmetrical by the presence of two signals at δ 87.1 and 89.0 ppm in 
the 13C NMR spectrum. The structure of cycloheptene-1,5-diyl complex (±)-180 was 
assigned on the basis of its NMR spectral data. In particular, the signal at δ 97.2 ppm in 
the 13C NMR spectrum and the triplet at δ 4.97 ppm in the 1H NMR spectrum were 
assigned to the central allyl carbon (C-4) and its attached proton. One of the overlapping 
signals at δ 4.38-4.49 ppm which appears as a quartet, was assigned to H-3. The nearly 
equivalent couplings (ca. J = 8.4 Hz) are due to vicinal couplings to H-4 and H-2 and H-
2’. 
III B. Decomplexation of Iron Coordinated Compounds 
Successful decomplexation reactions of iron coordinated compounds (±)-174, (±)-
176 and (±)-178 are shown in Scheme 49.  
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Scheme 49. Decomplexation of iron coordinated cyclic dienes. 
The structures of the products (±)-181, (±)-182 and (±)-183 were assigned based 
on their NMR spectral data. In particular, signals in the range of 5.5-6.0 ppm which 
integrated to four protons correspond to the olefinic protons of conjugated diene portion 
of the molecule. The structural assignment of (±)-181 was further confirmed from its 
single crystal X-ray diffraction analysis (Fig. 15). 
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Figure 15. X-ray crystal structure of (±)-181. 
Removal of iron from the cycloheptadienol complex (±)-173 was attempted using 
a variety of oxidizing agent/solvent conditions and the results are shown in Scheme 50. 
Use of ceric ammonium nitrate (CAN) in methanol gave the methyl ether (±)-184. 
Protection of cycloheptadienol complex (±)-173 as its silyl ether gave (±)-185. Attempted 
decomplexation of (±)-185 likewise gave the methyl ether (±)-184. Since we speculated 
that the methoxy group present in (±)-184 came from the solvent, decomplexation of (±)-
173 with CAN in either DMF or CH3CN was attempted. In each case, starting material 
and a complex mixture of unidentified pruducts were obtained. Similarly attempted 
decomplexation of (±)-173 with trimethylamine N-oxide gave a complex mixture of 
unidentified products. Finally decomplexation of (±)-173 with alkaline hydrogen 
peroxide afforded the desire cycloheptadienol (±)-186. 
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Scheme 50. Decomplexation of (±)-173. 
The formation of methyl ether (±)-184 from alcohol (±)-173 or silyl ether (±)-185 
was rationalized on the basis of an SN1-like substitution from the solvent methanol 
(Scheme 51). As the oxidation reaction proceeds with CAN, the solution becomes acidic. 
Protonation of the hydroxyl of (±)-173 or the silyl ether of (±)-185, followed by 
ionization regenerates the cycloheptadienyl cation (±)-172. Reaction of the cation thus 
formed with solvent gives the methyl ether complex which upon decomplexation gives 
(±)-184 (Scheme 51). 
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Scheme 51. Mechanistic rational for the formation of (±)-184 upon decomplexation of 
(±)-173 or (±)-185 with CAN/MeOH.  
 
III C. Singlet oxygen cycloaddition of iron free ligands 
To study singlet oxygen cycloaddition reactions of some iron free ligands, 
compound (±)-187 was prepared from (±)-176 (Eq. 7). 
   
   
 
 
66    
Exposure of the iron free ligand (±)-181 or (±)-187 to singlet oxygen 
cycloaddition condition generated a single endoperoxide (±)-188 or (±)-189 respectively 
(Scheme 52).  
 
   
 
 
 
 
 
Scheme 52. Cycloaddition of (±)-181 and (±)-187 with singlet oxygen.  
Structural assignment of endoperoxides (±)-188 and (±)-189 were based on their 
1H NMR spectral data. Cycloaddition occurs on the diene face opposite to syn- C-1/C-6 
substituents. Similar facial selectivity was also observed by Pearson, et al.,62 , Seitz, et 
al.,63 and others for substituted cycloheptadiene systems. In particular, peaks at δ 4.53 
(narrow m, 2H) for (±)-189 and at δ 4.79 (m, 2H) for (±)-188 corresponds to H-2 and H-5 
protons. Upfield shifts of H-7’ protons compare to H-7 in both (±)-188 and (±)-189 was 
due to the anisotopic effect of olefin functionality on H7’. 
67    
To resolve the racemic cycloheptadienes, asymmetric dihydroxylation of (±)-181 
with commercially available AD-mix β was studied (Scheme 53). Dihydroxylation occurs 
on the trans styryl double bond and gave a mixture of two diastereomeric diols (-)-190 
and (+)-191; the mixture was separable by preparative thin layer chromatography. The 
absolute configuration of the diol chiral centers of (-)-190 and (+)-191 were assigned 
based on the Sharpless mnemonic device.64 Cycloaddition of less polar cycloheptadiene 
diastereomer (-)-190, with N-phenyl-1,3,5-triaza-2,4-dione (PTAD), followed by reaction 
with 3,5-dinitrobenzoyl chloride gave (+)-193. The relative stereochemistry of all chiral 
centers of (+)-193 were assigned based on its single crystal X-ray diffraction analysis 
(Fig. 16), which also allowed assignment of the C-1 and C-6 stereocenters configurations 
of (-)-190 and (+)-191 as indicated.  
 
 
 
 
 
 
 
Scheme 53. Resolution of (±)-181 by asymmetric dihydroxylation. 
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Figure 16. X-ray crystal structure (+)-193. 
 
Due to difficulties in large scale chromatographic separation of the mixture of two 
diastereomeric diols (-)-190 and (+)-191, the mixture was exposed to the singlet oxygen 
cycloaddition conditions (Scheme 54) which gave a mixture of two  chromatographically 
separable diastereomeric endoperoxides (+)-194 and (+)-195. Notably the optical rotation 
attributed to of the (1’,2’-dihydroxyphenyl) side chain is presumably greater in 
magnitude compared to the 6,7-dioxabicyclo[3.2.2]octane. Treatment of (+)-194 and (+)-
195 with Pb(OAc)4 separately, gave the corresponding diol-cleavage proructs 
enantiomeric aldehydes (+)-196 and (-)-196. On the other hand, treatment of the mixture 
69    
of (-)-190 and (+)-191 with Pb(OAc)4 followed by reduction of intermediate aldehyde by 
NaBH4 gave a primary alcohol (±)-197. 
 
 
 
 
 
 
 
Scheme 54. Treatment of mixture of (-)-190 and (+)-191 with singlet oxygen.  
The structures of (+)-194 and (+)-195 were assigned on the basis of the structures 
of their precursors and also confirmed by the independent treatment of pure (-)-190 with 
singlet oxygen, which generated the corresponding endoperoxide (+)-194. The structures 
of enantiomeric aldehydes (+)-196 and (-)-196 were assigned based on the structures of 
their precursors. In particular, the peak at δ 9.63 ppm in the 1H NMR spectrum of each 
indicates the presence of the aldehyde functionality in the diol cleavage products (+)/(-)-
196. The structure of (±)-197 was assigned on the basis of its 1H NMR spectral data. A 
multiplate peak at 3.55-3.76 (m, 2H) in the 1H NMR spectra was assigned to the hydroxy 
methylene portion of the primary alcohol (±)-197.        
70    
III D. Synthesis of Bicyclo[4.4.1]undecatriene 
Treatment of (±)-182 with 1st generation Grubbs catalyst gave the ring-closed 
product (±)-199 (Scheme 55). The structure of (±)-199 was assigned based on its 1H and 
13C NMR spectral data. In particular, the 1H NMR spectrum of (±)-199 integrates to 18 
Hs; five of which were olefinic. Furthermore, the 13C NMR spectrum of (±)-199 
consisted of 15 signals with five olefinic methine carbons and one quaternary olefinic 
carbon. Olefin isomerization has previously been reported as a competitive side reaction 
of Ru-catalyzed olefin metathesis.65 The thermodynamically favored (±)-199 (because of 
extended conjugation) might form by the isomerization of initially formed 198 isomer. 
 
Scheme 55. Generation of bicyclo[4.4.1]undecatriene from (±)-182. 
Attempts to prepare crystalline derivatives of (±)-199 were made. In that 
direction, reduction of the two ester functional groups of (±)-199 was unsuccessful. In an 
different attempt, the ester functional groups of (±)-182 were reduced to the 
corresponding diol (±)-200 by diisobutylaluminium hydride (DIBAL-H) (Scheme 56). 
Conversion of the two primary alcohol groups of (±)-200 to different functional groups 
71    
(Scheme 54) gave (±)-201, and (±)-202. Attempted ring closing metathesis of solid (±)-
201 and (±)-202 were unsuccessful. 
 
  
           
 
 
 
Scheme 56. Reduction of (±)-182 by DIBAL-H.   
In conclution, synthesis of tricarbonyl(η5-6-styrylcyclohepta-2,4-dien-1-
yl)iron(+1) from cyclooctatetraene and its reactivity study was achieved. Based on the 
reactivity pattern structural diversities were created in the forms of functionalized 
endoperoxides and bicyclo[4.4.1]undecatriene.    
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Experimental 
 
General Data:   
All non-aqueous reactions were carried out under a nitrogen atmosphere. 
Spectroscopic grade solvents were used without further purification with the exception of 
ether and tetrahydrofuran which were distilled from sodium, using benzophenone as 
indicator. Methylene chloride was distilled from phosphorous pentaoxide and hexane was 
distilled before use. Column chromatography was performed using silica gel 62 grade 
(60-200 mesh and 200-400 mesh, Dynamic Adsorbents Inc). Melting points were 
recorded using a Mel-Temp apparatus and are uncorrected. Carbon and proton NMR 
were recorded in Varian Mercury 300 and 400 spectrometer. Elemental analyses were 
obtained from Midwest Microlabs, Indianapolis. IN, and high resolution mass spectra 
were obtained from the University of Nebraska center for Mass Spectrometry, Lincoln, 
NE. 
 
 
 
                                                              
Tricarbonyl (1,3-cyclohexadiene)iron (2): To a 500 mL round-bottomed flask equipped 
with a condenser, was charged 1,3-cyclohexadiene (4.20 g, 52.4 mmol), benzene (250 
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mL) and Fe2(CO)9 (50.00 g 137.4 mmol). After stirring for few minutes, the mixture was 
heated at reflux for 3 h under nitrogen. The mixture was cooled to room temperature and 
additional Fe2(CO)9 (26.0 g, 71.4 mmol) was added. The mixture was heated at reflux for 
another 4 h. After cooling to room temperature, the dark reaction mixture was filtered 
through celite using CH2Cl2 as eluent. The filtrate and the washings were concentrated. 
The crude mixture was purified by column chromatography (SiO2, 100% hexane) to 
afford the product as a yellow orange oil (10.05 g, 87%). 1H NMR (CDCl3, 400 MHz) δ 
1.54-1.64 (m, 2H), 1.66-1.76 (m, 2H), 3.19-3.24 (m, 2H), 5.27-5.30 (m, 2H); 13C NMR 
(CDCl3, 100 MHz) δ 23.8, 62.4, 85.4, 212.3. 
 
 
 
 
                                                          
Tricarbonyl(η5-cyclohexadienyl)iron(1+) tetrafluoroborate (3): To a 100 mL round-
bottomed flask was charged triphenylcarbenium tetrafluoroborate (7.64 g, 23.2 mmol), 
dry CH2Cl2 (25 mL) and stirred for few min at room temperature under nitrogen. A 
solution of iron complex 2 (4.25 g, 19.3 mmol) in dry CH2Cl2 (25 mL) was added. After 
5 min, an orange solid compound began to separate from the greenish-blue solution. The 
reaction mixture was stirred for 1 h and then whole mixture was poured into ether (350 
mL). The yellow solid cation was isolated by filtration and dried under high vacuum 
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(5.96 g, 100%). mp 207-210 0C; 13C NMR (CD3NO2, 100 MHz) δ 26.0, 67.4, 91.9, 104.6, 
210.9. 
                                                            
 
 
 
 
 
Tricarbonyl(5-phthalimido-1,3-cyclohexadiene)iron (±)-117: In a 100 mL Schlenk 
flask, iron cation 3 (920 mg, 2.95 mmol) was dissolved in dry CH2Cl2 (40 mL) with 
stirring at room temperature under nitrogen. Solid potassium phthalimide (820 mg, 4.43 
mmol) was added and the mixture was stirred for 5 h. The reaction mixture was quenched 
with water and extracted several times with CH2Cl2. The combined extracts were washed 
with brine, dried (Na2SO4) and concentrated. The residue was purified by column 
chromatography (SiO2, hexane-ethyl acetate = 6:1) to afford a light yellow solid (807 mg, 
75%). mp 166-169 0C; 1H NMR (CDCl3, 400 MHz) δ 2.00 (br d, J = 15.1 Hz, 1H), 2.31 
(ddd, J = 4.2, 11.4, 15.1 Hz, 1H), 2.77 (ddd, J = 1.0, 3.2, 6.3 Hz, 1H), 3.11-3.15 (m, 1H), 
4.80 (td, J = 3.7, 11.5 Hz, 1H), 5.53 (t, J = 5.6 Hz, 1H), 5.67 (t, J = 5.7 Hz, 1H), 7.60-
7.83 (m, 4H, NPhth); 13C NMR (CDCl3, 100 MHz) δ 27.3, 48.1, 57.1, 58.2, 86.0, 86.7, 
123.3, 132.1, 134.2, 168.2, 211.4. Anal. Calcd. for C17H11NO5Fe: C, 55.92; H, 3.04. 
Found: C, 56.10; H, 3.18. 
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N-(2,4-cyclohexadien-1-yl)phthalimide (±)-118: In a 250 mL round-bottom flask, iron 
complex (±)-117 (800 mg, 2.19 mmol) was dissolved in methanol (110 mL) with stirring. 
Solid ceric ammonium nitrate (360 mg, 6.56 mmol) was added and the mixture was 
stirred for 2 h. The reaction mixture was quenched with water and extracted several times 
with CH2Cl2. The combined extracts were washed with brine, dried (Na2SO4) and 
concentrated. The residue was purified by column chromatography (SiO2, hexane-ethyl 
acetate = 4:1) to give a colorless solid (400 mg, 81%). mp 138–140 0C; 1H NMR (CDCl3, 
400 MHz) δ 2.38 (ddd, J = 5.6, 10.0, 17.2 Hz, 1H), 2.78 (tdd J = 3.1, 15.2, 17.7 Hz, 1H), 
5.20 (tdd, J = 2.9, 9.6, 15.2 Hz, 1H), 5.68 (dd, J = 3.0, 9.6 Hz, 1H), 5.89-6.10 (m, 3H), 
7.71-7.86 (m, 4H); 13C NMR (CDCl3, 100 MHz) δ 27.5, 45.9, 123.2, 123.7, 125.3, 125.5, 
125.6, 132.1, 133.9, 176.2. Anal. Calcd. for C14H11NO2: C, 74.65; H, 4.92; N, 6.22. 
Found: C, 74.60; H, 4.94; N, 6.24. 
 
Reaction of (±)-118 with singlet oxygen: To a 25 mL two necked round-bottomed flask, 
equipped with a condenser, was charged diene (±)-118 (1.0 gm, 4.4 mmol), dry CHCl3 
(50 mL) and tetraphenylporphine (138 mg, 5 mol%). The deep purple solution was stirred 
at 0 0C while irradiated with a 60 W tungsten-halogen lamp for 8 h. The reaction mixture 
was concentrated under vacuum. The residue was purified through column 
chromatography (SiO2, hexane-ethyl acetate = 4:1) to give   a colorless solid (±)-119 (593 
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mg, 52%). Further elution (hexane–ethyl acetate = 3:1) gave a colorless solid (±)-120 
(257 mg, 18%). 
 
 
 
 
 
N-(8,9-Dioxobicyclo[2.2.2]oct-5-en-2-yl)phthalimide (±)-119: mp 155–157 0C; 1H 
NMR (CDCl3, 400 MHz) δ 2.42 (ddd, J = 2.0, 4.4, 13.6, Hz, 1H), 2.80 (ddd, J = 4.0, 9.6, 
13.6 Hz, 1H), 4.84-4.98 (m, 3H), 6.65 (ddd, J = 1.6, 6.0, 8.0 Hz, 1H), 6.88 (ddd, J = 1.6. 
6.0, 8.0 Hz, 1H), 7.71-7.74 and 7.79-7.8 (AA’BB’, 4H); 13C NMR (CDCl3, 100 MHz) δ 
28.5, 45.9, 71.2, 123.5, 129.5, 131.6, 134.0, 134.5, 168.3 (one peak observed by solvent). 
Anal. Calcd. for C14H11O4N: C, 65.36; H, 4.31. Found: C, 65.45; H, 4.39. 
 
 
 
  
 
  
N-(8,9-Dioxobicyclo[2.2.2]oct-5-en-2-yl)phthalimide (±)-120: mp 216–219 0C; 1H 
NMR (CDCl3, 400 MHz) δ 1.88 (ddd, J = 1.9, 11.8, 13.8 Hz, 1H), 3.64 (td, J = 4.2, 13.8 
Hz, 1H), 4.41 (ddd, J = 1.8, 4.5, 12.0 Hz, 1H), 4.67 (qd, J = 1.7, 6.3 Hz, 1H), 4.89 (qdd, J 
= 1.8, 3.6, 5.7 Hz, 1H), 6.75-6.87 (m, 2H),  7.70-7.74 and 7.78-7.83 (AA’BB’, 4H); 13C 
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NMR (CDCl3, 75 MHz) δ 21.0, 47.2, 70.9, 75.2, 123.5, 130.8, 132.0, 134.0, 134.3, 168.9. 
Anal. Calcd. for C14H11O4N: C, 65.36; H, 4.31. Found: C, 65.46; H, 4.34. 
 
 
 
 
 
N-(2R*,5S*-Dihydroxy-3-cyclohexene-1S*-yl) phthalimide (±)-121: To a 5 mL round-
bottom flask was charged with the major endoperoxide (±)-119 (25 mg, 0.097 mmol) in 
methanol (1.5 mL) at room temperature under nitrogen was added solid thiourea (7.0 mg, 
0.097 mmol).  The mixture was stirred for 15 h. The reaction mixture was concentrated 
under vacuum and the residue was purified by column chromatography (SiO2, hexane-
ethyl acetate = 1:3) to afford a colorless solid (19 mg, 75%). mp 180–183 0C; 1H NMR 
(CDCl3, 400 MHz) δ 1.97 (br d, J = 14.0 Hz, 1H), 2.28 (br s, OH, 1H), 2.35 (br s, OH, 
1H), 2.82 (dt, J = 4.8, 13.6, Hz, 1H), 4.42 (br s, 1H), 4.58 (ddd, J = 3.2, 10.0, 13.6 Hz, 
1H), 4.84 (br d, J = 9.2 Hz, 1H), 5.92 (s, 2H), 7.70-7.74 and 7.81-7.85 (4H, Phth); 13C 
NMR (CD3OD, 100 MHz) δ 35.1, 51.1, 65.2, 68.5, 124.1, 130.1, 133.5, 134.8, 135.4, 
170.2. Anal. Calcd. for C14H13NO4: C, 64.86; H, 5.05. Found: C, 64.92; H, 5.11. 
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N-(2S*,5R*-Dihydroxy-3-cyclohexen-1S*-yl)phthalimide (±)-122: To a 25 mL round-
bottom flask charged with the minor endoperoxide (±)-120  (0.10 gm, 0.40 mmol) in 
methanol (4 mL) at room temperature under nitrogen was added solid thiourea (40 mg, 
0.48 mmol). The mixture was stirred for 15 h. The reaction mixture was concentrated 
under vacuum and the residue was purified by column chromatography (SiO2, hexane-
ethyl acetate = 1:4) to afford a colorless solid (40 mg, 40%). mp 168-171 0C; 1H NMR 
(CDCl3, 400 MHz) δ 2.21 (br d, J = 12.8 Hz, 1H), 2.26 (d, J = 7.2 Hz, OH, 1H), 2.81 (d, 
J = 8.8 Hz, OH, 1H), 2.85 (ddd, J = 10.8, 12.8, 14.4 Hz, 1H), 4.17-4.23 (m, 1H), 4.43-
4.45 (m, 2H), 5.96-5.97 (m, 2H), 7.70-7.74 and 7.81-7.85 (4H, Phth); 13C NMR (CD3OD, 
100 MHz) δ 31.2, 52.7, 65.8, 69.1, 124.1, 128.3, 133.4, 135.4, 136.8, 170.3. Anal. Calcd. 
for C14H13NO4: C, 64.86; H, 5.05. Found: C, 64.77; H, 5.08. 
 
 
 
 
 
 
N-(2R*,5R*,-Dihydroxycyclohex-1S*-yl)phthalimide (±)-123: In  a  hydrogenation container, olefin (±)‐121 (0.20 g, 0.77 mmol) was dissolved in methanol (20 mL) at room  temperature.  To  the  mixture  was  added  10%  Pd/C  (60  mg)  and  the suspension was stirred under hydrogen (40 psi) for 5 h. The reaction mixture was 
79    filtered through celite. The filtrate was concentrated, adsorbed to silica and applied to a column of silica. Elution (hexane‐ethyl acetate = 1:4) gave a colorless solid (143 mg, 76%).   mp 198–200 0C;  1H NMR (CD3OD, 400 MHz) δ 1.60‐1.72 (m, 1H), 1.84‐1.91 (m, 4H), 2.42 (dt, J = 13.2, 2.4 Hz, 1H), 4.14 (pent, J = 2.6 Hz, 1H), 4.26 (dt, J = 6.4, 9.8, Hz, 1H), 4.47 (ddd,  J = 4.0, 10.0, 12.8 Hz, 1H), 7.75‐7.88 (m, 4H); 13C NMR (CD3OD,  100 MHz)  δ  29.8,  31.9,  36.3,  53.5,  66.7,  70.2,  124.0,  133.5,  135.3,  170.3. Anal. Calcd. for C14H15NO4: C, 64.36; H, 5.79. Found: C, 64.20; H, 5.73. 
 
 
 
 
N-(2S*,5S*-Dihydroxycyclohex-1S*-yl)phthalimide (±)-124: In a small hydrogenation 
container, olefin (±)-122 (40.0 mg, 0.154 mmol) was dissolved in methanol (7 mL) at 
room temperature.  To the mixture was added 10% Pd/C catalyst (ca. 5 mg) and the 
suspension was stirred under hydrogen (40 psi) for 7 h. The reaction mixture was filtered 
through celite. The filtrate was concentrated, adsorbed to silica gel and applied to a 
column of silica. Elution (hexane-ethyl acetate = 1:4) gave a colorless solid (25 mg, 
62%). mp 175–177 0 C; 1H NMR (CD3OD, 400 MHz) δ 1.60-1.95 (m, 5H), 2.88 (td, J = 
11.7, 13.5 Hz, 1H), 3.60-3.72 (m, 1H), 3.98 (s, 1H), 4.18 (ddd, J = 2.2, 3.8, 13.5 Hz, 1H), 
7.75-7.90 (m, 4H); 13C NMR (CD3OD, 100 MHz) δ 29.5, 30.4, 33.6, 55.4, 68.5, 70.8, 
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124.2, 133.3, 135.5, 170.6. Anal. Calcd. for C14H15NO4.1/2H2O: C, 62.21; H, 5.96. 
Found: C, 62.03; H, 5.70. 
 
 
 
 
1S*-(2R*,5R*-Dihydroxycyclohexyl)ammoinium chloride (±)-125: To a 10 mL round-
bottomed flask was charged diol (±)-123 (0.10 g, 0.38 mmol) and aqueous HCl  (6N, 6 
mL). The mixture was heated at reflux for 15 h. The reaction mixture was dried, re-
dissolved in deionized water (8 mL) and then extracted with ethyl acetate (8 mL X 3). 
The aqueous solution was concentrated, dried under high vacuum to afford a light brown 
gummy compound (64 mg, 100%). 1H NMR (CD3OD, 400 MHz) δ 1.53-1.64 (m, 2H), 
1.72-1.86 (m, 3H), 2.11 (br m, J = 13.4 Hz, 1H), 3.18-3.27 (m, 1H), 3.42-3.51 (m, 1H), 
4.08-4.11 (m, 1H); 13C NMR (CD3OD, 100 MHz) δ 29.2, 31.4, 36.4, 53.5, 65.8, 72.1. 
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N-(4R*,5S*-Dihydroxy-2-cyclohexane-1S*-yl)phthalimide (±)-126: To a solution of 
diene (±)-118 (750 mg, 3.  33 mmol) in acetone (15 mL) was added a solution of N-
methylmorpholine N-oxide (960 mg, 8.19 mmol) in water (4 mL) followed by a solution 
of OsO4 in toluene (2 mL, 10 mol%). The reaction mixture was stirred for 30 min at room 
temperature and then solid Na2S2O4 (0.6 g) was added and the mixture stirred for another 
30 min. The crude reaction mixture was purified by column chromatography (hexane-
ethyl acetate = 1:4) to give a colorless solid (447 mg, 52%). mp 178-181 0C; 1H NMR 
(CD3OD, 400 MHz) δ 2.12 (dtd, J = 1.6, 5.8, 13.4 Hz, 1H), 2.35 (ddd, J = 2.0, 10.2, 13.6 
Hz, 1H), 4.17-4.22 (m, 1H), 4.30-4.34 (m, 1H), 5.11-5.17 (m, 1H), 5.63 (dtd, J = 1.6, 2.4, 
10.2 Hz, 1H), 5.73 (dt, J = 1.6, 2.0, 10.4 Hz, 1H), 7.78-7.85 (AA’BB’, 4H); 13C NMR 
(CD3OD, 100 MHz) δ 33.4, 45.4, 68.6, 69.5, 124.2, 129.1, 131.9, 133.4, 135.5, 169.6. 
Anal. Calcd. for C14H13NO4: C, 64.86; H, 5.05. Found: C, 64.87; H, 5.02. 
 
 
 
 
 
 
N-(4R*,5S*-Diacetoxy-2-cyclohexen-1S*-yl)phthalimide (±)-127: To a 10 mL round-
bottom flask was charged diol (±)-126 (30 mg, 0.12 mmol) and CH2Cl2 (0.8 mL) at room 
temperature. To the stirring suspension was added dropwise pyridine (0.10 mL, 1.2 
mmol). Upon addition of pyridine the mixture became clear. Acetic anhydride (0.10 mL, 
1.2 mmol) was added and the mixture stirred for 12 h. The reaction mixture was 
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quenched with 1M HCl (5 mL) and extracted several times with CH2Cl2, washed with 
brine, dried (Na2SO4) and concentrated. The residue was purified by column 
chromatography (hexane-ethyl acetate = 1:1) to afford a colorless solid (27 mg, 68%). mp 
151-154 0C; 1H NMR (CDCl3, 300 MHz) δ 2.07 (s, 3H), 2.15 (s, 3H), 2.19-2.28 (m, 1H), 
2.54 (ddd, J = 2.1, 9.3, 13.8 Hz, 1H), 5.17 (ddd, J = 2.9, 6.3, 9.3 Hz, 1H), 5.62-5.67 (m, 
1H), 5.68-5.72 (m, 1H), 5.78 (s, 2H), 7.72-7.77 and 7.82-7.88 (4H, Phth); 13C NMR 
(CDCl3, 75 MHz) δ 21.1, 21.3, 30.0, 44.1, 67.9, 68.3, 123.6, 127.1, 129.9, 132.0, 134.4, 
168.0, 170.7, 170.4. Anal. Calcd. for C18H17NO6: C, 62.97; H, 4.99. Found: C, 63.64; H, 
5.12. 
 
 
 
 
 
N-(3S*,4R*-Dihydroxycyclohex-1R*-yl)phthalimide (±)-128: In a hydrogenation 
container, cyclohexenylphthalimide (±)-126 (0.10 mg, 0.38 mmol) was dissolved in 
methanol (10 mL) at room temperature. To the mixture 10%  Pd/C  catalyst (ca. 5 mg) 
was added and the mixture was stirred under hydrogen (40 psi) for 4 h. The reaction 
mixture was filtered through celite. The filtrate was concentrated, adsorbed onto silica gel 
and then applied to a column of silica. Elution (hexane-ethyl acetate = 1:4) gave a 
colorless solid (75 mg, 74%). mp 243–247 0C; 1H NMR (CD3OD, 400 MHz) δ 1.60-1.80 
(m, 2H), 1.84-1.96 (m, 2H), 2.28 (dq, J = 4.2, 13.0 Hz, 1H), 2.52 (dt, J = 2.4, 12.8 Hz, 
1H), 3.67 (ddd, J = 2.9, 4.5, 11.5 Hz, 1H), 4.03-4.04 (m, 1H), 4.58 (tt, J = 4.1, 12.6 Hz 
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1H), 7.75-7.88 (m, 4H); 13C NMR (d6-DMSO, 100 MHz) δ 27.3, 27.6, 34.3, 44.3, 68.6, 
70.2, 122.9, 131.5, 134.3, 168.0. FAB-HRMS m/z 268.1157 (calcd. for C14H15NO4Li 
(M+Li) m/z 268.1161). 
 
 
 
 
1R*-(3S*,4R*-Dihydroxycyclohexyl)ammonium chloride (±)129: To a 10 mL round-
bottomed flask was charged diol (±)-128 (40.0 mg, 0.153 mmol) and aqueous HCl (6N, 3 
mL).  The mixture was heated at reflux for 15 h. The reaction mixture was dried, re-
dissolved in deionized water (6 mL) and then extracted with ethyl acetate (5 mL X 3). 
The aqueous solution was concentrated and dried under high vacuum to afford a light 
yellow foamy solid (26 mg, 100%). 1H NMR (CD3OD, 400 MHz) δ 1.34- 2.15 (m, 6H), 
3.29-3.39 (m, 1H), 3.49-3.58 (m, 1H), 3.92-3.98 (m, 1H); 13C NMR (CD3OD, 75 MHz) δ 
27.1, 29.3, 36.5, 46.5, 69.3, 71.2. 
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N-(2R*,3S*,4R*,5S*-Tetrahydroxycyclohex-1S*-yl)phthalimide (±)-130: To a stirring 
solution of olefin (±)-121 (60 mg, 0.23 mmol) in acetone (1 mL) was added a solution of 
N-methylmorpholine N-oxide (70 mg, 0.58 mmol) in water (0.3 mL) followed by a 
solution of OsO4 in toluene (0.1 mL, 10 mol%). The reaction mixture was stirred for 20 h 
at room temperature and then Na2S2O4 (35 mg) was added and stirred for another 30 min. 
The mixture was concentrated, adsorbed to silica using methanol and applied to a column 
of silica. Elution (CH2Cl2-methanol = 9:1) gave a colorless solid (42 g, 62%). mp 267–
270 0C; 1H NMR (CD3OD, 400 MHz) δ 1.69 (td, J = 2.8, 13.2 Hz, 1H), 2.82 (dt, J = 2.8, 
13.2 Hz, 1H), 3.73 (dd, J = 3.2, 9.6 Hz, 1H), 3.93-4.00 (m, 2H), 4.43-4.50 (m, 2H), 7.78-
7.87 (m, 4H); 13C NMR (CD3OD, 100 MHz) δ 31.2, 51.6, 70.4, 70.7, 74.0, 74.4, 124.1, 
133.5, 135.4, 170.2. Anal. Calcd. for C14H15NO6: C, 57.33; H, 5.15. Found: C, 57.29; H, 
5.34. 
 
 
 
 
 
N-(2S*,3R*,4S*,5R*-Tetrahydroxycyclohex-1S*-yl)phthalimide (±)-131: To a stirring 
solution of olefin (±)-122 (30.0 mg, 0.115 mmol) in acetone (1 mL) was added a solution 
of    N-methylmorpholine N-oxide (30.0 mg, 0.240 mmol) in water (0.25 mL) followed 
by a solution of OsO4 in toluene (0.1 mL, 10 mol%). The reaction mixture was stirred for 
15 h at room temperature and then Na2S2O4  (0.02 g) was added and  stirring continued 
for another 30 min.  The reaction mixture was dried, re-dissolved in ethyl acetate, 
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adsorbed to silica gel and applied to a column of silica. Elution (100% ethyl acetate) gave 
a colorless solid (20 mg, 59%). mp 253-255 0 C; 1H NMR (CD3OD, 400 MHz) δ 1.89 (td, 
J = 3.8, 12.4 Hz, 1H), 2.86 (q, J = 12.4, Hz, 1H), 3.71 (dd, J = 2.8, 9.6 Hz, 1H), 3.82 
(ddd, J = 4.8, 10.0, 11.6 Hz, 1H), 3.94-3.99 (m, 2H), 4.69 (ddd, J = 2.0, 4.4, 14.0 Hz, 
1H), 7.78-7.87 (m, 4H); 13C NMR (CD3OD, 100 MHz) δ 31.3, 50.1, 70.5, 74.0, 74.1, 
74.2, 124.2, 133.3, 135.5, 170.7. Anal. Calcd. for C14H15NO6: C, 57.33; H, 5.15. Found: 
C, 57.53; H, 5.11. 
 
 
 
N-(2S*,3S*,4R*5R*-Tetrahydroxycyclohex-1R*-yl)phthalimide (±)-132: To a stirring 
solution of olefin (±)-126 (0.10 g, 0.38 mmol) in acetone (4 mL) was added a solution of 
N-methylmorpholine N-oxide (0.07 gm 0.57 mmol) in water (1 mL) followed by a 
solution of OsO4  in toluene (0.2 mL, 10 mol%). The reaction mixture was stirred for 8 h 
at room temperature. The reaction mixture was filtered and the residue was dissolved in a 
mixture of methanol and CH2Cl2 and adsorbed to silica gel and then applied to a column 
of silica. Elution (methanol:CH2Cl2 = 1:4, few drops of NH4OH) gave a colorless solid 
(22 mg, 21%). mp 243–245 0C; 1H NMR (d6-DMSO, 300 MHz) δ 1.79 (td, J = 3.6, 13.2 
Hz, 1H), 2.19 (dt, J = 1.8, 13.2 Hz, 1H), 3.46 (td, J = 2.7, 6.3 Hz, 1H), 3.86-3.96 (br m, 
2H), 4.02-4.10 (br m, 1H), 4.55 (dt, J = 4.2, 12.0 Hz, 1H), 4.84-4.94 (m, 3H), 5.03 (d, J = 
5.7 Hz 1H), 7.80-7.92 (m, 4H); 13C NMR (d6-DMSO, 75 MHz) δ 32.4, 46.5, 68.3, 69.2, 
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70.4, 75.3, 122.8, 131.6, 134.3, 168.4. FAB-HRMS m/z 300.1067 (calcd. for 
C14H15NO6Li (M+Li) m/z 300.1059). 
 
 
 
1S*-(2R*,3S*,4R*,5S*-Tetrahydroxycyclohexyl)ammonium chloride (±)-133: To a 
10 mL round-bottomed flask was charged tetraol (±)-130 (50 mg, 0.17 mmol) and HCl 
(6N, 4 mL).  The mixture was heated at reflux for 15 h. The reaction mixture was dried, 
re-dissolved in deionized water (6 mL) and then extracted with ethyl acetate (6 mL X 3). 
The aqueous solution was concentrated, dried under high vacuum to afford a light yellow 
solid (33 mg, 100%). mp 92–95 0C; 1H NMR (CD3OD, 400 MHz) δ 1.91-2.02 (m, 2H), 
3.19-3.28 (m, 1H), 3.62-3.69 (m, 2H), 3.86-3.89 (m, 1H), 3.93-3.96 (m, 1H); 13C NMR 
(CD3OD, 100 MHz) δ 31.46, 51.94, 69.56, 72.39, 73.02, 74.01. 
 
 
 
 
 
N-(3,4-Epoxy-2S*,5R*-dihydroxycyclohex-1R*-yl)phthalimide (±)-135: To a stirring 
solution of diol (±)-121 (50.0 mg, 0.193 mmol) and CH2Cl2 (1mL) was added a solution 
of mCPBA (0.1 g, 0.4 mmol, 70 wt%,) in CH2Cl2 (1 mL) at room temperature under 
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nitrogen.  After stirring for 7 h, the reaction mixture was quenched with a mixture  of 
Et3N and water (1:9, 10 mL) and then extracted with ethyl acetate (8 mL X 3). The 
combined extracts were washed with brine, dried (Na2SO4) and concentrated. The residue 
was re-dissolved in CH2Cl2, adsorbed to silica gel, and then applied to a column of silica. 
Elution (100% ethyl acetate) gave a colorless solid (22.0 g, 42%). mp 203–206 0C; 1H 
NMR (CD3OD, 400 MHz) δ 1.68 (br d, J = 14.0 Hz, 1H), 2.52 (ddd, J = 6.0, 12.4, 14.4 
Hz, 1H), 3.47-3.49 (narrow m, 2H), 4.25-4.29 (m, 1H), 4.52 (ddd, J = 3.2, 9.6, 13.0 Hz, 
1H), 4.66 (d, J = 9.2 Hz, 1H), 7.78-7.89 (m, 4H); 13C NMR (CD3OD, 100 MHz) δ 36.1, 
48.8, 57.3, 59.0, 64.9, 68.6, 124.1, 133.4, 135.5, 170.1. Anal. Calcd. for C14H13NO5: C, 
61.09; H, 4.76. Found: C, 60.58; H, 4.80. 
 
 
 
N-(3,4-Epoxy-2R*,5S*-dihydroxycyclohex-1R*-yl)phthalimide (±)-136: To a stirring 
solution of diol (±)-122 (53 mg, 0.20 mmol) and CH2Cl2 (2 mL) was added a solution of 
mCPBA (0.1 g, 70 wt%, 0.4 mmol) in CH2Cl2 (2 mL) at room temperature under 
nitrogen and stirred for 15 h. The reaction mixture was quenched with a mixture of Et3N 
and water (1:9, 7 mL) and then extracted several times with CH2Cl2. The combined 
CH2Cl2 solution was washed with sat. NaHCO3 solution followed by brine, dried 
(Na2SO4) and concentrated. The residue was redissolved in CH2Cl2, adsorbed to silica 
gel, and then applied to a column of silica. Elution (100% ethyl acetate) gave a colorless 
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solid (8 mg, 15%). mp 180–182 0C; 1H NMR (CD3OD, 300 MHz) δ 1.79 (br d, J = 12.4 
Hz, 1H), 2.78-2.92 (m, 1H), 3.39-3.48 (m, 3H), 3.97-4.15 (m, 4H), 7.77-7.86 (m, 4H); 
13C NMR (CD3OD, 75 MHz) δ 27.3, 52.5, 55.6, 58.1, 65.4, 69.9, 124.1, 133.4, 135.5, 
170.2. Due to the low yield for this epoxide, hydrolysis was not attempted. 
 
 
 
 
 
 
N-(2,3-Epoxy-4R*,5R*-dihydroxycyclohex-1R*yl)phthalimide (±)-137: To a stirring 
solution of diol (±)-126 (100 mg, 0.400 mmol) and CH2Cl2 (2 mL) was added a solution 
of mCPBA (0.2 g, 0.8 mmol) in CH2Cl2 (2 mL) at room temperature and stirred for 12 h. 
The reaction mixture was quenched with a mixture of Et3N and water (1:10, 10 mL) and 
then extracted several times with CH2Cl2. The combined extracts were washed with 
brine, dried (Na2SO4) and concentrated. The excess Et3N was removed under high 
vacuum to give a colorless solid (73 mg, 70%). mp 167-170 0C; 1H NMR (CDCl3, 400 
MHz) δ 2.03 (ddd, J = 2.0, 10.7, 13.7 Hz, 1H), 2.25 (dddd, J = 1.6, 4.2, 6.9, 13.7 Hz, 
1H), 2.89 (d, J = 11.6 Hz, 1H, OH), 3.05 (d, J = 10.0 Hz, 1H, OH), 3.48 (dd, J = 1.6, 3.6 
Hz, 1H), 3.65-3.68 (narrow m, 1H), 3.97-4.25 (m, 1H), 4.19 (ddd, J = 1.6, 4.3, 9.5 Hz, 
1H), 4.88 (dd, J = 6.9, 10.6 Hz, 1H), 7.75-7.80 and 7.85-7.89 (4H, Phth); 13C NMR 
(CDCl3, 100 MHz) δ 32.3, 41.7, 58.7, 58.9, 67.2, 68.4, 123.8, 131.9, 134.7, 167.8. Anal. 
Calcd. for C14H13NO5.1/4H2O: C, 60.10; H, 4.86. Found: C, 59.95; H, 4.69. 
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N-(2R*,3S*,4R*,5R*-Tetraacetoxycyclohex-1R*-yl)phthalimide (±)-138: To a 25 mL 
round-bottom flask was charged with epoxide (±)-137 (137 mg, 0.498 mmoL) and water 
(10 mL). To the suspension was added HClO4 (6 drops) and the suspension was heated at 
reflux. After 20 min of reflux the suspension turned clear. The reflux was continued for 
another 30 min at which time a colorless solid compound began to separate out. The 
mixture was stirred for 20 more min, cooled to room temperature and filtered. The 
colorless solid residue was dried under high vacuum (86 mg, 59%). mp 265–267 0 C. The 
crude product was used in the follow step without further characterization. A 25 mL 
round-bottom flask was charged with tetraol (70 mg, 0.24 mmol) at room temperature. 
Acetic anhydride (0.20 mL) was added followed by pyridine (0.15 mL). The suspension 
was stirred overnight. The clear reaction mixture was diluted with ethyl acetate (5 mL), 
quenched with 1M HCl (10 mL) and extracted with ethyl acetate (10 mL X 2). The 
combined extracts were washed with brine, dried (Na2SO4) and concentrated. The residue 
was purified by column chromatography (hexane-ethyl acetate = 1:1) to afford a colorless 
solid (79 mg, 71%). mp 67–70 0 C; 1H NMR (CDCl3, 400 MHz) δ 7.70-7.86 (m, 4H), 
5.70-5.64 (m, 1H), 5.43-5.38 (narrow m, 2H), 5.36-5.31 (narrow m, 1H), 5.04 (ddd, J = 
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11.1, 4.5, 3.3 Hz, 1H), 3.18 (br t, J = 11.0 Hz, 1H), 2.02, 2.06, 2.11, 2.17 (m & OAc, 
13H); 13C NMR (CDCl3, 75 MHz) δ 20.95, 21.0, 21.2, 27.4, 44.8, 67.9, 68.2, 69.3, 70.0, 
123.6, 131.7, 134.5, 168.6, 169.7, 170.1, 170.2. Anal. Calcd. for C22H23NO10: C, 57.26; 
H, 5.02. Found: C, 57.15; H, 5.04. 
Hydrolysis of epoxide (±)-135: To a 25 mL round-bottomed flask was charged epoxide 
(±)-135 (160 mg, 0.582 mmoL) and water (7 mL). To the suspension was added H2SO4 
(14 drops) and the suspension was heated at reflux. After 30 min the suspension turned 
clear. The reflux was continued for another 30 min and during which time a colorless 
solid compound began to separate out. The mixture was stirred for an additional 20 min, 
cooled to room temperature and filtered. The colorless solid residue was dried under high 
vacuum (119 mg, 70%). mp 270–272 0 C. The product was used in the next step without 
further characterization. To a 5 mL round-bottom flask was charged crude tetraol (136 
mg, 0.464 mmol) at room temperature. Acetic anhydride (0.5 mL) was added followed by 
pyridine (0.4 mL). The suspension was stirred overnight. The clear reaction mixture was 
diluted with ethyl acetate (10 mL) and quenched with 1M HCl solution (20 mL). The 
mixture was extracted with ethyl acetate (10 mL X 2) and the combined extracts were 
washed with brine, dried (Na2SO4) and concentrated. The residue was purified by column 
chromatography (hexane-ethyl acetate = 1:1) to afford a colorless solid (137 mg, 70%). 
The colorless solid was determined to be a mixture of two tetra-acetates by 1H NMR 
spectroscopy. Slow recrystallization of the mixture (ethyl acetate) gave two crystalline 
forms, which were manually separated (tweezers) to afford the pure diastereomers. 
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N-(2S*,3R*,4R*,5R*-Tetraacetoxycyclohex-1R*-yl)phthalimide (±)-139: mp 215–217 
0C; 1H NMR (CDCl3, 300 MHz) δ1.85, 2.02, 2.21 (13H, 4Xs and m, OAc), 2.93 (dt, J = 
2.1, 14.0 Hz, 1H), 4.70 (ddd, J = 4.8, 10.5, 13.2 Hz, 1H), 5.11 (dd, J = 2.8, 10.7 Hz, 1H), 
5.51-5.58 (m,  2H), 5.73 (dd, J = 9.6, 10.5 Hz, 1H), 7.70-7.88 (m 4H); 13C NMR (CDCl3, 
75 MHz) δ 20.6, 20.8, 20.7, 21.3, 28.7, 47.4, 67.5, 70.4, 71.6, 71.7, 123.8, 131.6, 134.6, 
168.0, 170.0, 170.1, 170.15, 170.17. Anal. Calcd. for C22H23NO10: C, 57.26; H, 5.04. 
Found: C, 57.18; H, 4.96. 
 
 
 
 
N-(2S*,3S*,4S*,5R*-Tetraacetoxycyclohex-1R*-yl)phthalimide (±)-140:   mp  218–
221 0C; 1H NMR (CDCl3, 300 MHz) δ 1.85 (s, OAc, 3H), 2.00-2.13 (br d, J = 14.4 Hz, 
1H), 2.15, 2.17, 2.21 (3Xs, OAc, 9H), 2.99 (ddd, J = 3.6, 12.5, 14.4 Hz, 1H), 4.92  (ddd, 
J = 4.2, 10.9, 12.2 Hz, 1H), 5.10-5.13 (narrow m, 1H), 5.16 (dt, J = 1.5, 3.0 Hz, 1H), 5.48 
(dt, J = 1.2, 3.5 Hz, 1H), 5.87 (dd, J = 3.6, 10.8 Hz, 1H), 7.73-7.90 (m, 4H); 13C NMR 
(CDCl3, 75 MHz) δ 20.8, 21.0, 21.1, 21.2, 29.2, 44.5, 68.1, 68.6, 68.7, 69.0, 123.7, 131.7, 
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134.5, 168.2, 169.0, 169.7, 169.74, 169.9. Anal. Calcd. for C22H23NO10: C, 57.3; H, 5.0. 
Found: C, 57.17; H, 4.98. 
 
 
 
 
1R*-(2R*,3S*,4R*,5R*-Tetrahydroxycyclohexyl)ammonium choloride (±)-141: To a 
25 mL round-bottomed flask was charged tetra-acetate (±)-138 (67 mg, 0.15 mmol) and 
6N HCl (4 mL).  The mixture was heated at reflux for 4 h. The reaction mixture was 
dried, re-dissolved in deionized water (6 mL) and then extracted with ethyl acetate (6 mL 
X 3). The aqueous solution was concentrated, dried under high vacuum to afford a light 
yellow solid (27 mg, 93%). mp 57–60 0C; 1H NMR (CH3OD, 400 MHz) δ 2.00-2.22 (m, 
2H), 3.80-3.87 (m, 1H), 3.89-3.95 (m, 1H), 3.97-4.03 (m, 1H), 4.08-4.17 (m, 2H). 
Reaction of (±)-119 with DBU: To a stirring solution of the major endoperoxide (±)-119 
(690 mg, 2.68 mmol) in CH2Cl2 (25 mL) at room temperature was added dropwise 1,8-
diazabicyclo[5.4.0]undec-7-ene (0.70 mL, 4.03 mmol). The mixture was stirred for 15 
min, then diluted with CH2Cl2 (20 mL), and finally neutralized with amberlite IRC-76. 
The mixture was filtered and the filtrate concentrated and applied to a column of silica. 
Elution (hexane-ethyl acetate = 1: 1) gave the 5-phthalimidocyclohexenone (±)-142 as a 
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colorless compound (278 mg, 40%). Further elution gave a mixture of epimeric 6-
phthalimidocyclohexenone (±)-144 and (±)-143 as a colorless solid (155 mg, 24%). 
 
 
 
N-(2S*-Hydroxy-5-oxo-3-cyclohexene-1S*-yl)phthalimide (±)-142:  mp 175–177 0C; 
1H NMR (CDCl3, 400 MHz) δ 2.67 (dd, J = 4.8, 16.4 Hz, 1H), 3.43 (dd, J = 13.6, 16.4 
Hz, 1H), 4.65 (ddd, J = 4.8, 10.0, Hz, 1H), 5.33 (br d, J = 10.4 Hz, 1H), 6.11 (d, J = 10.0 
Hz, 1H), 7.02 (dd, J = 1.6, 10.3 Hz, 1H)  7.78-7.89 (AA’BB’, 4H); 13C NMR (CDCl3, 75 
MHz) δ 40.2, 53.6, 67.7, 123.8, 129.6, 131.8, 134.8, 152.4, 168.5, 196.4. Anal. Calcd for 
C14H11NO4: C, 65.36; H, 4.31. Found: C, 65.01, H, 4.31. 
N-(5-Hydroxy-2-oxo-3-cyclohexen-1-yl)phthalimide (±)-143/(±)-144. mp 192-195 0C; 
δ (CD3OD, 400 MHz) 2.51-2.43 (m, 1H), 2.81 (td, J = 14.4, 11.4 Hz, 1H), 4.84-4.75 (m, 
1H), 4.98 (dd, J = 14.6, 5.0 Hz, 1H), 6.09 (dd, J = 10.8, 2.4 Hz, 1H), 7.12 (d, J = 10.4 Hz, 
1H), 7.96-7.78 (m, 4H) and δ (partial, CD3OD, 400 MHz) 2.26 (br d, J = 13.2 Hz, 1H), 
3.02 (dt, J = 13.2, 3.6 Hz, 1H), 4.60-4.58 (m, 1H), 5.35 (dd, J = 13.2, 4.8 Hz, 1H). 
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N-(2R*,5R*-Dihydroxy-3-cyclohexene-1S*-yl)phthalimide(±)-146: To a stirring 
solution of the major cyclohexenone (±)-142 (270 mg, 1.05 mmol) in methanol (22 mL) 
at room temperature was added CeCl3.7H2O (0.391 gm, 1.05 mmol) followed by solid 
NaBH4 (80 mg, 2.1 mmol). The reaction mixture was stirred for 45 min and then 
quenched with water (10 mL). The mixture was concentrated under vacuum to removed 
methanol. The concentrated mixture was diluted with water (20 mL) and then extracted 
with ethyl acetate (20 mL X 5). The combined extracts were washed with saturated 
NaHCO3 and dried (Na2SO4). The solution was concentrated and dried under high 
vacuum to afford a colorless solid (167 mg, 61%). mp 187–190 0C; 1H NMR (CD3OD, 
400 MHz) δ 2.09-2.15 (m, 1H), 2.46 (ddd, J = 10.0, 12.0, 13.2 Hz, 1H), 4.19 (ddd, J = 
3.0, 9.2, 13.6 Hz, 1H), 4.39-4.46 (m, 1H), 4.85-4.95 (m, 1H), 5.73 (td, J = 1.6, 10.4 Hz, 
1H), 5.78 (dq, J =1.9, 10.4, Hz, 1H), 7.78-7.89 (m, 4H); 13C NMR (CD3COCD3, 75 
MHz) δ 36.8, 54.5, 67.5, 67.7, 123.7, 131.8, 133.1, 134.0, 135.0, 169.0. Anal. Calcd. for 
C14H13NO4: C, 64.86; H, 5.05. Found: C, 64.93; H, 5.27. 
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N-(2R*,5S*-Dihydroxycyclohex-1S*-yl)phthalimide (±)-147: To a Parr apparatus was 
charged olefin (±)-146 (56 mg, 0. 22 mmol), methanol (10 mL) and 10% of Pd/C (ca. 5 
mg) catalyst. The mixture was stirred at room temperature under hydrogen (40 psi) for 5 
h. The reaction mixture was filtered through celite and the filtrate was concentrated and 
applied to a wet column of silica. Elution (100% ethyl acetate) gave a colorless 
compound (36 mg, 64%). mp 243–245 0C; 1H NMR (CD3OD, 300 MHz) δ 1.38-1.55 (m, 
2H), 1.93-2.18 (m, 3H), 2.25 (q, J = 12.0 Hz, 1H), 3.64-3.76 (m, 1H), 4.02 (ddd, J = 4.4, 
9.3, 13.5 Hz, 1H), 4.21-4.31 (m, 1H), 7.78-7.90 (m, 4H); 13C NMR (CD3OD, 75 MHz) δ 
32.4, 34.3, 38.2, 55.9, 69.6, 70.0, 124.1, 133.4, 135.4, 170.1. Anal. Calcd. for C14H15NO4: 
C, 64.36; H, 5.79. Found: C, 64.01; H, 5.76. 
 
 
 
 
N-(2S*,3S*,4R*,5S*-Tetraacetoxycyclohex-1R*-yl)phthalimide (±)-148 and N-
(2S*,3R*,4S*,5S*-Tetraacetoxycyclohex-1R*-yl)phthalimide (±)-149: To a stirring 
solution of olefin (±)-146 (160 mg, 0.620 mmol) in acetone (4 mL) was added a solution 
of N-methylmorpholine N-oxide (0.150 gm, 1.24 mmol) in water (0.8 mL) followed by a 
solution of OsO4 in toluene (0.4 mL, 10 mol%). The reaction mixture was stirred at room 
temperature for 30 h and then solid Na2S2O4 (0.10 gm, 0.62 mmol) was added and stirred 
for another 30 min. The crude reaction mixture was adsorbed on silica and then layered 
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onto a column of silica gel. Elution (ethyl acetate-methanol = 9:1) gave a colorless 
mixture of two tetraols (82 mg, 45%). To a round-bottom flask was charged the mixture 
of tetraols (82 mg, 0.27 mmol) and acetic anhydride (0.6 mL) at room temperature. To 
the stirring mixture pyridine (0.4 mL) was added dropwise and the mixture was stirred 
overnight. The reaction mixture was diluted with ethyl acetate (6 mL) and quenched with 
aqueous HCl (1M, 7 mL) solution. The aqueous layer was extracted with ethyl acetate (6 
mL X 3). The combined ethyl acetate layers were washed with brine, dried (Na2SO4) and 
concentrated. The residue was re-dissolved in CH2Cl2 and applied to a column of wet 
silica gel. Elution (hexane-ethyl acetate = 1:1) gave a colorless mixture of two 
tetraacetates    (104 mg, 82%). Anal. Calcd. for C22H23NO10: C, 57.26; H, 5.02. Found: C, 
57.27; H, 5.3. mp 150-160 0C; 1H NMR (CDCl3, 400 MHz) δ (mixture) 2.56 (dt, J = 
12.9, 10.9 Hz, 0.45H), 3.14 (q, J = 12.7 Hz, 0.55H),  4.40 (ddd, J = 13.6, 10.4, 4.8 Hz, 
0.55H), 4.77 (ddd, J = 13.4, 11.0, 4.8 Hz, 0.45H), 5.04 (ddd, J = 12.0, 4.4, 2.0 Hz, 
0.55H), 5.07 (dd, J = 10.4, 2.8 Hz, 0.55H), 5.24-5.22 (dd, J = 10.2, 2.6 Hz, 0.45H), 5.33 
(m, 0.45H), 5.63 (narrow m, 0.55H), 5.71 (t, J = 2.8 Hz, 0.45H), 5.77 (dd, J = 11.0, 2.6 
Hz, 0.45H), 5.92 (t, J = 10.4 Hz, 0.55H), 7.88-7.70 (m, 4H). 
Rearrangement of major endoperoxide (±)-119 with Grubb’s catalyst. In a 10 mL 
round-bottomed flask, major endoperoxide (±)-119 (50 mg, 0.19 mmol) was dissolved in 
dry CH2Cl2 (1.5 mL) at room temperature. To the stirring solution Grubb’s II catalyst 
(1.6 mg 10 mol%) was added and the mixture was stirred for 30 min. The mixture was 
concentrated under reduced pressure. Analysis of the crude product by 1H NMR indicated 
this to be a mixture of (±)-153 : 151 : 150 : (±)-152 ratio = 3 : 1.5 : 2 : 1. Separation of 
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the mixture by column chromatography   (hexane-ethyl acetate = 10:1 to 1:4) gave 
colorless solid 151 (8 mg, 24%). oxetane (7 mg, 14%) and diepoxide (29%) 
 
 
  
 
N-Vinylphthalimide (151): mp 84–86 0 C; 1H NMR (CDCl3, 300 MHz) δ 5.06 (d, J = 
10.3 Hz 1H), 6.10 (d, J = 16.3 Hz, 1H), 6.89 (dd, J = 9.9, 16.5 Hz, 1H), 7.76 ( dd, J = 3.5, 
5.5 Hz, 2H), 7.89 (dd, J = 3.4,  5.6 Hz, 2H); 13C NMR (CDCl3 75 MHz) δ 104.8, 123.9, 
124.0, 131.8, 134.9, 166.7. This spectral data are consistent with the literarute values.50 
 
 
  
Oxetane (±)-152: (7 mg, 14%); 1H NMR (CDCl3, 400 MHz) δ 3.04 (td, J = 8.0, 12.0 Hz, 
1H), 3.82 (ddd, J = 4.6, 7.6, 12.0 Hz, 1H), 6.07 (dd, J = 7.2, 11.6 Hz, 1H), 6.33 (q, J = 
7.2 Hz, 1H), 6.40 (ddd, J = 1.2, 5.0,  8.3 Hz, 1H), 6.88 (ddd, J = 0.8, 6.8, 11.5  Hz 1H), 
7.78-7.80 (m, 2H), 7.92-7.94 (m 2H), 10.15 (d, J = 7.2 Hz, 1H); 13C NMR (CDCl3, 75 
MHz) δ 33.8, 74.9, 77.8, 123.9, 129.8, 131.9, 134.9, 150.5, 167.4, 191.3. 
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N-(2,4-Cyclohexadien-1-yl)phthalimide bisepoxide (±)-153: (14 mg, 29%);  mp 205–
207 0C; 1H NMR (CDCl3, 400 MHz) δ 2.13 (ddd, J = 2.6, 6.6, 15.0 Hz, 1H), 2.40 (ddd, J 
= 2.4, 9.2, 14.8 Hz 1H), 3.26 (dd, J = 2.6, 3.8, Hz, 1H), 3.30 (td, J = 2.4, 4.0 Hz, 1H), 
3.54-3.56 (m, 1H), 3.58-3.60 (m, 1H), 4.59 (ddd, J = 2.4, 6.8, 9.4  Hz,  1H), 7.75-7.77 
(AA’BB’. 2H), 7.86-7.88 (AA’BB’ 2H); 13C NMR (CDCl3, 75 MHz) δ 26.0, 43.5, 47.3, 
49.3, 49.7, 50.7, 123.7, 131.9, 134.6, 168.0. Anal. Calcd. for C14H11NO4: C, 65.36; H, 
4.31. Found: C, 65.15; H, 4.36. 
 
 
 
 
N-(2,3-Epoxy-4R*,5S*-dihydroxycyclohex-1R*-yl)phthalimide (±)-154: In a 10 mL 
round-bottom flask, endoperoxide (±)-119 (150 mg, 0.584 mmol) was dissolved in dry 
CH2Cl2 (5 mL) at room temperature. To the stirring solution Grubb’s II catalyst (50 mg 
10 mol%) was added and the mixture was stirred for 30 min. The mixture was 
concentrated under reduced pressure and applied to a wet (hexane) column of silica. The 
column was eluted with ethyl acetate and hexane mixture (1:4) for a while and then left to 
99    
stand overnight. Further elution, (100% ethyl acetate) gave a colorless solid (40 mg, 
26%). mp 215–218 0C; 1H NMR (CH3OD, 400 MHz) δ 1.81-1.91 (m, 1H), 1.98 (q, J = 
12.0 Hz, 1H), 3.38 (dd, J = 1.5,  3.6 Hz, 1H), 3.45 (dd, J = 1.5, 3.6 Hz, 1H), 3.64 (ddd, J 
= 3.6, 8.4, 12.0 Hz, 1H), 3.87 (dd, J = 1.5, 8.5 Hz, 1H), 4.58 (dd, J = 6.9, 11.4 Hz, 1H), 
7.78-7.90 (m, 4H); 13C NMR (CH3OD, 75 MHz) δ 35.3, 46.6, 58.8, 59.8, 68.3, 74.8, 
124.4, 133.3, 135.8, 169.1. FAB-HRMS m/z 276.0875 (Calcd. for C14H14NO5 (M+H) 
m/z 276.0872). Hydrolysis of this epoxide in a fashion similar to that previously describe 
gave N-(2S*,3R*,4S*,5R*-tetrahydroxycyclohex-1S*-yl)phthalimide (74%). 
 
 
 
 
3-Phenyl-7-phthalimido-2-oxa-3-azabicyclo[2.2.2]oct-5-ene (±)-158: In a 25 mL 
round-bottom flask, nitrosobenzene (220 mg, 2.04 mmol) was dissolved in dry CH2Cl2 (8 
mL) at room temperature under nitrogen. Diene (±)-118 (230 mg, 1.02 mmol) was added 
in one portion and the mixture was stirred for 2 h. The reaction mixture was concentrated 
under reduced pressure. The residue was purified by column chromatography (SiO2, 
hexane-ethyl acetate = 4:1) to afford a colorless solid (224 mg, 67%). mp = 148 – 151 0C; 
1H NMR (CDCl3, 400 MHz) δ 2.59 (td, J = 3.6, 13.6 Hz, 1H), 2.81 (ddd, J = 3.2, 9.6, 
13.2 Hz, 1H), 4.63-4.67 (m, 1H), 4.90 (td, J = 4.0, 9.6 Hz, 1H), 5.01 (dt, J = 1.6, 5.2 Hz, 
1H), 6.38 (ddd, J = 1.8, 6.4, 8.2 Hz, 1H), 6.53 (ddd, J = 1.6, 5.6, 8.4 Hz, 1H), 6.96 (t, J = 
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7.6 Hz, 1H), 7.03 (d, J = 7.6 Hz, 2H), 7.24 (t, J = 7.6, Hz, 2H), 7.70-7.84 (m, 4H); 13C 
NMR (CDCl3, 100 MHz) δ 27.6, 48.2, 57.1, 69.4, 117.7, 122.5, 123.3, 128.4, 128.7, 
131.7, 132.6, 134.3, 151.8, 168.5. Anal. Calcd. for C20H16N2O3: C, 72.28; H, 4.85; N, 
8.43. Found: C, 72.11, H, 4.89, N, 8.46. 
 
 
 
 
 
N-[(1S*,2S*,5S*)-2-Hydroxy-5-(phenylamino)cyclohex-3-enyl]phthalimide (±)-159: 
To a stirring solution of olefin (±)-158 (200 mg, 0.600 mmol) in a mixture of CH3CN (8 
mL) and water (0.7 mL) was added Mo(CO)6 (158 mg, 0.600 mmol) and the mixture was 
heated at reflux for 1 h. The reaction mixture was concentrated under reduced pressure 
and applied to a column of silica. Elution (hexane-ethyl acetate = 1:1) gave a light yellow 
foamy solid (90 mg, 45%). mp 73-75 0 C; 1H NMR (CD3OD, 400 MHz) δ 2.05 (br d, J = 
13.2 Hz, 1H), 2.77 (dt, J = 4.8, 13.2 Hz, 1H), 4.23 (br s, 1H), 4.39 (ddd, J = 3.4, 9.8, 13.2 
Hz 1H), 4.84 (dd, J = 1.4, 9.8, Hz, 1H), 5.82-5.95 (m, 2H), 6.64 (d, J = 7.6 Hz, 2H), 6.71 
(d, J = 7.2 Hz, 1H), 7.17 (dd, J = 7.0, 8.6 Hz, 2H), 7.65-7.80 (m, 4H); 13 C NMR (CDCl3, 
100 MHz) δ 29.9, 48.0, 51.2 68.4, 113.3, 117.9, 123.4, 128.4, 129.6, 131.9, 133.8, 134.2, 
146.7, 169.0. FAB-HRMS m/z 334.1321 (calcd for C20H18N2O3 (M+) m/z 334.1317). 
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N-[(1S*,2R*,3R*4R*,5S*)-2,3,4-Trihydroxy-5-phenylamino)cyclohexyl]phthalimide 
(±)-160: To a stirring solution of olefin (±)-159 (50 mg, 0.15 mmol) in acetone (0.8 mL) 
was added a solution of N-methylmorpholine N-oxide (30.0 mg, 0.230 mmol) in water 
(0.3 mL) followed by a solution of OsO4 in toluene (0.1 mL, 10 mol%). The reaction 
mixture was stirred for 15 h at room temperature and then Na2S2O4 (26 mg) was added 
and stirred for another 30 min. The reaction mixture was concentrated under reduced 
pressure and applied to a column of silica. Elution (hexane-ethyl acetate = 1:4) gave a 
colorless solid  (18 mg, 33%). mp 253-255 0 C; 1H NMR (CD3OD, 300 MHz) δ 1.78 (br 
d, J = 13.3 Hz, 1H), 3.00 (dt, J = 3.9, 13.3 Hz, 1H), 3.70-3.78 (m and dd J = 2.7, 9.3, Hz, 
2H), 4.11 (narrow t, J = 2.6 Hz, 1H), 4.43 (ddd, J = 4.2, 10.8, 13.2 Hz, 1H), 4.55 (d, J = 
9.6, 10.2 Hz, 1H), 6.62 (t, J = 7.2 Hz, 1H), 6.72 (d, J = 8.4 Hz, 2H), 7.11 (dd, J = 7.5, 8.4 
Hz, 2H), 7.76-7.83 (m, 4H); 13C NMR (CD3COCD3, 75 MHz) δ 28.1, 51.6, 53.3, 69.9, 
71.9, 73.7, 113.6, 117.4, 123.7, 129.8, 132.7, 135.1, 148.6, 168.8. FAB-HRMS m/z 
369.1447 (calcd for C20H21N2O5 (M+H)  m/z 369.1450). 
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N-[(1S*,2S*,5R*)-2-Hydroxy-5-(phenylamino)cyclohexyl]phthalimide (±)-161: In a 
hydrogenation container olefin (±)-158 (0.3 g, 0.9 mmol) was dissolved in methanol (30 
mL) at room temperature. To the reaction mixture was added an aqueous slurry of Raney-
Ni (0.5 mL) catalyst and the mixture was stirred under hydrogen (40 psi) for 4 h. The 
reaction mixture was filtered through celite and concentrated under reduced pressure. The 
residue was re-dissolved in ethyl acetate, adsorbed to silica and then applied to a column 
of silica. Elution (hexane-ethyl acetate = 1:1) gave a light yellow solid (225 mg, 74%). 
mp 242–245 0C; 1H NMR (CD3OD, 400 MHz) δ 1.74-2.05 (m, 5H), 2.51 (dt, J = 3.6, 
13.1 Hz 1H), 3.80 (br s, 1H), 4.27-4.40 (m, 2H), 6.59 (t, J = 7.6 Hz, 1H), 6.69 (d, J = 7.6 
Hz, 2H), 7.09 (t, J = 7.6 Hz, 2H) 7.74-7.83 (m, 4H); 13C NMR (CD3OD, 100 MHz) δ 
29.4, 30.3, 33.4, 54.1, 70.3, 114.6, 118.1, 124.1, 130.2, 133.5, 135.3, 149.2, 170.4, one 
signal obscured by solvent. Anal. Calcd for C20H20N2O3: C, 71.41; H, 5.99. Found: C, 
71.50; H, 6.04. 
 
 
 
 (±)-162: A round-bottomed flask was charged with diamino alcohol (±)-161 (50.0 mg, 
0.148 mmol) and 6N HCl (3 mL). The mixture was heated at reflux for 15 h. The reaction 
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mixture was dried, redissolved in deionized water (6 mL) and then extracted with ethyl 
acetate (5 X 3 mL). The aqueous solution was concentrated and dried under high vacuum 
to afford a colorless foamy solid (43 mg, 100%). 1H NMR (CD3OD, 400 MHz) δ 1.62-
1.89 (m, 5H), 2.16-2.26 (m, 1H), 3.35-3.43 (m, 1H), 3.50-3.58 (m, 1H), 3.76-3.83 (m, 
1H), 7.35-7.46 (m, 5H); 13C NMR (CD3OD, 75 MHz) δ 24.8, 28.3, 29.4, 52.3, 59.3, 69.4, 
125.1, 131.4, 131.7, 134.9. 
 
 
 
 
 
3-Phenyl-7-phthalimido-2-oxa-3-azabicyclo[2.2.2]oct-5-ene-5,6-diol (±)-163: To a 
stirring solution of olefin (±)-158 (70 mg, 0.21 mmol) in acetone (2.5 mL) was added a 
solution of N-methylmorpholine N-oxide (73 mg, 0.62 mmol) in water (0.5 mL) followed 
by a solution of OsO4 in toluene (0.2mL, 15 mol%). The reaction mixture was stirred for 
10 h at room temperature and then Na2S2O4 (52 mg) was added and stirred for another 30 
min. The mixture was concentrated and adsorbed to silica using CH2Cl2. This was 
layered onto a silica gel column. Elution (hexane-ethyl acetate = 1:1) gave a colorless 
solid (63 mg, 81%). mp 183–186 0C; 1H NMR (CDCl3, 400 MHz) δ 2.29 (ddd, J = 4.8, 
11.6, 14.4 Hz, 1H), 2.72 (ddd, J = 1.2, 7.6, 14.4 Hz, 1H), 3.44 (d, J = 7.6 Hz, 1H, OH), 
3.71 (d, J = 10.0 Hz, 1H, OH), 3.98-4.13 (m, 2H), 4.34 (t, J = 7.6 Hz, 1H), 4.58 (dt, J = 
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3.2, 9.2 Hz, 1H), 4.88 (ddd, J = 4.0, 8.0, 11.2 Hz, 1H), 7.04 (t, J = 7.2 Hz, 1H), 7.22 (d, J 
= 8.0 Hz, 2H), 7.24 (dd, J = 7.2, 8.8 Hz, 2H), 7.73-7.86 (m, 4H); 13C NMR (CDCl3, 100 
MHz) δ 19.7, 45.0, 59.5, 64.1, 66.0, 76.6, 116.1, 122.8, 123.8, 129.4, 131.5, 134.7, 149.8, 
168.6. Anal. Calcd. for C20H18N2O5.0.6H2O: C, 63.69; H, 5.13. Found: C, 63.66; H, 4.93. 
 
 
 
 
 
 
N-[(1S*,2R*,3S*,5S*)-2,3,4-Trihydroxy-5-(phenylamino)cyclohexyl]phthalimide (±)-
164: In a hydrogenation container, diol (±)-163 (0.160 g, 0.437 mmol) was dissolved in 
methanol (30 mL) at room temperature. To the reaction mixture, aqueous slurry of 
Raney-Ni (0.3 mL) catalyst was added and the mixture was stirred under hydrogen (40 
psi) for 2 h. The reaction mixture was filtered through celite. The filtrate was 
concentrated, adsorbed to silica gel and then applied to a column of silica. Elution (100% 
ethyl acetate) gave a colorless solid (91 mg, 57%). mp 233–235 0C; 1H NMR (CD3OD, 
400 MHz), δ 2.03 (td, J = 3.8, 13.2 Hz, 1H), 2.31 (dt, J = 3.2, 13.2 Hz, 1H), 3.84 (dd, J = 
3.0, 4.3, Hz, 1H), 3.99-4.03 (m, 1H), 4.21 (t, J = 2.6 Hz, 1H), 4.34 (dd, J = 2.6, 10.8, Hz, 
1H), 4.64 (ddd, J = 3.8, 10.8, 13.2 Hz, 1H), 6.57 (t, J = 7.6 Hz, 1H), 6.62 (d, J = 8.0 Hz, 
2H), 7.08 (t, J = 7.6 Hz, 2H), 7.75-7.83 (m, 4H); 13C NMR (CD3OD, 100 MHz) δ 30.1, 
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48.3, 54.9, 70.2, 70.7, 76.4, 114.2, 117.9, 124.1, 130.3, 133.4, 135.4, 149.4, 170.3. FAB-
HRMS m/z 369.1448 (Calcd for C20H21N2O5 (M+H) m/z 369.1450) 
 
 
 
 
 
(±)-165: In a 10 mL round-bottomed flask was charged triol (±)-164 (35.0 mg, 0.095 
mmol) and 6N HCl (3 mL). The mixture was heated at reflux for 15 h. The reaction 
mixture was dried re-dissolved in deionized water (6 mL) and then extracted with ethyl 
acetate (5 mL X 3). The aqueous solution was concentrated, dried under high vacuum to 
afford a colorless solid (17 mg, 57%). 1H NMR (CD3OD, 300 MHz), δ 1.74-1.89 (m, 
1H), 2.20 (d, J = 13.8 Hz, 1H), 3.56-3.69 (m, 2H), 3.87-3.94 (s, 1H), 3.98-4.04 (s, 1H), 
4.13-4.18 (s, 1H), 7.48-7.61 (m, 5H); 13C NMR (CD3OD, 75 MHz) δ 26.4, 47.8, 65.4, 
68.5, 71.9, 74.9, 125.0, 131.1, 131.7, 136.4. 
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3-Mandeloyl-7-phthalimido-2-oxa-3-azabicyclo[2.2.2]oct-5-enes (±)-167: To a 
rapidely stirring solution of (±)-118 (0.600 g, 2.67 mmol) and NaIO4 (0.683 g, 3.19 
mmol) in CH2Cl2 (10 mL), DMF (10 mL) and water (5 mL) was added, over a period of 
45 min, a solution of (±)-mandelohydroxamic acid (0.441 g, 2.64 mmol) in DMF (10 
mL). The mixture was stirred for an additional 3 h, then poured into water and extracted 
several times with CH2Cl2. The combined extracts were washed with brine, dried 
(Na2SO4) and concentrated. The residue was purified by column chromatography (SiO2, 
hexane-ethyl acetate, 1:1) to afford a colorless solid (0.795 g, 77%). From 1H NMR, 
mixture of (±)-167, (±)-168 and (±)-169 (5:3:2). Recrystallization (MeCN) of two batches 
gave (±)-167 (0.513 g, 25%). mp 160-162 0C; 1H NMR (300 MHz, CDCl3) δ 2.49 (ddd, J 
= 2.7, 4.5, 13.5, 1H), 2.60 (ddd, J = 3.3, 9.0, 13.5 Hz, 1H), 4.15 (d, J = 7.5 Hz, 1H), 4.73 
(t, J = 3.9 Hz, 1H), 4.81 (td, J = 4.5, 9.0 Hz, 1 H), 5.25-5.36 (m and d, J = 6.6 Hz, 2 H 
total), 5.79 (t, J = 6.6 Hz, 1 H), 6.57 (t, J = 6.6 Hz, 1 H), 7.19-7.30 (m, 5 H), 7.65-7.80 
(m, 4 H); ¹³C NMR (75 MHz, CDCl3): δ = 26.6, 47.6, 48.6, 71.6, 71.8, 123.5, 127.8, 
128.08, 128.12, 128.2, 131.4, 134.47, 134.51, 137.5, 168.1, 173.1. Anal. Calcd for 
C22H18N2O5: C, 67.69; H, 4.64. Found: C, 67.48; H, 4.65. 
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(7S)-3-[(R)-Mandeloyl]-7-phthalimido-2-oxa-3-azabicyclo[2.2.2]oct-5-ene [(+)-167]: 
Reaction of (±)-118 (0.300 g, 1.33 mmol) with the nitrosoacyl generated from (R)-
mandelohydroxamic acid (0.212 g, 1.27 mmol) was carried out in a fashion similar to the 
typical procedure for 14-16 using (±)-mandelohydroxamic acid. Purification of the 
residue by column chromatography (silica gel, hexanes-EtOAc, 1:1) gave a colorless 
solid (0.316 g, 62%). Recrystallization (MeCN) gave (+)-167 (57 mg, 11%); mp 180-183 
˚C; [α]D = +126.5 (c 0.429, CH2Cl2). The ¹H NMR spectrum of this product was identical 
to that of the racemic compound.        
 
Reaction of 3-Mandeloyl-7-phthalimido-2-oxa-3-azabicyclo[2.2.2]oct-5-ene with 
Acetic Anhydride(±)-168*: To a mixture of (±)-167, (±)-168,  and (±)-179 (80 mg, 0.20 
mmol) in CH2Cl2 (1 mL), at r.t. was added dropwise pyridine (0.10 mL, 1.0 mmol) 
followed by Ac2O (0.10 mL, 1.1 mmol). The mixture was stirred for 12 h, diluted with 
CH2Cl2 and quenched with 1 M HCl. The mixture was extracted several times with 
CH2Cl2 and the combined extracts were washed with brine, dried (Na2SO4), and 
concentrated. Purification of the residue by preparative TLC (hexane-EtOAc = 7:3) gave 
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(±)-168* (17 mg, 19%) as a colorless oil, followed by a mixture of (±)-167* and (±)-169* 
(ca. 8:3 ratio, 39 mg, 41%) as a colorless oil. 1H NMR (400 MHz, CDCl3) δ 2.16 (s, 3 H), 
2.38-2.43 (m, 2 H), 4.47-4.55 (m, 1 H), 5.00-5.05 (m, 1 H), 5.33-5.38 (br s, 1 H), 6.13 (s, 
1 H), 6.55 (br t, J = 6.8 Hz, 1 H), 6.89 (br t, J = 7.2 Hz, 1 H), 7.39-7.55 (m, 5 H), 7.70-
7.80 (m, 4 H);13C NMR (75 MHz, CDCl3) δ  20.9, 26.9, 47.3, 48.9, 72.2, 73.7, 123.5, 
128.4, 128.5, 128.9, 129.2, 131.5, 134.3, 134.5, 135.0, 168.2, 170.7; one CO signal not 
observed.HRMS (ESI): m/z [M + Na]+ calcd for C24H20N2NaO6: 455.1219; found: 
455.1216. 
 
 
 
 
(2R*)-2-Hydroxy-N-[(1R*,4R*,5R*)-4-hydroxy-5-phthalimidocyclohex-2-enyl]-2-
phenylacetamide (±)-170: To a flame dried 10 mL Schlenk flask under nitrogen at room 
temperature was charged titanocene dichloride (93 mg, 0.38 mmol), activated zinc dust 
(50 mg, 0.75 mmol) and freshly distilled THF (1.2 mL). The mixture was stirred for 45 
min. The mixture turned red to olive green. The green mixture was cooled to - 30°C and 
to the cooled mixture was added a solution of (±)-167 (60 mg, 0.15 mmol) in methanol 
(1.5 mL). The reaction mixture was stirred for 1 h maintaining the temperature between -
15 to -30 °C. The reaction mixture was warmed to room temperature and quenched with 
sat. NH4Cl (5 mL) solution. The whole mixture was filtered through celite and aqueous 
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layer was extracted with ethyl acetate (3 X 5 mL). The combined ethyl acetate extracts 
were washed with brine, dried (Na2SO4), concentrated and applied to a column of silica. 
Elution (100% ethyl acetate) gave a colorless solid (40 mg, 66%). mp = 223-225 °C; 1H 
NMR (CD3OD, 400 MHz) δ 1.75 (tdd, J = 1.6, 3.2, 14.0 Hz, 1H), 2.64 (dt, J = 4.8, 14.0 
Hz, 1H), 4.40 (ddd, J = 3.1, 9.4, 13.9 Hz, 1H), 4.49-4.54 (m, 1H), 4.98 (s, 1H), 5.75-5.81 
(m, 1H), 5.94 (br d, J = 10.0 Hz, 1H), 7.24 (t, J = 7.6 Hz, 1H), 7.31 (t, J = 8.0 Hz, 2H), 
7.45 (d, J = 7.6 Hz, 1H), 7.74-7.78 (m, 2H), 7.81-7.84 (m, 2H), one signal obscured by 
solvent; 13C NMR (CD3OD, 100 MHz) δ 32.4, 45.8, 52.1, 67.9, 75.8, 124.2, 127.4, 128.4, 
129.4, 129.7, 133.4, 135.6, 136.5, 141.8, 170.1, 175.2; HRMS (ESI): m/z [M + Na]+ 
calcd for C22H20N2NaO5: 415.1270; found: 415.1274. 
 
 
  
 
 (2R)-2-Hydroxy-N-[(1R,4R,5R)-4-hydroxy-5-phthalimidocyclohex-2-enyl]-2-
phenylacetamide (-)-170: The reduction of (+)-167 (50 mg, 0.13 mmol) in methanol (1.5 
mL) with titanium was carried out in a fashion similar to the reduction of (±)-167. 
Purification by column chromatography (100% ethyl acetate) gave a colorless foamy 
solid (27 mg, 54%). mp = 193-195 °C; [α]D = - 106 (c 0.270, MeOH); The 1H NMR 
spectrum was identical to the racemic compound.   
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(2R*)-2-Hydroxy-N-[(1S*,4R*,5R*)-4-hydroxy-5-phthalimidocyclohexyl]-2-
phenylacetamide (±)-171: To a parr apparatus was charged olefin (±)-170 (30 mg, 0.077 
mmol), methanol (6 mL) and 10% of Pd/C (ca. 2.5 mg) catalyst. The mixture was stirred 
at room temperature under hydrogen (40 psi) for 2 h. The reaction mixture was filtered 
through celite. The filtrate was concentrated and applied to a column of silica. Elution 
(100% ethyl acetate) gave a colorless solid (23 mg, 76%). mp = 150-152 °C; 1H NMR 
(CD3OD, 300 MHz) δ 1.50-2.05 (m, 6H), 2.43 (dt, J = 3.0, 12.3 Hz, 1H), 4.04-4.34 (m, 
3H), 5.03 (br s, 1H), 7.23-7.51 (5H, Ar), 7.71-7.84 (m, 4H, Ar), one signal obscured by 
the solvent; 13C NMR (CD3OD, 75 MHz) δ 29.0, 30.7, 33.3, 46.4, 54.1, 69.7, 75.6, 124.1, 
128.4, 129.4, 129.8, 133.4, 135.4, 141.8, 170.2, 175.1. HRMS (ESI): m/z [M + Na]+ 
calcd for C22H22N2NaO5: 417.1426; found 417.1422 
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(2R)-2-Hydroxy-N-[(1S,4R,5R)-4-hydroxy-5-phthalimidocyclohexyl]-2-
phenylacetamide (-)-171: The reduction of (-)-170 (25 mg, 0.064 mmol) with H2 in the 
presence of 10% Pd/C was carried out in a fashion similar to the reduction of (±)-170. 
Purification by column chromatography (100% ethyl acetate) gave colorless oil (20 mg, 
80%). [α]D = - 84 (c 0.20, MeOH); The 1H NMR spectral data was identical to the 
racemic compound.    
   
 
 
 
Tricarbonyl(η4-cyclooctatetraene)iron(0) (7): To a 500 mL round-bottomed flask was 
added cyclooctatetraene (5.0 mL, 48 mmol) dissolved in benzene   (200 mL). Iron 
pentacarbonyl (14 mL, 96 mmol) was added followed by the addition of trimethylamine 
N-oxide dihydrate (21.33 g, 191.9 mmol). The reaction mixture was heated at reflux for 2 
h then filtered and concentrated. The solid residue was washed several times with 
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benzene and the washings were filtered and concentrated. The deep-brownish residue was 
purified by column chromatography (SiO2, hexane-ethyl acetate = 20:1) to afford a deep 
brown crystal like solid (9.83 g, 100%). mp 82 - 860C (lit.27, 92 – 93.50C); IR (KBr, cm-1) 
2043, 1960; 1H NMR (CDCl3, 300 MHz) δ 5.25 (s, 8H); 13C NMR (CDCl3, 75 MHz) δ 
100.1, 212.5. 
 
 
 
 
Tricarbonyl(η4–6-styrylcyclohepta-1,3,5-triene)iron (0) (±)-14: To a 1 L round-
bottomed flask, (cyclooctatetraene)Fe(CO)3 (10.0 g, 40.9 mmol) was dissolved in dry 
acetone (50 mL) at -23 0C under N2. Dry pyridine (3 mL, 40.9 mmol) was added and 
mixture stirred for 5 min. A solution/suspension of tropylium tetrafluoroborate (8.73 g, 
49.1 mmol) in dry acetone (400 mL) was added and the reaction mixture was stirred for 8 
h maintaining the temperature at -23 0C. The reaction mixture was warmed to room 
temperature and stirred overnight. The clear reddish solution was concentrated under 
reduced pressure and dried. To the solid residue was added ether (200 mL) and the slurry 
stirred for 2 h and filtered. The above process was repeated three times with the solid 
residue. The combined filtrates were concentrated and the residue was purified by 
column chromatography (100% hexane) to give a bright yellow solid (10.42 g, 75%). mp  
43–47 0C (lit. 60, mp 64-66 0C); 1H NMR (CDCl3, 300 MHz) δ 3.10-3.03 (m, 1H), 3.34-
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3.21 (m, 2H), 5.18-5.10 (m, 1H), 5.43-5.33 (m, 2H), 5.92-5.82 (m, 2H), 6.46 (d, J = 16.0 
Hz, 1H), 7.37-7.19 (m, 5H); 13C NMR (CDCl3, 75 MHz) δ 46.9, 55.8, 64.9, 87.6, 95.3, 
126.4, 127.4, 127.6, 128.9, 129.1, 130.4, 134.2, 137.6, 211.3. The NMR spectral data 
obtained for the product were consistent with the literature values.60 
 
 
 
 
 
Tricarbonyl(η5-6-styrylcyclohepta-2,4-dien-1-yl)iron(+1) tetrafluoroborate (±)-172: 
To a 250 mL round-bottomed flask, (7-styrenyl-1,3,5-cycloheptatriene)Fe(CO)3 (8.0 g, 
24 mmol) was dissolved in  acetic anhydride (150 mL) at 0 0C with stirring. An ice-cold 
solution of fluoroboric acid (60 wt%, 23.40 mL, 240.0 mmol) in acetic anhydride (25 
mL) was added dropwise to the stirring mixture. After 20 min of stirring a yellow-gray 
precipitate began to form. The reaction mixture was added dropwise into a large excess 
of ether (3.5 L). The solid yellow cation was isolated by filtration and dried under high 
vacuum (8.88 g, 88%). IR (KBr) 2112, 2067, 760, 697 cm-1; 1H NMR (d6-acetone, 300 
MHz) δ 1.23-1.34 (m, 1H), 2.50-2.63 (m, 1H), 4.25 (br d, J = 8.0 Hz, 1H), 4.80-4.96 (m, 
2H), 5.93 (dd, J = 16.0, 8.0 Hz, 1H), 6.29 (m, 1H), 6.62 (m, J = 16.0 Hz, 2H), 7.33 (m, 
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5H), 7.47 (tq, J = 6.0, 1.0 Hz, 1H). The NMR spectral data obtained for the product were 
consistent with the literature values.60 
 
 
 
 
 
Tricarbonyl(η4-6-styrylcyclohepta-2,4-diene-1-ol)iron (±)-173: In a 500 mL round 
bottomed flask, solid cation (±)-172 (4.10 g, 9.71 mmol) was dissolved in  water (250 
mL) and the mixture was stirred for 20 min. To the clear light yellow solution was added 
solid sodium bicarbonate (8.07 g, 95.2 mmol). After a few minutes, a yellow colored 
solid began to precipitate. The reaction mixture was stirred for 45 min, at which time it 
was   extracted several times with dichloromethane. The combined extracts were washed 
with brine, dried (MgSO4) and concentrated. The yellow sticky, foamy residue was 
purified by column chromatography (Al2O3, hexane-ethyl acetate = 4:1) to give the 
product as a yellow solid (2.37 g, 70%). mp 122 - 1260C; IR (KBr) 3200-3400, 2049, 
1979, 746, 693 cm-1; 1H NMR (CDCl3, 300 MHz) δ 1.04 (br d, J = 12.0 Hz, 1H), 1.64 (d, 
J = 6.0 Hz, 1H), 1.75 (br d, J = 12.0 Hz, 1H), 2.81-2.96 (m, 3H), 4.12 (pentet, J = 5.5 Hz, 
1H), 5.30-5.37 (m, 1H), 5.38-5.45 (m, 1H), 5.98 (dd, J = 8.0, 16.0 Hz, 1H), 6.37 (d, J = 
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16.0 Hz, 1H), 7.17-7.38 (m, 5H); 13C NMR (CDCl3, 75 MHz) δ 38.6, 43.1, 62.0, 62.2, 
70.8, 88.17, 88.2, 126.4, 127.6, 128.8, 128.9, 135.7, 137.4, 210.0. 
 
 
 
 
 
Tricarbonyl[dimethyl  2-(6-styryl-2-4-cycloheptadien-1-yl)propanedioate]iron (±)-
177: To a stirring solution of dimethyl malonate (0.060 mL, 0.43 mmol) in THF (6 mL) 
at 0 0C under nitrogen was added a solution of n-BuLi (0.20 mL, 1.6M in hexane, 0.43 
mmol) and stirred for 30 min. To the stirring mixture was added cation (±)-172 (100 mg, 
0.24 mmol) and the mixture was stirred for an additional 45 min and gradually warmed to 
room temperature. The reaction was quenched with water and extracted several times 
with ether, washed with brine, dried (Na2SO4) and concentrated. The residue was purified 
by column chromatography (SiO2, hexane - ethyl acetate = 7:3) to give a yellow oil (50 
mg, 46%). 1H NMR (CDCl3, 400 MHz) δ 0.83-0.85 (m, 1H), 1.05 (q, J = 12.4 Hz, 1H), 
2.74-2.84 (m, 3H), 2.90 (d, J = 6.8 Hz, 1H), 3.29 (d, J = 5.6 Hz, 1H), 3.72 (s, OMe, 3H), 
3.74 (s, OMe, 3H), 5.30 (pentet, J = 4.4 Hz, 2H), 5.93 (dd, J = 8.8, 16.0 Hz, 1H), 6.33 (d, 
J = 16.0 Hz, 1H), 7.18-7.32 (m, 5H); 13C NMR (CDCl3, 75 MHz) δ 33.5, 39.1, 42.9, 
52.7, 58.6, 59.8, 61.6, 87.9, 88.3, 126.2, 127.4, 128.7, 128.8, 136.3, 137.3, 168.6. The 
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signal for the metal carbonyl was not observed.  FAB-HRMS (calcd for C23H22O7 Fe(M+) 
466.0715), m/z 466.0707. 
 
 
 
 
 
Tricarbonyl[(6-styryl-2,4-cycloheptadien-1-yl)phthalimide]iron (±)-174: To a stirring 
suspension of cation (±)-172 (1.00 g, 2.37 mmol) in dry CH2Cl2 (100 mL) under N2 at 
room temperature was added solid potassium phthalimide (0.659 g, 3.56 mmol). The 
reaction mixture was stirred for 12 h and then quenched with water. The mixture was 
extracted several times with CH2Cl2, dried (Na2SO4) and concentrated. The residue was 
purified by column chromatography (SiO2, hexane-ethyl acetate = 4:1) to afford a light 
yellow solid (820 mg, 72%). mp 185 – 188 0C; 1H NMR (CDCl3, 300 MHz) δ 1.62-1.68 
(m, J = 12.6 Hz, 1H), 2.13 (q, J = 12.6 Hz, 1H), 2.87 (br d, J = 7.5 Hz, 1H), 3.07-3.14(m, 
J = 3.9, 8.1 Hz, 2H), 4.88 (dd, J = 3.6, 12.6 Hz, 1H), 5.56 (dd, J = 5.1, 7.5 Hz, 1H), 5.69 
(dd, J = 5.1, 7.5 Hz, 1H), 6.13 (dd, J = 8.1, 15.9 Hz, 1H), 6.50 (d, J = 16.0 Hz, 1H), 7.33-
7.46 (m, 5H), 7.84 (dd, J = 3.0, 5.5 Hz, 2H), 7.94 (dd, J =  3.1, 5.6 Hz, 2H); 13C NMR 
(CDCl3, 75 MHz) δ 33.8, 43.7, 50.8, 56.5, 61.9, 88.6, 89.6, 123.4, 126.4, 127.6, 128.8, 
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129.2, 132,2, 134.3, 135.5, 137.4, 168.2, 210.1. Anal. Calcd for C26H19NO5Fe: C, 64.88; 
H, 3.98. Found: C, 64.85; H, 3.97. 
 
 
 
 
 
 
Tricarbonyl[(6-styryl-2,4-cycloheptadien-1-yl)triphenylphosponium (1+) 
tetrafluoroborate]iron (±)-175: To a suspension of the iron cation (±)-172 (300 mg, 
0.710 mmol) in dichloromethane (15 mL) was added triphenylphosphine (0.186 g, 0.710 
mmol) at room temperature under nitrogen. The mixture was stirred for 45 min, the clear 
light yellow solution was concentrated and dried. The glassy solid residue was washed 
with pentane and dried under high vacuum to afford a  glassy light yellow solid (410 mg, 
83%). mp  155-158 0C; 1H NMR (CDCl3, 400 MHz) δ 1.04-1.10 (m, J = 5.2, 12.0 Hz, 
1H), 1.86 (br s, 1H), 2.72 (dd, J = 7.2, 15.6 Hz, 1H), 3.02 (d, J = 7.2 Hz, 1H), 3.13 (br t, J 
= 8.8 Hz, 1H), 4.22 (t, J = 12.4 Hz, 1H), 4.99 (br t, J = 5.2 Hz, 1H), 5.31 (m, 1H), 5.88 
(dd, J = 8.4, 15.6 Hz, 1H), 6.44 (d, J = 15.6 Hz, 1H), 7.15-7.31 (m, 5H), 7.76-7.81 (m, 
15H); 13C NMR (CD3COCD3, 75 MHz) δ 30.1, 34.5 (d, JPC = 35.8),  42.8 (d, JPC = 14.1), 
49.4 (d, JPC = 6.4), 62.5, 88.4, (d, JPC = 1.7), 90.9, 118.5, (d, JPC = 81.3), 127.1, 128.3, 
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129.4, 129.5 (d, JPC = 6.6), 130.0 (d, JPC = 44.0), 131.4 (d, JPC = 11.9), 134.4 (d, JPC = 
19.6), 135.1 (d, JPC = 9.2), 136.0 (d, JPC = 2.8), 206.4.  
 
 
 
 
 
Tricarbonyl[dimethyl 2-propargyl-2-(6-styrenyl-2-4-cycloheptadien-1-
yl)propanedioate]iron (±)-176: To a flame-dried 10 mL Schlenk flask was charged THF 
(4 mL), dimethyl propagyl malonate (0.100 mL, 0.462 mmol) and n-BuLi (0.200 mL, 
2.5M in hexane, 0.497 mmol) at 0 OC under nitrogen. The mixture was stirred for 45 min, 
iron cation (±)-172 (150 mg, 0.355 mmol) was added and stirred for another 3 h. The 
reaction mixture was quenched with water, extracted several times with ether, and the 
combined ether extracts were washed with brine, dried (Na2SO4) and concentrated. The 
residue was purified by column chromatography (SiO2, hexane-ethyl acetate, 4:1) to 
afford a light yellow oil (136 mg, 77%). 1H NMR (CDCl3, 300 MHz) δ 0.90 (br m, J = 
12.3 Hz, 1H), 1.38 (d, J = 12.4 Hz, 1H), 2.07 (narrow t, J = 2.1 Hz, 1H), 2.71-2.91 (m, 
4H), 2.99-3.08 (m, 2H), 3.76 (s, OMe, 3H), 3.77 (s, OMe, 3H), 5.28 (m, J = 6.9 Hz, 2H), 
5.93 (dd, J = 8.4, 15.9 Hz, 1H), 6.34 (d, J = 15.6 Hz, 1H), 7.19-7.35 (m, 5H); 13C NMR 
(CDCl3, 75 MHz) δ 22.7, 31.2, 42.3, 43.4, 52.9, 53.0, 58.2, 61.2, 62.9, 71.9, 79.3, 88.0, 
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89.2, 126.3, 127.5, 128.7, 136.4, 137.3, 169.8, 170.0. The signal for the metal carbonyl 
was not observed. 
 
 
 
 
 
 
(±)-179 and (±)-180: A flame-dried 10 mL  Schlenk flask was charged THF (2.5 mL), 
iron cation (±)-172 (100 mg, 0.237 mmol) at 0 0C under nitrogen. To the stirring 
suspension was added NaBH3CN (0.023 g, 0.360 mmol) and the mixture was stirred for 
30 min. The reaction mixture was warmed to room temperature and stirred for another 30 
min. The light yellow mixture was quenched with water, extracted several times with 
ether, and the combined ether extracts were washed with brine, dried (Na2SO4) and 
concentrated. The residue was purified by column chromatography (SiO2, hexane-ethyl 
acetate, 4:1) to afford a yellow oily fraction (64 mg, 81%). 1H NMR (CDCl3, 300 MHz) 
mixture, δ 1.11-1.19 (bm, 1H), 1.27 (dd, J = 4.5, 12.6 Hz, 1H), 1.57-1.70 (m, 1H), 2.03-
2.30 (m, 3H), 2.43-2.62 (m, 1H), 2.72-2.87 (m, 3H), 3.01 (d, J = 7.5 Hz, 1H), 3.10 (md, J 
= 9.9 Hz, 1H), 3.22 (t, J = 6.6 Hz, 1H), 4.38-4.49 (m, 2H), 4.97 (bt, J = 8.4 Hz, 1H), 
5.38-5.51 (m, 2H), 6.03-6.17 (m, J = 9 Hz, 2H), 6.40 (d, J = 15.6 Hz, 1H), 6.46 (d, J = 
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15.9 Hz, 1H), 7.27-7.49 (m, 10H); 13C NMR (CDCl3, 300 MHz) δ 16.4, 27.8, 29.9, 30.1, 
30.3, 42.7, 58.1, 59.4, 61.3, 62.3, 74.6, 87.1, 88.9, 97.2, 126.1, 126.3, 127.1, 127.3, 128.3, 
128.7, 128.73, 128.8, 137.4, 137.6, 137.8. 
 
 
 
 
(6-Styrenyl-2,4-cyclohepta-1-yl)phthalimide (±)-181: In a 200 mL Schlenk flask, iron 
complex (±)-174 (500 mg, 1.04 mmol) was dissolved in MeOH (75 mL) at room 
temperature under N2. Solid ceric ammonium nitrate (1.71 g, 3.12 mmol) was added and 
the mixture was stirred for 1 h. After 2 h of stirring a white insoluble compound began to 
separate from the clear brown solution. The reaction mixture was stirred overnight and 
then quenched with water and extracted several times with CH2Cl2. The combined 
extracts were washed with brine, dried (Na2SO4) and concentrated. The residue was 
purified by column chromatography (SiO2, hexane-ethyl acetate=3:1) to afford a light 
yellow solid. (315 mg, 88%). mp 110-112 0C; 1H NMR (CDCl3, 300 MHz) δ 2.05 (md, J 
= 13.2 Hz, 1H), 2.86 (td, J = 11.1, 13.2 Hz, 1H), 3.56-3.58 (m, 1H), 5.29 (d, J = 10.5 Hz, 
1H), 5.78-5.89 (m, 4H), 6.18 (dd, J = 8.4, 15.9 Hz, 1H), 6.48 (d, J = 15.9 Hz, 1H), 7.21-
7.35 (m, 5H), 7.72 (dd, J = 3.1, 5.4 Hz, 2H), 7.87 (dd, J = 3.1, 5.4 Hz, 2H); 13C NMR 
(CDCl3, 100 MHz) δ 38.2, 44.0, 50.5, 123.3, 123.9, 124.0, 126.2, 127.3, 128.6, 129.8, 
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132.0, 132.2, 133.6, 134.1, 136.9, 137.2, 167.7. Anal. calcd for C23H19NO2: C, 80.91; H, 
5.61. Found: C, 80.61; H, 5.67. 
 
  
 
 
 
Dimethyl 2-allyl-2-(6-styryl-2-4-cycloheptadien-1-yl)propanedioate (±)-182: A flame-
dried 200 mL Schlenk flask was charged with freshly distilled ether (120 mL) at 0 °C 
under nitrogen.  Dimethyl allylmalonate (1.00 mL, 6.16 mmol) was added followed by 
dropwise addition of a solution of n-butyl lithium (4.5 mL, 7.1 mmol, 1.6M in hexane). 
The mixture was stirred for 1 h. Solid iron cation (±)-172 (2.0 g, 4.7 mmol) was added 
and stirred for 3 h at room temperature. The reaction mixture was quenched with water 
and extracted several times with ether. The combined ether extracts were washed with 
brine, dried (Na2SO4), and concentrated. The residue was purified by column 
chromatography (SiO2, hexane-ethyl acetate = 4:1) to afford a mixture of product and 
dimethyl allylmalonate (2.608 g). The mixture (2.608 g) was dissolved in methanol (100 
mL) and ceric ammonium nitrate (7.50 gm, 13.7 mmol) was added, and the mixture 
stirred for 1 h at room temperature. The mixture was concentrated, diluted with water and 
extracted several times with ether. The combined ether extracts were washed with brine, 
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dried (Na2SO4), and concentrated. The residue was purified by column chromatography 
(SiO2, hexane-ethyl acetate = 20:1) to give the product as a colorless oil (1.17 gm, 67%). 
1H NMR (CDCl3, 400 MHz) δ 1.68-1.55 (m, 1H), 2.09 (dd, J = 5.4, 13.3 Hz, 1H), 2.60 -
2.78 (dd, J =  8.2, 10.4 Hz, 2H), 3.11 (bd, J = 8.7 Hz, 1H), 3.38-3.48 (bm, 1H), 3.72 (s, 
6H), 5.05 (br s, 1H), 5.08 (d, J = 7.5 Hz, 1H), 5.69-5.87 (br m, 5H), 6.11 (ddd, J = 1.1, 
8.1, 15.7  Hz, 1H), 6.41 (d, J = 15.9 Hz, 1H), 7.34-7.15 (5H, Ar); 13C NMR (CDCl3, 100 
MHz) δ 37.9, 38.8, 43.0, 47.4, 52.5, 61.7, 119.1, 124.4, 124.7, 126.3, 127.3, 128.7, 129.6, 
132.8, 133.2, 134.3, 137.0, 137.6, 171.4. ESI-HRMS m/z 389.1728 (calcd for 
C23H26O4Na m/z 389.1729). 
 
 
 
 
 
Dimethyl 2-propargyl-2-(6-styryl-2-4-cycloheptadien-1-yl)propanedioate (±)-183: To 
a stirring solution of iron complex (±)-176 (136 mg, 0.270 mmol) in methanol (4 mL) at 
room temperature under nitrogen was added ceric ammonium nitrate (0.44 g, 0.81 mmol). 
The mixture was stirred for 2 h, and then concentrated. Water was added to the residue 
and the mixture was extracted several times with CH2Cl2. The combined CH2Cl2 extracts 
were washed with brine, dried (Na2SO4) and concentrated. The residue was purified by 
123    
column chromatography (SiO2, hexane-ethyl acetate, 4:1) to afford a yellowish liquid (42 
mg, 59%). 1H NMR (CDCl3, 300 MHz) δ 1.69 (md, J = 12.0 Hz, 1H), 2.06 (narrow t, J = 
2.7 Hz, 1H), 2.19 (dd, J = 5.7, 13.2 Hz, 1H), 2.94 (d, J= 2.4 Hz, 2H),  3.41 (bd, J = 9.3 
Hz, 1H), 3.52 (bm, 1H), 3.76 (s, 6H), 5.76-5.85 (m, 4H), 6.14 (dd, J = 7.8, 15.9 Hz, 1H), 
6.46 (d, J = 15.9 Hz, 1H), 7.17-7.36 (m, 5H); 13C NMR (CDCl3, 75 MHz) δ 23.8, 27.0, 
37.4, 42.5, 47.2, 52.8, 60.2, 71.9, 79.1, 124.5, 124.8, 126.2, 127.3, 128.6, 129.6, 132.6, 
133.4, 137.1, 137.5, 170.3 
 
 
 
 
Methyl 6-Styryl-2,4-cycloheptadienyl ether (±)-184: To a 100 mL round-bottomed 
flask complexed alcohol (±)-173 (820 mg, 2.34 mmol) was charged. Methanol (30 mL) 
was added at room temperature followed by the addition of solid ceric ammonium nitrate 
(2.56 gm, 4.66 mmol). The reaction mixture was stirred for 30 min, and then water (15 
mL) was added. The mixture was extracted several times with ether, washed with brine, 
dried (MgSO4) and concentrated. The residue was purified by column chromatography 
(SiO2, hexane-ethyl acetate = 20:1) to give a colorless oil (0.26 g, 49.0%). IR 1098,  747, 
691 cm-1; 1H NMR (CDCl3, 300 MHz) δ 2.05 (q, J = 12.0 Hz, 1H),  2.24 (d, J = 12.0 Hz, 
1H), 3.39 (s, 4H), 4.15 (d, J = 10.0 Hz, 1H), 5.74 (m, 3H), 5.88 (d, J = 11.0 Hz, 1H), 6.19 
(dd, J = 8, 16 Hz, 1H), 6.46 (d, J = 16.0 Hz, 1H), 7.33 (m, 5H); 13C NMR (CDCl3, 75 
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MHz) δ 38.1, 42.8,  56.5, 79.8,  122.7,  124.2,  126.3,  127.5, 128.8, 129.6, 132.8, 136.6, 
136.7, 137.7. 
 
 
 
 
6-Styryl-2,4-cycloheptadiene-1-ol (±)-186:  To a 100 mL round-bottomed flask alcohol 
(±)-173 (0.30 g, 0.85 mmol) was dissolved into methanol (12 mL) with slight warming.  
A solution of H2O2 (5.70 mL, 51.0 mmol, 30 wt %) was added to the reaction mixture at 
0 0C under N2. A solution of NaOH (240.0 mg, 5.950 mmol) in methanol (8 mL) was 
added to the reaction mixture dropwise. The reaction mixture immediately turned deep 
brown in color. The mixture was stirred for 30 min at 0 0C followed by another 30 min at 
room temperature. The mixture was quenched with water (30 mL) and extracted several 
times with ether. The combined extracts were washed with brine, dried (MgSO4) and 
concentrated. The residue was purified by column chromatography (SiO2, hexane-ethyl 
acetate = 4:1) to give the product as a colorless foamy solid (90.0 mg, 50%).  mp 59 - 
630C; IR (KBr) 3200-3400, 746, 692 cm-1; 1H NMR (CDCl3, 400 MHz) δ 1.64 (d, J = 6.0 
Hz, 1H), 2.13-2.27 (m, 2H), 3.40-3.48 (m, 1H), 4.61 (d, J = 8.0 Hz, 1H), 5.66-5.87 (m, 
4H), 6.18 (dd, J = 8.0, 16.0, Hz, 1H), 6.42 (d, J = 16.0 Hz, 1H), 7.19-7.37 (m, 5H); 13C 
NMR (CDCl3, 100 MHz) δ 41.9, 42.0, 71.1, 122.7, 124.3, 126.4, 127.5, 128.8, 129.6, 
132.7, 136.9, 137.5,  138.1. 
125    
 
 
 
 
tButyldiphenylsilyl 6-Styryl-2,4-cycloheptadienyl ether (±)-187: In a 25 mL oven dried 
round-bottomed flask was dissolved alcohol (±)-187 (0.11 g, 0.51 mmol) into dry 
dichloromethane (5 mL) at room temperature under N2. Solid imidazole (80.0 mg, 1.17 
mmol) was added and stirred the mixture for 30 min. t-Butyldiphenylsilyl chloride (0.20 
mL, 0.76 mmol) was added dropwise and the resultant mixture stirred for 3 h, at which 
time additional imidazole (40.0 mg, 0.58 mmol) was added followed by additional t-
butyldiphenylsilyl chloride (0.10 mL, 0.38 mmol). The reaction mixture was stirred for 
14 h. Water (10 mL) was added, and the mixture was extracted several times with 
dichloromethane. The light yellow solution was washed with brine, dried (Na2SO4) and 
concentrated. The oily residue was purified by column chromatography (SiO2, hexane-
ethyl acetate = 20:1), to give the product as colorless oil (0.19 g, 82%). 1H NMR (CDCl3, 
300 MHz) δ 1.07 (s, 9H),  1.93 (d, J = 12.9 Hz, 1H), 2.09-2.25 (m, J = 12.6 Hz, 1H), 2.91 
(m, 1H), 4.62 (d, J = 8.1 Hz, 1H),  5.54-5.65 (m, 2H),  5.66-5.77 (m, 1H), 5.93-6.12 (m, 
2H), 6.18 (dd, J = 3.0, 16.0 Hz, 1H),  7.18-7.52 (m, 10H), 7.67-7.79 (m, 5H);  13C NMR 
(CDCl3, 75 MHz) δ 19.4,  27.24, 42.5, 42.7, 72.6, 121.3, 124.2, 126.3, 127.3,  127.87, 
127.9, 128.7,  129.4, 129.88, 129.9,  132.9,  134.2,  134.5, 136.09,  136.1,  136.6, 137.7, 
140.0. 
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(±)-188: To a 50 mL two-necked round-bottomed flask, equipped with a condenser, was 
charged diene (±)-181 (200 mg, 0.5 80 mmol), dry CHCl3 (10 mL) and 
tetraphenylporphine (35 mg, 10 mol%). The deep purple solution was irradiated with a 60 
W tungsten-halogen lamp for 10 h, while ultra-pure O2 was bubbled through the solution. 
The reaction mixture was concentrated under vacuum. The residue was purified through 
column chromatography (SiO2, hexane-ethyl acetate = 1:1) to give   a colorless solid (70 
mg, 50% based on the recovered starting material). mp  175-177 0C, 1H NMR (CDCl3, 
400 MHz) δ 1.77 (md, J = 9.6 Hz, 1H), 2.11 (q, J = 10.1 Hz, 1H), 3.01 (q, J = 3.3 Hz, 
1H), 4.66-4.81 (m, 2H), 4.84 (dd, J = 3, 9.9 Hz, 1H), 5.98 (dd, J = 6.3, 11.1 Hz, 1H), 
6.43-6.51 (m, 2H), 6.89 (dd, J = 6.3, 6.1 Hz, 1H), 7.21-7.33 (m, 5H), 7.75 (dd, J = 3.6, 
5.6 Hz, 2H), 7.86 (dd, J = 3.5, 5.6 Hz, 2H); 13C NMR (CDCl3, 100 MHz) δ 29.8, 45.8, 
52.0, 80.4, 81.1, 123.6, 123.8, 126.4, 127.9, 128.7, 128.8, 130.8, 131.8, 131.9, 134.5, 
136.8, 167.8. Anal. Calcd. for C23H19NO4: C, 73.98; H, 5.13. Found: C, 73.87; H, 5.27 
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Cycloaddition product with oxygen (±)-189: To a 50 mL oven dried - necked round-
bottomed flask fitted with a condenser, was added a solution of diene (±)-187 (70.0 mg, 
0.15 mmol) in dry dichloromethane (4 mL). Solid tetraphenylporphine (0.9 mg, 1 mol%) 
was added to the reaction mixture. The deep purple solution was irradiated with a 60 W 
tungsten-halogen lamp for 8 h, while ultra-pure O2 was bubbled through the solution. The 
reaction mixture was evaporated under reduced pressure, re-dissolved in methanol (10 
mL) and filtered through celite. The filtration was repeated several times to remove 
tetraphenylporphine and then finally the solution was concentrated. The residue was 
purified to give a colorless oil column chromatography (SiO2, hexane-ethyl acetate = 
20:1), (50 mg, 69%). 1H NMR (CDCl3, 300 MHz) δ 1.08 (s, 9H), 1.43-1.65 (m, 1H), 
1.75-2.10 (m, 1H), 2.55-2.73 (m, 1H), 4.03-4.21 (m, 1H), 4.43-4.67 (m, 2H), 5.99 (dd, J 
= 16, 8 Hz, 1H), 6.38 (d, J = 16 Hz, 1H),  6.41-6.63 (m, 2H), 7.15-7.39 (m, 5H), 7.40-
7.55 (m, 5H), 7.59-7.73 (m, 5H); 13C NMR (CDCl3, 75 MHz) δ 19.4, 27.1, 34.6, 41.9, 
73.4,  80.9,  81.2,  126.3, 127.2,  127.7, 127.9, 127.93, 128.0, 128.8, 130.0, 130.2, 130.3, 
130.7, 133.7,  133.8, 135.8,  135.9, 137.0. 
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Asymmetric dihydroxylation of (±)-181: To a 25 mL round-bottomed flask was 
charged a mixture of tBuOH (3 mL) and water (3 mL) and stirred for 5 min at room 
temperature. Solid AD mix-β (0.826 g) was added to the stirring solution followed by the 
addition of methylsulfonamide (60 mg, 0.59 mmol). The mixture was stirred until the two 
layers were separated. The mixture was cooled to 0 0C upon which inorganic salt was 
precipitated out. Alkene (200 mg, 0.59 mmol) was added in one portion and the mixture 
was stirred for 72 h maintaining the temperature at 0 0C. The reaction mixture was 
quenched with water, extracted several times with ethyl acetate, and the combined 
extracts were washed with brine. The organic layer was concentrated under reduced 
pressure. The residue was purified by column chromatography (SiO2, hexane-ethyl 
acetate=1:1) to give a mixture of diastereomers as colorless oily liquid (149 mg, 71%). 
The diastereomers could be separated by preparative TLC (SiO2, hexane-ethyl ether = 
1:1).   
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Less polar diol (F1) (-)-190: [α]D = - 5.1 (c, 0.500, CH2Cl2), 1H NMR (CDCl3, 300 
MHz) δ 1.89 (d, J = 12.9 Hz, 1H), 2.66 (d , J = 11.9 Hz, 1H), 2.76 (OH, 1H), 2.93 (q, J = 
11.4 Hz, 1H), 2.99 (OH 1H), 3.71 (m, J = 3.0 Hz, 1H), 4.71 (d, J = 6.6 Hz, 1H), 5.05 (dd, 
J = 3, 11.1 Hz, 1H), 5.63 (dd, J = 1.5, 11.4 Hz, 1H), 5.77-5.90 (m, 3H), 7.29-7.35 (m, 
5H), 7.68 (dd, J = 3, 5.4 Hz, 2H), 7.80 (dd, J = 3.1, 5.5 Hz, 2H); 13C NMR (CDCl3, 75 
MHz) δ 35.4, 41.5, 50.9, 75.1, 79.2, 123.4, 124.6, 125.8, 126.9, 128.5, 128.9, 132.1, 
132.9, 133.1, 134.2, 140.9, 167.9. Anal. Calcd for C23H21O4N.3/4H2O: C, 71.02; H, 5.83. 
Found: C, 71.19; H, 5.83. 
 
 
 
 
More polar diol (F2) (+)-191: [α]D = + 74.1 (c, 0.486, CH2Cl2), 1H NMR (CDCl3, 300 
MHz) δ 1.99 (d, J = 10.8 Hz, 1H), 2.51 (d, J = 10.8 Hz, 1H), 2.64 (q, J = 11.1 Hz, 1H), 
2.72 (OH, 1H), 2.91 (OH, 1H), 3.73 (dd, J = 3.6, 6.6 Hz, 1H), 4.61 (d, J = 6.9 Hz, 1H), 
4.99 (dd, J = 11.4, 1.5 Hz, 1H), 5.61 (d, J = 10.2 Hz, 1H), 5.70-5.83 (m, 3H), 7.22-7.34 
(m, 5H), 7.65 (dd, J = 3.3, 5.5 Hz, 2H), 7.77 (dd, J = 3.1, 5.6 Hz, 2H); 13C NMR (CDCl3, 
75 MHz) δ 31.5, 41.2, 51.2, 75.3, 79.3, 123.5, 124.5, 125.4, 126.7, 128.5, 128.9, 132.2, 
132.9, 134.2, 136.5, 141.0, 167.9. 
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PTAD adduct 192: To a colorless solution of less polar diol (-)-190 (69.0 mg, 0.184 
mmoL) in CH2Cl2 (1.5 mL) at room temperature was added dropwise a solution of 4-
phenyl-1,2,4-triazoline-3,5-dione in CH2Cl2 and the mixture was occasionally stirred. 
The process was continued until the light red color of  unreacted 4-phenyl-1,2,4-
triazoline-3,5-dione persisted. The mixture was concentrated and applied to a column of 
silica. Elution: (hexane-ethyl acetate, 1:4) gave a color less solid (94 mg, 93%). 1H NMR 
(CDCl3, 300 MHz) δ 1.58 (td, J = 3.9, 12.9 Hz, 1H), 2.09 (td, J = 3.9, 12.3 Hz, 1H), 2.28 
(q, J = 12.3 Hz, 1H), 3.49 (bs, 1H), 4.51 (dd, J = 4.2, 12.3 Hz, 1H), 4.81 (d, J = 6.0 Hz, 
1H), 5.02 (d, J = 6.6 Hz, 1H), 5.40 (d, J = 6.6 Hz, 1H), 6.35 (dd, J = 7.2 Hz, 1H), 6.61 
(dd, J = 7.5 Hz, 1H), 7.33-7.49 (m, 10H), 7.72-7.84 (m, 4H). 
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Bis(dinitrobenzoate) PTAD adduct (+)-193: To a stirring solution of 4-phenyl-1,2,4-
triazoline-3,5-dione adduct (192) (94.0 mg, 0.171 mmoL) in dry CH2Cl2 (2 mL) at room 
temperature under nitrogen was added 4-(dimethylamino)pyridine (0.045 g, 0.376 
mmoL) and the mixture was stirred for 15 min. To the stirring reaction mixture was 
added 3,5-dinitrobenzoyl chloride (0.085 g, 0.376 mmoL) and the mixture was stirred for 
3 h. The reaction mixture was diluted with CH2Cl2 (4 mL) and washed with 0.1 M HCl 
solution. The combined CH2Cl2 washings were washed with brine, dried (Na2SO4) and 
concentrated. The residue was purified by column chromatography (SiO2, hexane-ethyl 
acetate, 1:1) to afforded a light yellow solid (131 mg, 81%). mp = 240-242 0C;  [α]D = + 
50.1, CH2Cl2)1H NMR (CDCl3, 300 MHz) δ, 1.74 (td, J = 3.9, 12.3 Hz, 1H), 2.11-2.27 
(m, 1H), 2.35 (bd, J = 12.6 Hz, 1H), 4.55 (dd, J = 4.2, 12.0 Hz, 1H),  5.06 (d, J = 6.9 Hz, 
1H), 5.55 (d, J = 6.9 Hz, 1H), 5.86 (dd, J = 2.4, 9 Hz, 1H), 6.48 (dd, J = 6.9 Hz, 1H), 6.59 
(d, J = 8.7 Hz, 1H), 6.68 (dd, J = 8.7 Hz, 1H), 7.31-7.53 (m, 8H), 7.65-7.84 (m, 6H), 
132    
8.97-9.35 (m, 6H); 13C NMR (CDCl3, 75 MHz) δ 28.7, 41.4, 50.7, 51.3, 54.9, 78.3, 78.7, 
123.0, 123.4, 123.7, 124.6, 125.6, 127.4, 128.6, 129.4, 129.5, 129.6, 130.5, 131.3, 131.4, 
132.2, 132.8, 134.2, 134.7, 148.8, 148.9, 151.6, 152.4, 161.6, 162.5, 167.4. Anal. Calcd. 
for C45H30N8O16 · 1/2 H2O: C, 57.57; H, 3.22. Found: C, 57.04; H, 3.58 
 
 
 
 
N-(6-Hyroxymethylene-2,4-heptadien-1-yl)phthalimide (±)-197: In a 25 mL round-
bottom flask the mixture of diastereomeric  diols (-)-190 and (+)-191 (300 mg, 0.808 
mmol) was dissolved in dry CH2Cl2 (12 mL) at 0 0C under N2. After 5 min of stirring 
solid Pb(OAc)4 (0.43 g, 0.97 mmol) was added and the mixture was stirred for 1 h. The 
reaction mixture was quenched with water, extracted several times with CH2Cl2, and the 
combined extracts were washed with brine, dried (Na2SO4) and concentrated. The crude 
mixture (204 mg) was re-dissolved in a mixture of MeOH (5 mL) and CH2Cl2 (2 mL) at 
00 C and solid NaBH4 (1.0 mg, O.26 mmol) was added. After stirring for 1 h, the reaction 
mixture was quenched with water, extracted several times with ethyl acetate and the 
combined extracts were washed with brine, dried (Na2SO4) and concentrated. The residue 
was purified by column chromatography (SiO2, hexane-ethyl acetate=1:1) to afford the 
product as a colorless liquid (88 mg, 40%). 1H NMR (CDCl3, 400 MHz) δ 1.95-1.84 (m, 
1H), 2.03-1.96 (m, 1H), 2.66-2.56 (m, 1H), 2.86-2.77 (m, 1H), 3.67-3.55 (m, 2H), 5.19 
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(dd, J = 3.0, 11.2 Hz, 1H), 5.75-5.65 (m, 2H), 5.88-5.77 (m, 2H), 7.71 (dd, J = 5.5, 3.0 
Hz, 2H), 7.83 (dd, J = 5.1, 3.2 Hz, 2H); 13C NMR (CDCl3, 100 MHz) δ 33.9, 42.5, 50.7, 
66.5, 123.3, 124.1, 124.9, 131.9, 132.9, 134.0, 134.6, 167.9. 
 
Singlet oxygen cycloaddition of the mixture of  (-)-190 and (+)-191:  To a 100 mL 
two-necked round-bottomed flask, equipped with a condenser, was charged dienediol 
mixture 190 and 191 (500 mg, 1.33 mmol), dry CHCl3 (40 mL) and tetraphenylporphine 
(82 mg, 10 mol%). The deep purple solution was irradiated with a 60 W tungsten-halogen 
lamp for 72 h to consume all the starting material, while ultra-pure O2 was bubbled 
through the solution. The reaction mixture was concentrated under vacuum, and the 
residue was purified by column chromatography (SiO2, hexane-ethyl acetate = 1:1) to 
afford a less polar (F1) foamy endoperoxide 194 (179 mg, 33%) and a more polar (F2) 
foamy endoperoxide 195 (133 mg, 25%). 
 
 
 
 
Less polar endoperoxide (+)-194: [α]D = + 46.0 (c, 0.214, CH2Cl2); 1H NMR (CDCl3, 
300 MHz) δ 1.60 (md, J = 12.6 Hz, 1H), 2.03-2.10 (m, 1H), 2.29 (dd, J = 5.7, 12.3 Hz, 
1H), 2.48 (d, J = 4.8 Hz, OH), 2.68 (d, J = 3.9 Hz, OH), 3.43 (m, 1H), 4.68-4.73 (m, 3H), 
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5.18 (d, J = 7.2 Hz, 1H), 6.41 (dd, J = 7.5, 8.4 Hz, 1H), 6.71 (dd, J = 7.2, 9.1 Hz, 1H), 
7.26-7.39 (m, 5H), 7.73 (dd, J = 2.7, 5.1 Hz, 2H), 7.82 (dd, J = 3.3, 5.7 Hz, 2H); (CDCl3, 
75 MHz) δ 27.6, 43.8, 52.2, 74.0, 76.9, 78.1, 79.8, 123.6, 125.8, 126.5, 128.4, 128.8, 
128.9, 131.8, 134.5, 141.0, 167.8. 
 
 
 
 
More polar endoperoxide (+)-195: [α] = + 29.9 (c, 1.175, CH2Cl2).  1H NMR (CDCl3, 
300 MHz) δ 1.61 (d, J = 12.9 Hz, 1H), 1.96 (d, J = 12.3 Hz, 1H), 2.19 (q, J = 12.6 Hz, 
1H), 3.14 (OH, 2H), 3.73 (d, J = 3.9 Hz, 1H), 4.45 (d, J = 6.9 Hz, 1H), 4.54 (dd, J = 3.9, 
12.6 Hz, 1H), 4.65 (d, J = 7.5 Hz, 2H), 6.43 (dd, J = 8.7, 9.0 Hz, 1H), 6.61 (dd, J = 8.8, 
9.1 Hz, 1H), 7.26-7.36 (m, 5H), 7.72 (dd, J = 3.1, 5.7 Hz, 2H), 7.80 (dd, J = 3.3, 6.1 Hz, 
2H); 13C NMR (CDCl3, 75 MHz) δ 23.4, 43.9, 52.4, 75.1, 77.0, 79.7, 81.4, 123.5, 126.5, 
126.6, 127.3, 128.6, 129.0, 131.7, 134.4, 140.7, 167.8.  
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2-Formyl-4-phthalimido-6,7-dioxabicyclo[3.2.2]non-8-ene (-)-196: In a 25 mL round-
bottom flask more polar endoperoxide (+)-195  (46 mg, 0.11 mmol) was dissolved in dry 
CH2Cl2 (3 mL) at room temperature under N2. After 5 min of stirring solid Pb(OAc)4 (60 
mg, 0.14 mmol) was added and the mixture was stirred for 10 min. The reaction mixture 
was quenched with water, extracted several times with CH2Cl2, and the combined 
extracts were washed with brine, dried (Na2SO4) and concentrated. The residue was 
purified by column chromatography (SiO2, hexane-ethyl acetate = 1:1) to give the 
product as a colorless oil (23 mg, 73%). [α]D = – 100 (c 0.287, CH2Cl2); 1H NMR 
(CDCl3, 400 MHz) δ 2.11 (q, J = 12.8 Hz, 1H), 3.14 (dd, J = 5.2, 12.8 Hz, 1H), 4.78-4.83 
(m, 3H), 5.24 (d, J = 6.8 Hz, 1H), 6.41 (dd, J = 8.4, 8.7 Hz, 1H), 6.75 (dd, J = 8.0, 12.1 
Hz, 1H), 7.75 (dd, J = 3.6, 5.8 Hz, 2H), 7.84 (dd, J = 3.4, 5.8 Hz, 2H), 9.63 (s, 1H); 13C 
(CDCl3, 100 MHz) δ 23.8, 52.1, 54.3, 75.4, 80.0, 123.7, 124.6, 129.7, 131.7, 134.6, 
167.7, 199.0. 
 
 
 
 
2-Formyl-4-phthalimido-6,7-dioxabicyclo[3.2.2]non-8-ene (+)-196: In a 25 mL round-
bottom flask less polar endoperoxide (+)-194  (190 mg, 0.467 mmol) was dissolved in 
dry CH2Cl2 (15 mL) at room temperature under N2. After 5 min of stirring solid 
Pb(OAc)4 (0.248 g, 0.560 mmol) was added and the mixture was stirred for 10 min. The 
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reaction mixture was quenched with water, extracted several times with CH2Cl2, and the 
combined extracts were washed with brine, dried (Na2SO4) and concentrated. The residue 
was purified by column chromatography (SiO2, hexane-ethyl acetate = 1:1) to give the 
product as a colorless oil (94 mg, 70%). [α]D = + 112 (c, 0.424, CH2Cl2); 1H NMR 
(CDCl3, 400 MHz) δ 2.11 (q, J = 12.8 Hz, 1H), 3.14 (dd, J = 5.2, 12.8 Hz, 1H), 4.78-4.83 
(m, 3H), 5.24 (d, J = 6.8 Hz, 1H), 6.41 (dd, J = 8.4, 8.7 Hz, 1H), 6.75 (dd, J = 8.0, 12.1 
Hz, 1H), 7.75 (dd, J = 3.6, 5.8 Hz, 2H), 7.84 (dd, J = 3.4, 5.8 Hz, 2H), 9.63 (s, 1H); 13C 
(CDCl3, 100 MHz) δ 23.8, 52.1, 54.3, 75.4, 80.0, 123.7, 124.6, 129.7, 131.7, 134.6, 
167.7, 199.0. 
 
 
 
 
5,5-Bis(methoxycarbonyl) bicyclo[4.4.1]undeca-1,7,9-triene (±)-199: To a stirring 
solution of (±)-182 (30.0 mg, 0.080 mmol) in CH2Cl2 (2 mL) at room temperature was 
added Grubbs 1st generation catalyst (3 mg, 5 mol%). The reaction mixture was stirred 
for 45 min, concentrated and the residue was purified by column chromatography (SiO2, 
hexane-ethyl acetate = 20:1) to gave the product as a colorless oil (19 mg, 88%). 1H 
NMR (CDCl3, 300 MHz) δ 2.27 (dd, J = 14.2, 1.2 Hz, 1H), 2.55 (dd, J = 14.2, 1.5 Hz, 
1H), 2.85-2.75 (m, 1H), 2.96-2.89 (m, 2H), 3.29 (dq, J = 17.3, 2 Hz, 1H), 3.75 (s, 3H), 
3.66 (s 3H), 3.84-3.76 (m, 1H), 5.66-5.57 (m, 2H), 6.12-6.18 (m, 1H), 6.31-6.26 (m, 1H), 
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6.44-6.39 (m, 1H); 13C NMR (CDCl3, 75 MHz) δ 32.8, 40.3, 43.6, 50.6, 52.5, 52.9, 63.0, 
127.4, 128.4, 131.4, 132.5, 132.9, 146.8, 171.1, 173.0. ESI-HRMS m/z 262.1198 (calcd 
for C15H18O4 m/z 262.1205). 
 
 
 
 
 
(±)-200: A flame dried 100 mL Schlenk flask was charged with (±)-182 (582 mg, 1.59 
mmol) and freshly distilled CH2Cl2 (30 mL) at -78 °C under nitrogen. To this was added 
dropwise a solution of DIBAL-H (10.0 mL, 9.54 mmol, 1M solution in hexane) and the 
resultant mixture was stirred for 1 h. The reaction mixture was warmed to room 
temperature and stirred for 2 h. The mixture was cooled to 0 °C and quenched with water 
(0.4 mL), NaOH solution (0.4 mL, 15% w/v). Water (1 mL) was added and stirred for 15 
min at room temperature. MgSO4 was added followed by ethyl acetate (30 mL) and 
stirred for another 15 min, filtered, concentrated and applied to a column of silica. 
Elution (hexane-ethyl acetate = 1:1) gave a colorless oil (317 mg, 64%). 1H NMR 
(CDCl3, 300 MHz) δ 1.71-1.59 (m, 1H), 2.29-2.03 (m, 3H), 2.55 (s, OH, 1H), 2.67 (s, 
OH, 1H), 2.84 (dm, J = 8.3 Hz, 1H), 3.43-3.30 (bm, 1H), 3.88-3.67 (m, 4H), 5.07 (bs, 
1H), 5.12 (br d, J = 8.6 Hz, 1H), 5.91-5.72 (m, 4H), 6.05-5.96 (dd, J = 4.2, 10.9 Hz, 1H), 
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6.18 (dd, J = 8.2, 15.9 Hz, 1H), 6.45 (d, J = 15.9 Hz, 1H), 7.38-7.18 (m, Ar, 5H); 13C 
NMR (CDCl3, 300 MHz) δ 35.4, 35.9, 40.3, 44.2, 47.0, 67.7, 67.8, 118.3, 124.8, 125.1, 
126.3, 127.3, 128.7, 129.4, 133.3, 134.4, 135.1, 137.0, 137.6. 
 
 
 
 
(±)-201: To a stirring solution of (±)-200 (170 mg, 0.540 mmol) in CH2Cl2 (8 mL) at 
room temperature was added pyridine (0.100 mL, 1.37 mmol), DMAP (6 mg, 10 mol%) 
and TsCl (260 mg, 1.37 mmol). The reaction mixture was stirred overnight, quenched 
with saturated NH4Cl solution and the aqueous layer were extracted several times with 
CH2Cl2. The combined CH2Cl2 extracts were washed with brine, dried (Na2SO4) and 
concentrated. The residue was purified by column chromatography. (hexane-ethyl acetate 
= 1:1) to give colorless foamy solid (109 mg, 32%). 1H NMR (CDCl3, 400 MHz) δ 1.52-
1.41 (m, 1H), 1.83 (dd, J = 5.4, 13.1 Hz, 1H), 2.16 (bd, J = 6.7 Hz, 2H), 2.42 (s, 6H), 
2.58 (d, J = 9.8 Hz, 1H), 3.20 (br s, 1H), 4.01-3.86 (m, 4H), 5.07-4.96 (m, 2H), 5.82-5.54 
(m, 5H), 6.06-5.98 (dd, J = 8.1, 15.5 Hz, 1H), 6.36 (d, J = 15.9 Hz, 1H), 7.36-7.19 (m, 
9H, Ar), 7.77-7.72 (m, 4H, Ar); 13C NMR (CDCl3, 100 MHz) δ 21.8, 27.0, 35.3, 35.7, 
40.9, 42.9, 46.8, 70.1, 70.4, 120.1, 124.5, 125.3, 126.2, 127.4, 128.08, 128.11, 128.7, 
129.7, 130.12, 130.14, 131.8, 131.8, 131.8, 131.8, 132.25, 132.28, 132.3, 132.7, 136.9, 
137.4, 145.27, 145.3.  
139     
 
 
 
(±)-202: To a stirring solution of (±)-200 (50 mg, 0.16 mmol) in CH2Cl2 (2.5 mL) at 
room temperature under nitrogen was added DMAP (66.0 mg, 0.352 mmol) and stirred 
for 10 min. To the stirring solution was added 4-nitrobenzoyl chloride (60 mg, 0.51 
mmol). The reaction mixture was stirred for overnight, diluted with CH2Cl2 and quenched 
with sat. NaHCO3. The aqueous layer was extracted several times with CH2Cl2. The 
combined CH2Cl2 extracts were washed with brine, dried (Na2SO4) and concentrated. 
The residue was purified by column chromatography (hexane-ethyl acetate = 1:1) to give 
a light yellow glassy solid (45 mg, 47%). 1H NMR (CDCl3, 300 MHz) δ 1.85-1.72 (m, 
1H), 2.25-2.16 (dd, J = 5.2, 13.5 Hz, 1H), 2.47-2.21 (m, 2H), 2.84 (bd, J = 8.4 Hz, 1H), 
3.37-3.25 (bm, 1H), 4.58-4.44 (m, 4H), 5.12 (d, J = 3.5 Hz, 1H), 5.16 (s, 1H), 5.92-5.69 
(m, 4H), 6.15-5.99 (m, 2H), 6.36 (d, J = 15.9 Hz, 1H), 7.28-7.14 (5H, Ar), 8.24-8.08 (8H, 
Ar); 13C NMR (CDCl3, 75 MHz) δ 36.5, 36.7, 42.1, 43.2, 47.2, 67.1, 67.2, 119.9, 123.9, 
124.7, 125.6, 126.2, 127.6, 128.8, 129.9, 130.9, 132.4, 132.5, 133.5, 135.2, 137.1, 137.3, 
150.9, 164.6. 
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Appendix 
          Crystal data and structure refinement for (±)‐158. Identification code   dont4 Empirical formula   C20 H16 N2 O3 Formula weight   332.35 Temperature   100(2) K Wavelength   1.54178 Å Crystal system   Monoclinic Space group   C 2/c Unit cell dimensions  a = 25.6400(13) Å  a= 90°.   b = 5.4993(3) Å  b= 99.259(3)°.   c = 22.3486(12) Å  g = 90°. Volume  3110.1(3) Å3 Z  8 Density (calculated)  1.420 Mg/m3 Absorption coefficient  0.789 mm‐1 F(000)  1392 Crystal size  0.32 x 0.02 x 0.02 mm3 
147    Theta range for data collection  3.49 to 67.88°. Index ranges  ‐30<=h<=29, 0<=k<=6, 0<=l<=26 Reflections collected  21439 Independent reflections  2775 [R(int) = 0.0603] Completeness to theta = 67.88°  97.7 %  Absorption correction  Semi‐empirical from equivalents Max. and min. transmission  0.9844 and 0.7864 Refinement method  Full‐matrix least‐squares on F2 Data / restraints / parameters  2775 / 0 / 227 Goodness‐of‐fit on F2  1.025 Final R indices [I>2sigma(I)]  R1 = 0.0433, wR2 = 0.1001 R indices (all data)  R1 = 0.0602, wR2 = 0.1064 Extinction coefficient  0.00024(6) Largest diff. peak and hole  0.262 and ‐0.202 e.Å‐3                
148                Crystal data and structure refinement for (±)‐119. Identification code   donu Empirical formula   C14 H11 N O4 Formula weight   257.24 Temperature   100(2) K Wavelength   1.54178 Å Crystal system   Monoclinic Space group   P 21/c Unit cell dimensions  a = 11.2217(2) Å  a= 90°.   b = 6.91770(10) Å  b= 106.3860(10)°.   c = 14.8259(2) Å  g = 90°. Volume  1104.16(3) Å3 Z  4 Density (calculated)  1.547 Mg/m3 Absorption coefficient  0.962 mm‐1 F(000)  536 
149    Crystal size  0.20 x 0.15 x 0.09 mm3 Theta range for data collection  4.11 to 67.93°. Index ranges  ‐13<=h<=12, 0<=k<=8, 0<=l<=17 Reflections collected  9222 Independent reflections  1969 [R(int) = 0.0183] Completeness to theta = 67.93°  97.7 %  Absorption correction  Semi‐empirical from equivalents Max. and min. transmission  0.9184 and 0.8309 Refinement method  Full‐matrix least‐squares on F2 Data / restraints / parameters  1969 / 0 / 217 Goodness‐of‐fit on F2  1.009 Final R indices [I>2sigma(I)]  R1 = 0.0327, wR2 = 0.0871 R indices (all data)  R1 = 0.0338, wR2 = 0.0881 Extinction coefficient  0.0021(4) Largest diff. peak and hole  0.256 and ‐0.197 e.Å‐3               
150                     Crystal data and structure refinement for (±)‐120. Identification code   donv Empirical formula   C14 H11 N O4 Formula weight   257.24 Temperature   100(2) K Wavelength   1.54178 Å Crystal system   Orthorhombic Space group   P 21 21 21 Unit cell dimensions  a = 6.77800(10) Å  a= 90°.   b = 8.5059(2) Å  b= 90°.   c = 19.6445(4) Å  g = 90°. Volume  1132.56(4) Å3 
151    Z  4 Density (calculated)  1.509 Mg/m3 Absorption coefficient  0.938 mm‐1 F(000)  536 Crystal size  0.15 x 0.12 x 0.03 mm3 Theta range for data collection  4.50 to 67.63°. Index ranges  0<=h<=8, 0<=k<=10, 0<=l<=23 Reflections collected  9242 Independent reflections  1191 [R(int) = 0.0210] Completeness to theta = 67.63°  98.6 %  Absorption correction  Semi‐empirical from equivalents Max. and min. transmission  0.9724 and 0.8721 Refinement method  Full‐matrix least‐squares on F2 Data / restraints / parameters  1191 / 0 / 172 Goodness‐of‐fit on F2  0.994 Final R indices [I>2sigma(I)]  R1 = 0.0290, wR2 = 0.0763 R indices (all data)  R1 = 0.0305, wR2 = 0.0773 Absolute structure parameter  0.6(3) Largest diff. peak and hole  0.176 and ‐0.191 e.Å‐3 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Crystal data and structure refinement for (±)‐127. Identification code   donw Empirical formula   C18 H17 N O6 Formula weight   343.33 Temperature   100(2) K Wavelength   1.54178 Å Crystal system   Monoclinic Space group   P 21/c Unit cell dimensions  a = 8.4527(2) Å  a= 90°.   b = 8.9213(2) Å  b= 91.6100(10)°.   c = 21.1061(5) Å  g = 90°. Volume  1590.96(6) Å3 Z  4 Density (calculated)  1.433 Mg/m3 Absorption coefficient  0.912 mm‐1 F(000)  720 Crystal size  0.53 x 0.41 x 0.07 mm3 
153    Theta range for data collection  4.19 to 67.86°. Index ranges  ‐10<=h<=10, 0<=k<=10, 0<=l<=23 Reflections collected  13190 Independent reflections  2766 [R(int) = 0.0195] Completeness to theta = 67.86°  95.8 %  Absorption correction  Semi‐empirical from equivalents Max. and min. transmission  0.9389 and 0.6436 Refinement method  Full‐matrix least‐squares on F2 Data / restraints / parameters  2766 / 0 / 229 Goodness‐of‐fit on F2  1.032 Final R indices [I>2sigma(I)]  R1 = 0.0322, wR2 = 0.0806 R indices (all data)  R1 = 0.0331, wR2 = 0.0812 Extinction coefficient  0.0016(2) Largest diff. peak and hole  0.268 and ‐0.188 e.Å‐3                
154                  Crystal data and structure refinement for (±)‐132. Identification code   donx Empirical formula   C14 H15 N O6 Formula weight   293.27 Temperature   100(2) K Wavelength   1.54178 Å Crystal system   Monoclinic Space group   P 21/n Unit cell dimensions  a = 12.0696(6) Å  a= 90°.   b = 6.9279(4) Å  b= 108.536(2)°.   c = 15.8178(8) Å  g = 90°. Volume  1254.02(11) Å3 Z  4 Density (calculated)  1.553 Mg/m3 Absorption coefficient  1.042 mm‐1 
155    F(000)  616 Crystal size  0.23 x 0.11 x 0.04 mm3 Theta range for data collection  4.05 to 67.59°. Index ranges  ‐14<=h<=13, 0<=k<=8, 0<=l<=18 Reflections collected  10253 Independent reflections  2215 [R(int) = 0.0278] Completeness to theta = 67.59°  97.6 %  Absorption correction  Semi‐empirical from equivalents Max. and min. transmission  0.9595 and 0.7956 Refinement method  Full‐matrix least‐squares on F2 Data / restraints / parameters  2215 / 45 / 185 Goodness‐of‐fit on F2  1.013 Final R indices [I>2sigma(I)]  R1 = 0.0891, wR2 = 0.2428 R indices (all data)  R1 = 0.0996, wR2 = 0.2512 Largest diff. peak and hole  0.571 and ‐0.564 e.Å‐3               
156         
 
 
 
 
 
 
 Crystal data and structure refinement for (±)‐161. Identification code   dony Empirical formula   C20 H20 N2 O3 Formula weight   336.38 Temperature   100(2) K Wavelength   1.54178 Å Crystal system   Monoclinic Space group   P 21/c Unit cell dimensions  a = 14.9286(4) Å  a= 90°.   b = 6.8883(2) Å  b= 99.053(2)°.   c = 16.4514(5) Å  g = 90°. Volume  1670.67(8) Å3 Z  4 Density (calculated)  1.337 Mg/m3 Absorption coefficient  0.735 mm‐1 F(000)  712 Crystal size  0.24 x 0.16 x 0.05 mm3 
157    Theta range for data collection  3.00 to 67.49°. Index ranges  ‐17<=h<=16, 0<=k<=8, 0<=l<=18 Reflections collected  13354 Independent reflections  2920 [R(int) = 0.0217] Completeness to theta = 67.49°  96.7 %  Absorption correction  Semi‐empirical from equivalents Max. and min. transmission  0.9642 and 0.8434 Refinement method  Full‐matrix least‐squares on F2 Data / restraints / parameters  2920 / 0 / 235 Goodness‐of‐fit on F2  1.009 Final R indices [I>2sigma(I)]  R1 = 0.0344, wR2 = 0.0923 R indices (all data)  R1 = 0.0402, wR2 = 0.0969 Extinction coefficient  0.0008(2) Largest diff. peak and hole  0.232 and ‐0.167 e.Å‐3                
158           
 
 
 
 
Crystal data and structure refinement for (±)‐135. 
Identification code   donz 
Empirical formula   C14 H13 N O5 
Formula weight   275.25 
Temperature   100(2) K 
Wavelength   1.54178 Å 
Crystal system   Monoclinic 
Space group   P 21/n                                        
Unit cell dimensions  a = 5.52500(10) Å  a= 90°. 
  b = 17.7359(2) Å  b= 92.8490(10)°. 
  c = 12.5209(2) Å  g = 90°. 
Volume  1225.42(3) Å3 
Z  4 
Density (calculated)  1.492 Mg/m3 
Absorption coefficient  0.966 mm‐1 
F(000)  576 
Crystal size  0.21 x 0.09 x 0.07 mm3 
159    
Theta range for data collection  4.33 to 68.17°. 
Index ranges  ‐6<=h<=6, 0<=k<=21, 0<=l<=15 
Reflections collected  10319 
Independent reflections  2194 [R(int) = 0.0196] 
Completeness to theta = 68.17°  97.9 %  
Absorption correction  Semi‐empirical from equivalents 
Max. and min. transmission  0.9354 and 0.8228 
Refinement method  Full‐matrix least‐squares on F2 
Data / restraints / parameters  2194 / 0 / 234 
Goodness‐of‐fit on F2  0.990 
Final R indices [I>2sigma(I)]  R1 = 0.0322, wR2 = 0.0839 
R indices (all data)  R1 = 0.0343, wR2 = 0.0858 
Extinction coefficient  0.0013(3) 
Largest diff. peak and hole  0.266 and ‐0.173 e.Å‐3 
 
 
            
160               Crystal data and structure refinement for (±)‐154. Identification code   don1a Empirical formula   C14 H13 N O5 Formula weight   275.25 Temperature   100(2) K Wavelength   1.54178 Å Crystal system   Monoclinic Space group   P 21/n Unit cell dimensions  a = 7.2305(4) Å  a= 90°.   b = 20.6353(11) Å  b= 104.012(4)°.   c = 8.5115(5) Å  g = 90°. Volume  1232.16(12) Å3 Z  4 Density (calculated)  1.484 Mg/m3 Absorption coefficient  0.961 mm‐1 F(000)  576 Crystal size  0.24 x 0.15 x 0.04 mm3 Theta range for data collection  4.28 to 67.47°. 
161    Index ranges  ‐8<=h<=8, 0<=k<=24, 0<=l<=10 Reflections collected  10020 Independent reflections  2145 [R(int) = 0.0249] Completeness to theta = 67.47°  98.8 %  Absorption correction  Semi‐empirical from equivalents Max. and min. transmission  0.9626 and 0.8021 Refinement method  Full‐matrix least‐squares on F2 Data / restraints / parameters  2145 / 56 / 251 Goodness‐of‐fit on F2  1.007 Final R indices [I>2sigma(I)]  R1 = 0.0407, wR2 = 0.0918 R indices (all data)  R1 = 0.0481, wR2 = 0.0959 Extinction coefficient  0.0004(2) Largest diff. peak and hole  0.211 and ‐0.200 e.Å‐3 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 Crystal data and structure refinement for (±)‐137. Identification code   don1b Empirical formula   C14 H13 N O5 Formula weight   275.25 Temperature   100(2) K Wavelength   1.54178 Å Crystal system   ? Space group   ? Unit cell dimensions  a = 5.4050(3) Å  a= 76.891(3)°.   b = 7.6853(4) Å  b= 89.431(4)°.   c = 15.2798(8) Å  g = 78.624(3)°. Volume  605.62(6) Å3 Z  2 Density (calculated)  1.509 Mg/m3 Absorption coefficient  0.978 mm‐1 F(000)  288 Crystal size  0.42 x 0.18 x 0.04 mm3 
163    Theta range for data collection  2.97 to 67.23°. Index ranges  ‐6<=h<=6, ‐8<=k<=9, 0<=l<=18 Reflections collected  4840 Independent reflections  2009 [R(int) = 0.0155] Completeness to theta = 67.23°  98.2 %  Absorption correction  Semi‐empirical from equivalents Max. and min. transmission  0.9619 and 0.6843 Refinement method  Full‐matrix least‐squares on F2 Data / restraints / parameters  2009 / 72 / 253 Goodness‐of‐fit on F2  1.023 Final R indices [I>2sigma(I)]  R1 = 0.0598, wR2 = 0.1653 R indices (all data)  R1 = 0.0635, wR2 = 0.1689 Extinction coefficient  0.0035(9) Largest diff. peak and hole  0.368 and ‐0.546 e.Å‐3                
164              Crystal data and structure refinement for (±)‐149. Identification code   don1c Empirical formula   C22 H23 N O10 Formula weight   461.41 Temperature   100(2) K Wavelength   1.54178 Å Crystal system   Monoclinic Space group   P 21/n Unit cell dimensions  a = 8.8800(3) Å  a= 90°.   b = 10.6102(3) Å  b= 91.799(2)°.   c = 23.7595(8) Å  g = 90°. Volume  2237.48(12) Å3 Z  4 Density (calculated)  1.370 Mg/m3 Absorption coefficient  0.931 mm‐1 F(000)  968 Crystal size  0.45 x 0.13 x 0.12 mm3 Theta range for data collection  3.72 to 67.79°. Index ranges  ‐10<=h<=10, 0<=k<=12, 0<=l<=28 
165    Reflections collected  18364 Independent reflections  3972 [R(int) = 0.0193] Completeness to theta = 67.79°  98.6 %  Absorption correction  Semi‐empirical from equivalents Max. and min. transmission  0.8965 and 0.6795 Refinement method  Full‐matrix least‐squares on F2 Data / restraints / parameters  3972 / 0 / 303 Goodness‐of‐fit on F2  1.012 Final R indices [I>2sigma(I)]  R1 = 0.0325, wR2 = 0.0821 R indices (all data)  R1 = 0.0348, wR2 = 0.0839 Extinction coefficient  0.00039(8) Largest diff. peak and hole  0.271 and ‐0.198 e.Å‐3                  
166                 Crystal data and structure refinement for (±)‐140. Identification code   don1d Empirical formula   C22 H23 N O10 Formula weight   461.41 Temperature   100(2) K Wavelength   1.54178 Å Crystal system   Monoclinic Space group   P 21/c Unit cell dimensions  a = 7.3527(2) Å  a= 90°.   b = 21.4079(7) Å  b= 93.921(2)°.   c = 14.1359(5) Å  g = 90°. Volume  2219.87(12) Å3 Z  4 Density (calculated)  1.381 Mg/m3 Absorption coefficient  0.938 mm‐1 F(000)  968 
167    Crystal size  0.20 x 0.18 x 0.18 mm3 Theta range for data collection  3.75 to 67.16°. Index ranges  ‐8<=h<=8, 0<=k<=25, 0<=l<=16 Reflections collected  17338 Independent reflections  3890 [R(int) = 0.0265] Completeness to theta = 67.16°  98.8 %  Absorption correction  Semi‐empirical from equivalents Max. and min. transmission  0.8493 and 0.8346 Refinement method  Full‐matrix least‐squares on F2 Data / restraints / parameters  3890 / 0 / 302 Goodness‐of‐fit on F2  0.997 Final R indices [I>2sigma(I)]  R1 = 0.0391, wR2 = 0.0966 R indices (all data)  R1 = 0.0479, wR2 = 0.1019 Largest diff. peak and hole  0.244 and ‐0.191 e.Å‐3                
168              Crystal data and structure refinement for (±)‐139. Identification code   don1e Empirical formula   C22 H23 N O10 Formula weight   461.41 Temperature   100(2) K Wavelength   1.54178 Å Crystal system   Monoclinic Space group   C 2/c Unit cell dimensions  a = 27.7646(12) Å  a= 90°.   b = 11.6104(5) Å  b= 123.535(2)°.   c = 16.3768(7) Å  g = 90°. Volume  4400.5(3) Å3 Z  8 Density (calculated)  1.393 Mg/m3 Absorption coefficient  0.946 mm‐1 F(000)  1936 Crystal size  0.44 x 0.12 x 0.05 mm3 Theta range for data collection  3.82 to 67.98°. Index ranges  ‐33<=h<=26, 0<=k<=13, 0<=l<=19 
169    Reflections collected  17563 Independent reflections  3843 [R(int) = 0.0431] Completeness to theta = 67.98°  98.1 %  Absorption correction  Semi‐empirical from equivalents Max. and min. transmission  0.9542 and 0.6809 Refinement method  Full‐matrix least‐squares on F2 Data / restraints / parameters  3843 / 0 / 302 Goodness‐of‐fit on F2  0.995 Final R indices [I>2sigma(I)]  R1 = 0.0373, wR2 = 0.0972 R indices (all data)  R1 = 0.0464, wR2 = 0.1035 Largest diff. peak and hole  0.236 and ‐0.200 e.Å‐3 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Crystal data and structure refinement for (±)‐181.  Identification code   don1g  Empirical formula   C23H19NO2  Formula weight   341.39  Temperature / K   100.0  Crystal system   Triclinic  Space group   P‐1  a / Å, b / Å, c / Å   8.8410(3), 9.9197(4), 21.4535(7)  α/°, β/°, γ/°   79.572(3), 89.780(3), 70.498(4)  Volume / Å3   1740.99(12)  Z   4  ρcalc / mg mm‐3   1.302  μ / mm‐1   0.657  F(000)   720  
171    Crystal size / mm3   0.15 × 0.08 × 0.05  Theta range for data collection   4.20 to 71.15°  Index ranges   ‐10 ≤ h ≤ 10, ‐11 ≤ k ≤ 12, ‐26 ≤ l ≤ 26  Reflections collected   23107  Independent reflections   6592[R(int) = 0.0283]  Data/restraints/parameters   6592/0/462  Goodness‐of‐fit on F2   1.066  Final R indexes [I>2σ (I)]   R1 = 0.0428, wR2 = 0.1268  Final R indexes [all data]   R1 = 0.0505, wR2 = 0.1334  Largest diff. peak/hole / e Å‐3   0.273/‐0.239 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Crystal data and structure refinement for (+)193. Identification code   don1o  Empirical formula   C49H38N8O18  Formula weight   1026.87  Temperature / K   100.6  Crystal system   monoclinic  Space group   P21  a / Å, b / Å, c / Å   12.2658(2), 12.6155(3), 30.2568(8)  α/°, β/°, γ/°   90.00, 100.078(2), 90.00  Volume / Å3   4609.66(19)  
173    Z   4  ρcalc / mg mm‐3   1.480  μ / mm‐1   0.979  F(000)   2128  Crystal size / mm3   0.33 × 0.08 × 0.03  2Θ range for data collection   7.4 to 147.64°  Index ranges   ‐11 ≤ h ≤ 14, ‐14 ≤ k ≤ 15, ‐37 ≤ l ≤ 37  Reflections collected   25828  Independent reflections   14394[R(int) = 0.0389]  Data/restraints/parameters   14394/1/1355  Goodness‐of‐fit on F2   1.072  Final R indexes [I>2σ (I)]   R1 = 0.0682, wR2 = 0.1886  Final R indexes [all data]   R1 = 0.0758, wR2 = 0.1973  Largest diff. peak/hole / e Å‐3   0.570/‐0.591      
